1	The	DT	O	the	det	4	SENT_1	[p1l672t81r717b102],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l736t83r821b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l840t83r1029b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l1048t83r1228b109],
5	of	IN	O	of	_	0	SENT_1	[p1l1247t81r1276b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_1	[p1l1288t83r1487b102],

1	To	TO	O	to	dep	6	SENT_2	[p1l10t326r122b381],
2	TH	NN	O	th	nn	4	SENT_2	[p1l150t327r258b380],
3	E	NN	O	e	nn	4	SENT_2	[p1l278t327r314b380],
4	EDITOR	NN	O	editor	pobj	1	SENT_2	[p1l351t326r687b382],
5	:	:	O	:	_	0	SENT_2	[p1l351t326r687b382],
6	Brock	NNP	PERSON	Brock	_	0	SENT_2	[p1l720t303r972b383],
7	et	FW	O	et	nn	8	SENT_2	[p1l999t320r1077b382],
8	al.	FW	O	al.	dep	6	SENT_2	[p1l1102t303r1199b382],
9	found	VBN	O	find	partmod	6	SENT_2	[p1l1235t303r1488b382],
10	that	IN	O	that	complm	19	SENT_2	[p1l1518t303r1690b382],
11	the	DT	O	the	det	12	SENT_2	[p1l1717t303r1849b382],
12	methylation	NN	O	methylation	nsubj	19	SENT_2	[p1l1880t303r2133b382, p1l7t431r302b532],
13	of	IN	O	of	_	0	SENT_2	[p1l338t431r438b510],
14	a	DT	O	a	det	16	SENT_2	[p1l456t458r500b510],
15	particular	JJ	O	particular	amod	16	SENT_2	[p1l533t431r963b532],
16	combination	NN	O	combination	prep_of	12	SENT_2	[p1l997t431r1543b510],
17	of	IN	O	of	_	0	SENT_2	[p1l1580t431r1680b510],
18	genes	NNS	O	gene	prep_of	16	SENT_2	[p1l1698t457r1939b532],
19	had	VBD	O	have	ccomp	9	SENT_2	[p1l1978t431r2134b510],
20	an	DT	O	a	det	23	SENT_2	[p1l11t585r114b638],
21	astounding	JJ	O	astounding	amod	23	SENT_2	[p1l152t559r643b660],
22	odds	NNS	O	odds	nn	23	SENT_2	[p1l679t559r880b638],
23	ratio	NN	O	ratio	dobj	19	SENT_2	[p1l921t560r1119b638],
24	of	IN	O	of	_	0	SENT_2	[p1l1159t559r1259b638],
25	25.25	CD	NUMBER	25.25	prep_of	23	SENT_2	[p1l1279t565r1508b638],
26	for	IN	O	for	_	0	SENT_2	[p1l1551t559r1674b638],
27	the	DT	O	the	det	28	SENT_2	[p1l1710t559r1843b638],
28	recurrence	NN	O	recurrence	prep_for	19	SENT_2	[p1l1881t585r2133b638, p1l12t713r239b766],
29	of	IN	O	of	_	0	SENT_2	[p1l279t687r379b766],
30	early	JJ	O	early	amod	34	SENT_2	[p1l400t687r860b788],
31	—	JJ	O	—	amod	34	SENT_2	[p1l400t687r860b788],
32	stage	NN	O	stage	nn	34	SENT_2	[p1l400t687r860b788],
33	lung	NN	O	lung	nn	34	SENT_2	[p1l898t687r1092b788],
34	cancer	NN	O	cancer	prep_of	28	SENT_2	[p1l1128t713r1427b766],
35	.	.	O	.	_	0	SENT_2	[p1l1128t713r1427b766],

1	They	PRP	O	they	nsubj	2	SENT_3	[p1l1468t687r1679b788],
2	examined	VBD	O	examine	_	0	SENT_3	[p1l1714t687r2134b766],
3	the	DT	O	the	det	4	SENT_3	[p1l12t815r145b894],
4	effect	NN	O	effect	dobj	2	SENT_3	[p1l185t815r427b894],
5	of	IN	O	of	_	0	SENT_3	[p1l462t815r562b894],
6	each	DT	O	each	prep_of	4	SENT_3	[p1l583t815r775b894],
7	of	IN	O	of	_	0	SENT_3	[p1l815t815r915b894],
8	these	DT	O	these	det	9	SENT_3	[p1l936t815r1159b894],
9	genes	NNS	O	gene	prep_of	6	SENT_3	[p1l1199t841r1440b916],
10	in	IN	O	in	_	0	SENT_3	[p1l1481t816r1564b893],
11	three	CD	NUMBER	three	num	13	SENT_3	[p1l1604t815r1824b894],
12	different	JJ	O	different	amod	13	SENT_3	[p1l1864t815r2133b894, p1l12t960r146b1022],
13	types	NNS	O	type	prep_in	2	SENT_3	[p1l171t960r394b1044],
14	of	IN	O	of	_	0	SENT_3	[p1l426t943r526b1022],
15	tissues	NNS	O	tissue	prep_of	13	SENT_3	[p1l537t944r850b1039],
16	,	,	O	,	_	0	SENT_3	[p1l537t944r850b1039],
17	performing	VBG	O	perform	partmod	2	SENT_3	[p1l883t943r1385b1044],
18	at	IN	O	at	quantmod	20	SENT_3	[p1l1409t960r1488b1022],
19	least	JJS	O	least	mwe	18	SENT_3	[p1l1511t943r1710b1022],
20	30	CD	NUMBER	30	num	23	SENT_3	[p1l1735t949r1834b1022],
21	different	JJ	O	different	amod	23	SENT_3	[p1l1864t943r2133b1022, p1l12t1088r146b1150],
22	statistical	JJ	O	statistical	amod	23	SENT_3	[p1l178t1071r594b1150],
23	tests	NNS	O	test	dobj	17	SENT_3	[p1l630t1088r823b1150],
24	without	IN	O	without	_	0	SENT_3	[p1l857t1071r1195b1151],
25	a	DT	O	a	det	26	SENT_3	[p1l1226t1098r1270b1149],
26	correction	NN	O	correction	prep_without	17	SENT_3	[p1l1304t1072r1744b1150],
27	for	IN	O	for	_	0	SENT_3	[p1l1779t1071r1903b1150],
28	multiple	JJ	O	multiple	amod	31	SENT_3	[p1l1935t1071r2133b1150, p1l12t1199r699b1300],
29	—	NN	O	—	nn	31	SENT_3	[p1l1935t1071r2133b1150, p1l12t1199r699b1300],
30	hypothesis	NN	O	hypothesis	nn	31	SENT_3	[p1l1935t1071r2133b1150, p1l12t1199r699b1300],
31	testing	NN	O	testing	prep_for	26	SENT_3	[p1l727t1200r1044b1300],
32	.	.	O	.	_	0	SENT_3	[p1l727t1200r1044b1300],

1	A	DT	O	a	det	3	SENT_4	[p1l1072t1207r1138b1277],
2	Bonferroni1	NN	O	bonferroni1	nn	3	SENT_4	[p1l1159t1199r1668b1278],
3	correction	NN	O	correction	nsubj	4	SENT_4	[p1l1694t1200r2134b1278],
4	applied	VBD	O	apply	_	0	SENT_4	[p1l11t1327r324b1428],
5	to	TO	O	to	_	0	SENT_4	[p1l361t1344r443b1406],
6	the	DT	O	the	det	7	SENT_4	[p1l482t1327r615b1406],
7	data	NNS	O	datum	prep_to	4	SENT_4	[p1l653t1327r835b1406],
8	in	IN	O	in	mark	14	SENT_4	[p1l871t1328r954b1405],
9	Table	NNP	O	Table	nsubj	14	SENT_4	[p1l987t1327r1217b1406],
10	3	CD	NUMBER	3	num	9	SENT_4	[p1l1255t1333r1300b1406],
11	of	IN	O	of	_	0	SENT_4	[p1l1341t1327r1440b1406],
12	the	DT	O	the	det	13	SENT_4	[p1l1459t1327r1592b1406],
13	article	NN	O	article	prep_of	9	SENT_4	[p1l1629t1327r1897b1406],
14	indicates	VBZ	O	indicate	advcl	4	SENT_4	[p1l1934t1327r2133b1406, p1l12t1472r219b1534],
15	that	IN	O	that	complm	28	SENT_4	[p1l248t1455r418b1534],
16	only	RB	O	only	quantmod	17	SENT_4	[p1l441t1455r621b1556],
17	2	CD	NUMBER	2	nsubj	28	SENT_4	[p1l644t1461r691b1533],
18	of	IN	O	of	_	0	SENT_4	[p1l720t1455r820b1534],
19	the	DT	O	the	det	21	SENT_4	[p1l829t1455r959b1534],
20	11	CD	NUMBER	11	num	21	SENT_4	[p1l990t1461r1085b1533],
21	results	NNS	O	result	prep_of	17	SENT_4	[p1l1113t1455r1390b1534],
22	originally	RB	O	originally	advmod	23	SENT_4	[p1l1420t1455r1827b1556],
23	shown	VBN	O	show	partmod	21	SENT_4	[p1l1852t1455r2134b1535],
24	to	TO	O	to	aux	26	SENT_4	[p1l12t1600r94b1662],
25	be	VB	O	be	cop	26	SENT_4	[p1l131t1583r227b1662],
26	significant	JJ	O	significant	xcomp	23	SENT_4	[p1l263t1583r732b1684],
27	remain	VBP	O	remain	cop	28	SENT_4	[p1l761t1584r1067b1662],
28	significant	JJ	O	significant	ccomp	14	SENT_4	[p1l1103t1583r1592b1684],
29	.	.	O	.	_	0	SENT_4	[p1l1103t1583r1592b1684],

1	Nadeem	NNP	PERSON	Nadeem	nn	2	SENT_5	[p1l20t1719r382b1798],
2	Riaz	NNP	PERSON	Riaz	_	0	SENT_5	[p1l428t1726r625b1813],
3	,	,	O	,	_	0	SENT_5	[p1l428t1726r625b1813],
4	M	NN	O	m	appos	2	SENT_5	[p1l670t1725r741b1797],
5	.	.	O	.	_	0	SENT_5	[p1l760t1724r904b1798],

1	Sc	NN	O	sc	_	0	SENT_6	[p1l760t1724r904b1798],
2	.	.	O	.	_	0	SENT_6	[p1l760t1724r904b1798],

1	Stanford	NNP	ORGANIZATION	Stanford	nn	3	SENT_7	[p1l12t1861r295b1922],
2	University	NNP	ORGANIZATION	University	nn	3	SENT_7	[p1l327t1867r664b1941],
3	Stanford	NNP	ORGANIZATION	Stanford	_	0	SENT_7	[p1l12t1974r317b2045],
4	,	,	O	,	_	0	SENT_7	[p1l12t1974r317b2045],
5	CA	NNP	O	CA	nn	7	SENT_7	[p1l345t1979r441b2035],
6	94305	CD	NUMBER	94305	num	7	SENT_7	[p1l464t1978r660b2035],
7	nadeem.riaz@gmai	NNS	O	nadeem.riaz@gmai	appos	3	SENT_7	[p1l15t2054r865b2134],
8	|	CD	NUMBER	|	dep	7	SENT_7	[p1l15t2054r865b2134],
9	.	.	O	.	_	0	SENT_7	[p1l15t2054r865b2134],

1	com	NN	O	com	_	0	SENT_8	[p1l15t2054r865b2134],
2	1	CD	NUMBER	1	dep	1	SENT_8	[p1l13t2163r62b2214],
3	.	.	O	.	_	0	SENT_8	[p1l13t2163r62b2214],

1	Manly	NNP	O	Manly	nn	2	SENT_9	[p1l137t2156r345b2231],
2	KF	NNP	O	KF	_	0	SENT_9	[p1l368t2161r473b2227],
3	,	,	O	,	_	0	SENT_9	[p1l368t2161r473b2227],
4	Nettletone	NNP	O	Nettletone	nn	5	SENT_9	[p1l503t2156r852b2215],
5	D	NNP	O	D	appos	2	SENT_9	[p1l879t2161r946b2227],
6	,	,	O	,	_	0	SENT_9	[p1l879t2161r946b2227],
7	Hwang	NNP	PERSON	Hwang	nn	8	SENT_9	[p1l978t2161r1213b2231],
8	IT	NNP	O	IT	appos	5	SENT_9	[p1l1231t2160r1320b2224],
9	.	.	O	.	_	0	SENT_9	[p1l1231t2160r1320b2224],

1	Genomics	NNS	O	genomic	_	0	SENT_10	[p1l1352t2156r1702b2227],
2	,	,	O	,	_	0	SENT_10	[p1l1352t2156r1702b2227],
3	prior	RB	O	prior	advmod	4	SENT_10	[p1l1733t2156r1897b2231],
4	probability	NN	O	probability	conj_and	1	SENT_10	[p1l1921t2156r2134b2231, p1l12t2241r193b2316],
5	,	,	O	,	_	0	SENT_10	[p1l1921t2156r2134b2231, p1l12t2241r193b2316],
6	and	CC	O	and	_	0	SENT_10	[p1l225t2241r345b2299],
7	statistical	JJ	O	statistical	amod	8	SENT_10	[p1l374t2241r695b2299],
8	tests	NNS	O	test	conj_and	1	SENT_10	[p1l723t2253r871b2299],
9	of	IN	O	of	_	0	SENT_10	[p1l902t2240r978b2299],
10	multiple	JJ	O	multiple	amod	11	SENT_10	[p1l992t2241r1266b2316],
11	hypotheses	NNS	O	hypothesis	prep_of	8	SENT_10	[p1l1294t2241r1683b2316],
12	.	.	O	.	_	0	SENT_10	[p1l1294t2241r1683b2316],

1	Genome	NNP	O	Genome	nn	2	SENT_11	[p1l1716t2245r1991b2299],
2	Res	NNP	O	Res	_	0	SENT_11	[p1l2018t2246r2133b2303],
3	2004	CD	DATE	2004	num	2	SENT_11	[p1l11t2338r600b2405],
4	;	:	O	;	_	0	SENT_11	[p1l11t2338r600b2405],
5	14:997	CD	NUMBER	14:997	number	6	SENT_11	[p1l11t2338r600b2405],
6	—	CD	NUMBER	—	dep	2	SENT_11	[p1l11t2338r600b2405],
7	1001	CD	DATE	1001	dep	6	SENT_11	[p1l11t2338r600b2405],
8	.	.	O	.	_	0	SENT_11	[p1l11t2338r600b2405],

1	To	TO	O	to	dep	8	SENT_12	[p1l10t2622r122b2678],
2	THE	DT	O	the	det	3	SENT_12	[p1l166t2623r330b2677],
3	EDITOR	NN	O	editor	pobj	1	SENT_12	[p1l382t2622r719b2678],
4	:	:	O	:	_	0	SENT_12	[p1l382t2622r719b2678],
5	Brock	NNP	PERSON	Brock	nsubj	8	SENT_12	[p1l770t2599r1022b2679],
6	et	FW	O	et	nn	7	SENT_12	[p1l1068t2616r1146b2678],
7	al.	FW	O	al.	dep	5	SENT_12	[p1l1190t2599r1287b2678],
8	suggest	VBP	O	suggest	_	0	SENT_12	[p1l1343t2616r1671b2700],
9	that	IN	O	that	complm	13	SENT_12	[p1l1716t2599r1888b2678],
10	their	PRP$	O	they	poss	11	SENT_12	[p1l1933t2599r2137b2678],
11	assay	NN	O	assay	nsubj	20	SENT_12	[p1l11t2754r230b2828],
12	can	MD	O	can	aux	13	SENT_12	[p1l253t2753r398b2806],
13	identify	VB	O	identify	ccomp	8	SENT_12	[p1l423t2727r741b2828],
14	micrometastases	NNS	O	micrometastase	dobj	13	SENT_12	[p1l764t2728r1459b2806],
15	in	IN	O	in	_	0	SENT_12	[p1l1487t2728r1568b2805],
16	lymph	NN	O	lymph	nn	17	SENT_12	[p1l1594t2727r1854b2828],
17	nodes	NNS	O	node	prep_in	13	SENT_12	[p1l1881t2727r2132b2806],
18	and	CC	O	and	_	0	SENT_12	[p1l11t2855r169b2934],
19	hence	RB	O	hence	advmod	20	SENT_12	[p1l208t2855r455b2934],
20	improve	VB	O	improve	ccomp	8	SENT_12	[p1l493t2856r841b2956],
21	the	DT	O	the	det	22	SENT_12	[p1l880t2855r1013b2934],
22	staging	NN	O	staging	dobj	20	SENT_12	[p1l1054t2856r1374b2956],
23	of	IN	O	of	_	0	SENT_12	[p1l1411t2855r1511b2934],
24	NSCLC	NN	ORGANIZATION	nsclc	prep_of	22	SENT_12	[p1l1529t2861r1858b2934],
25	.	.	O	.	_	0	SENT_12	[p1l1529t2861r1858b2934],

1	However	RB	O	however	advmod	4	SENT_13	[p1l1901t2863r2133b2934, p1l12t3009r202b3079],
2	,	,	O	,	_	0	SENT_13	[p1l1901t2863r2133b2934, p1l12t3009r202b3079],
3	they	PRP	O	they	nsubj	4	SENT_13	[p1l253t2983r435b3084],
4	report	VBP	O	report	_	0	SENT_13	[p1l476t3000r743b3084],
5	no	DT	O	no	det	6	SENT_13	[p1l783t3009r888b3062],
6	data	NNS	O	datum	dobj	4	SENT_13	[p1l935t2983r1118b3062],
7	on	IN	O	on	_	0	SENT_13	[p1l1162t3009r1268b3062],
8	the	DT	O	the	det	9	SENT_13	[p1l1313t2983r1445b3062],
9	outcome	NN	O	outcome	prep_on	4	SENT_13	[p1l1492t3000r1859b3062],
10	when	WRB	O	when	advmod	15	SENT_13	[p1l1900t2983r2134b3062],
11	DNA	NN	MISC	dna	nn	13	SENT_13	[p1l11t3118r219b3190],
12	methylation	NN	O	methylation	nn	13	SENT_13	[p1l262t3111r778b3212],
13	markers	NNS	O	marker	nsubjpass	15	SENT_13	[p1l824t3111r1175b3191],
14	were	VBD	O	be	auxpass	15	SENT_13	[p1l1219t3137r1421b3190],
15	detected	VBN	O	detect	advcl	4	SENT_13	[p1l1467t3111r1826b3190],
16	in	IN	O	in	_	0	SENT_13	[p1l1871t3112r1954b3189],
17	the	DT	O	the	det	19	SENT_13	[p1l2001t3111r2133b3190],
18	primary	JJ	O	primary	amod	19	SENT_13	[p1l11t3240r361b3340],
19	tumor	NN	O	tumor	prep_in	15	SENT_13	[p1l391t3256r659b3318],
20	but	CC	O	but	_	0	SENT_13	[p1l692t3239r831b3318],
21	not	RB	O	not	_	0	SENT_13	[p1l861t3256r1004b3318],
22	in	IN	O	in	_	0	SENT_13	[p1l1032t3240r1116b3317],
23	the	DT	O	the	det	25	SENT_13	[p1l1151t3239r1284b3318],
24	lymph	NN	O	lymph	nn	25	SENT_13	[p1l1317t3239r1587b3340],
25	nodes	NNS	O	node	prep_in	15	SENT_13	[p1l1622t3239r1897b3318],
26	.	.	O	.	_	0	SENT_13	[p1l1622t3239r1897b3318],

1	Ha	FW	O	ha	nn	4	SENT_14	[p1l20t3373r274b3453],
2	|	FW	O	|	nn	4	SENT_14	[p1l20t3373r274b3453],
3	u	FW	O	u	nn	4	SENT_14	[p1l20t3373r274b3453],
4	|	FW	O	|	_	0	SENT_14	[p1l20t3373r274b3453],
5	<	JJR	O	<	dep	4	SENT_14	[p1l20t3373r274b3453],
6	Tezcan	NNP	PERSON	Tezcan	dep	5	SENT_14	[p1l301t3380r634b3467],
7	,	,	O	,	_	0	SENT_14	[p1l301t3380r634b3467],
8	M.D.	NNP	ORGANIZATION	M.D.	nn	13	SENT_14	[p1l679t3380r885b3452],
9	Kootenai	NNP	ORGANIZATION	Kootenai	nn	13	SENT_14	[p1l17t3521r305b3575],
10	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_14	[p1l333t3520r566b3575],
11	Center	NNP	ORGANIZATION	Center	nn	13	SENT_14	[p1l588t3520r810b3575],
12	Coeur	NNP	ORGANIZATION	Coeur	nn	13	SENT_14	[p1l12t3613r212b3669],
13	d’Alene	NNP	O	d’Alene	appos	6	SENT_14	[p1l235t3608r502b3679],
14	,	,	O	,	_	0	SENT_14	[p1l235t3608r502b3679],
15	ID	NNP	O	ID	nn	17	SENT_14	[p1l535t3614r604b3668],
16	83814	CD	NUMBER	83814	num	17	SENT_14	[p1l630t3612r822b3669],
17	htezcan@niccresearch.org	NN	O	htezcan@niccresearch.org	dep	4	SENT_14	[p1l15t3688r917b3768],

1	THE	DT	O	the	det	3	SENT_15	[p2l10t192r174b246],
2	AUTHORS	NNS	O	author	nn	3	SENT_15	[p2l217t191r625b247],
3	REPLY	NN	O	reply	_	0	SENT_15	[p2l674t192r940b247],
4	:	:	O	:	_	0	SENT_15	[p2l674t192r940b247],
5	We	PRP	O	we	nsubj	6	SENT_15	[p2l986t176r1118b247],
6	acknowledge	VBP	O	acknowledge	dep	3	SENT_15	[p2l1164t168r1723b269],
7	the	DT	O	the	det	8	SENT_15	[p2l1770t168r1903b247],
8	conﬁrmation	NN	O	conﬁrmation	dobj	6	SENT_15	[p2l1950t194r2133b247, p2l12t296r429b375],
9	by	IN	O	by	_	0	SENT_15	[p2l467t296r564b397],
10	Toyooka	NNP	PERSON	Toyooka	prep_by	6	SENT_15	[p2l594t296r956b397],
11	et	FW	O	et	nn	12	SENT_15	[p2l993t313r1070b375],
12	al.	FW	O	al.	nsubj	28	SENT_15	[p2l1103t296r1200b375],
13	of	IN	O	of	_	0	SENT_15	[p2l1244t296r1344b375],
14	our	PRP$	O	we	poss	15	SENT_15	[p2l1364t322r1510b375],
15	findings	NNS	O	finding	prep_of	12	SENT_15	[p2l1544t296r1909b397],
16	concerning	VBG	O	concern	_	0	SENT_15	[p2l1949t322r2133b375, p2l12t425r349b525],
17	methylation	NN	O	methylation	prep_concerning	15	SENT_15	[p2l393t424r919b525],
18	of	IN	O	of	_	0	SENT_15	[p2l967t424r1068b503],
19	p16	NN	O	p16	prep_of	17	SENT_15	[p2l1092t431r1236b525],
20	and	CC	O	and	_	0	SENT_15	[p2l1278t424r1438b503],
21	CDH13	NN	O	cdh13	prep_of	17	SENT_15	[p2l1484t431r1763b503],
22	in	IN	O	in	_	0	SENT_15	[p2l1810t425r1894b502],
23	lung	NN	O	lung	nn	24	SENT_15	[p2l1940t424r2138b525],
24	adenocarcinomas	NNS	O	adenocarcinoma	prep_in	19	SENT_15	[p2l11t552r753b631],
25	in	IN	O	in	_	0	SENT_15	[p2l788t553r870b630],
26	Japanese	JJ	MISC	japanese	amod	27	SENT_15	[p2l895t560r1267b653],
27	patients	NNS	O	patient	prep_in	24	SENT_15	[p2l1301t553r1698b653],
28	}	VBD	O	}	rcmod	10	SENT_15	[p2l1301t553r1698b653],
29	Park	NN	O	park	nsubj	30	SENT_15	[p2l1731t552r1924b632],
30	suggests	VBZ	O	suggest	ccomp	28	SENT_15	[p2l1956t579r2133b653, p2l12t697r223b781],
31	that	IN	O	that	complm	36	SENT_15	[p2l258t680r427b759],
32	we	PRP	O	we	nsubj	36	SENT_15	[p2l450t707r566b760],
33	may	MD	O	may	aux	36	SENT_15	[p2l599t706r776b781],
34	have	VB	O	have	aux	36	SENT_15	[p2l804t680r990b759],
35	inappropriately	RB	O	inappropriately	advmod	36	SENT_15	[p2l1022t680r1668b781],
36	staged	VBD	O	stage	ccomp	30	SENT_15	[p2l1698t680r1969b781],
37	the	DT	O	the	det	38	SENT_15	[p2l2001t680r2134b759],
38	disease	NN	O	disease	dobj	36	SENT_15	[p2l12t808r330b887],
39	in	IN	O	in	_	0	SENT_15	[p2l371t809r455b886],
40	our	PRP$	O	we	poss	41	SENT_15	[p2l497t834r645b887],
41	patients	NNS	O	patient	prep_in	36	SENT_15	[p2l682t809r1057b909],
42	,	,	O	,	_	0	SENT_15	[p2l682t809r1057b909],
43	since	IN	O	since	mark	60	SENT_15	[p2l1106t809r1324b887],
44	the	DT	O	the	det	46	SENT_15	[p2l1367t808r1502b887],
45	survival	NN	O	survival	nn	46	SENT_15	[p2l1545t808r1884b887],
46	rates	NNS	O	rate	nsubj	60	SENT_15	[p2l1925t825r2132b887],
47	among	IN	O	among	_	0	SENT_15	[p2l11t962r312b1037],
48	patients	NNS	O	patient	prep_among	46	SENT_15	[p2l335t937r677b1037],
49	with	IN	O	with	_	0	SENT_15	[p2l702t936r898b1015],
50	T1	NN	O	t1	nn	51	SENT_15	[p2l923t942r1035b1014],
51	lesions	NNS	O	lesion	prep_with	48	SENT_15	[p2l1062t936r1356b1015],
52	and	CC	O	and	_	0	SENT_15	[p2l1387t936r1544b1015],
53	patients	NNS	O	patient	prep_with	48	SENT_15	[p2l1571t937r1912b1037],
54	with	IN	O	with	_	0	SENT_15	[p2l1939t936r2134b1016],
55	T2	NN	O	t2	nn	56	SENT_15	[p2l8t1070r119b1142],
56	lesions	NNS	O	lesion	prep_with	48	SENT_15	[p2l149t1064r443b1143],
57	were	VBD	O	be	cop	60	SENT_15	[p2l470t1090r672b1143],
58	not	RB	O	not	neg	60	SENT_15	[p2l702t1081r844b1143],
59	significantly	RB	O	significantly	advmod	60	SENT_15	[p2l871t1064r1414b1165],
60	different	JJ	O	different	advcl	6	SENT_15	[p2l1440t1064r1838b1143],
61	.	.	O	.	_	0	SENT_15	[p2l1440t1064r1838b1143],

1	In	IN	O	in	_	0	SENT_16	[p2l1872t1072r1960b1142],
2	our	PRP$	O	we	poss	3	SENT_16	[p2l1991t1090r2137b1143],
3	study	NN	O	study	prep_in	38	SENT_16	[p2l13t1192r256b1293],
4	,	,	O	,	_	0	SENT_16	[p2l13t1192r256b1293],
5	the	DT	O	the	det	8	SENT_16	[p2l311t1192r444b1271],
6	adjusted	JJ	O	adjusted	amod	8	SENT_16	[p2l493t1192r848b1293],
7	hazard	NN	O	hazard	nn	8	SENT_16	[p2l898t1192r1195b1271],
8	ratio	NN	O	ratio	nsubj	38	SENT_16	[p2l1244t1193r1441b1271],
9	for	IN	O	for	_	0	SENT_16	[p2l1491t1192r1614b1271],
10	the	DT	O	the	det	11	SENT_16	[p2l1661t1192r1794b1271],
11	risk	NN	O	risk	prep_for	8	SENT_16	[p2l1844t1192r2008b1272],
12	of	IN	O	of	_	0	SENT_16	[p2l2053t1192r2152b1271],
13	recurrence	NN	O	recurrence	prep_of	11	SENT_16	[p2l12t1346r468b1399],
14	of	IN	O	of	_	0	SENT_16	[p2l514t1320r614b1399],
15	a	DT	O	a	det	20	SENT_16	[p2l640t1347r685b1399],
16	stage	NN	O	stage	nn	20	SENT_16	[p2l730t1337r950b1421],
17	T2	NN	O	t2	nn	20	SENT_16	[p2l993t1326r1104b1398],
18	lung	NN	O	lung	nn	20	SENT_16	[p2l1149t1320r1343b1421],
19	cancer	NN	O	cancer	nn	20	SENT_16	[p2l1386t1346r1667b1399],
20	tumor	NN	O	tumor	prep_of	13	SENT_16	[p2l1710t1337r1996b1416],
21	,	,	O	,	_	0	SENT_16	[p2l1710t1337r1996b1416],
22	as	IN	O	as	_	0	SENT_16	[p2l2046t1347r2132b1399],
23	compared	VBN	O	compare	prepc_as	8	SENT_16	[p2l21t1447r446b1547],
24	with	IN	O	with	pcomp	23	SENT_16	[p2l482t1447r677b1526],
25	the	DT	O	the	det	26	SENT_16	[p2l718t1447r850b1525],
26	risk	NN	O	risk	pobj	24	SENT_16	[p2l891t1447r1055b1526],
27	of	IN	O	of	_	0	SENT_16	[p2l1091t1447r1191b1525],
28	recurrence	NN	O	recurrence	prep_of	26	SENT_16	[p2l1213t1473r1667b1526],
29	of	IN	O	of	_	0	SENT_16	[p2l1709t1447r1809b1525],
30	a	DT	O	a	det	34	SENT_16	[p2l1830t1474r1874b1525],
31	stage	NN	O	stage	nn	34	SENT_16	[p2l1915t1464r2134b1547],
32	T	NN	O	t	nn	34	SENT_16	[p2l17t1580r78b1651],
33	1	CD	NUMBER	1	num	34	SENT_16	[p2l84t1580r128b1651],
34	cancer	NN	O	cancer	prep_of	28	SENT_16	[p2l155t1600r446b1669],
35	,	,	O	,	_	0	SENT_16	[p2l155t1600r446b1669],
36	was	VBD	O	be	cop	38	SENT_16	[p2l473t1601r633b1653],
37	1.71	CD	PERCENT	1.71	number	38	SENT_16	[p2l665t1580r833b1652],
38	(	CD	PERCENT	(	_	0	SENT_16	[p2l864t1579r1072b1665],
39	95	CD	PERCENT	95	num	42	SENT_16	[p2l864t1579r1072b1665],
40	%	NN	PERCENT	%	nn	42	SENT_16	[p2l864t1579r1072b1665],
41	confidence	NN	O	confidence	nn	42	SENT_16	[p2l1098t1574r1558b1652],
42	interval	NN	O	interval	dep	38	SENT_16	[p2l1584t1574r1923b1669],
43	,	,	O	,	_	0	SENT_16	[p2l1584t1574r1923b1669],
44	0.86	CD	NUMBER	0.86	appos	38	SENT_16	[p2l1955t1580r2134b1652],
45	to	TO	O	to	_	0	SENT_16	[p2l21t1717r102b1779],
46	3.41	CD	NUMBER	3.41	prep_to	44	SENT_16	[p2l141t1707r336b1796],
47	;	:	O	;	_	0	SENT_16	[p2l141t1707r336b1796],
48	P	NN	O	p	dep	38	SENT_16	[p2l376t1707r742b1796],
49	=	JJ	O	=	amod	51	SENT_16	[p2l376t1707r742b1796],
50	0.13	CD	NUMBER	0.13	tmod	49	SENT_16	[p2l376t1707r742b1796],
51	)	NN	O	)	dep	48	SENT_16	[p2l376t1707r742b1796],
52	,	,	O	,	_	0	SENT_16	[p2l376t1707r742b1796],
53	which	WDT	O	which	nsubj	55	SENT_16	[p2l779t1701r1041b1780],
54	is	VBZ	O	be	cop	55	SENT_16	[p2l1077t1702r1142b1779],
55	similar	JJ	O	similar	rcmod	38	SENT_16	[p2l1183t1701r1487b1779],
56	to	TO	O	to	_	0	SENT_16	[p2l1522t1718r1602b1779],
57	that	DT	O	that	det	58	SENT_16	[p2l1641t1701r1813b1779],
58	reported	VBN	O	report	prep_to	55	SENT_16	[p2l1844t1718r2134b1801, p2l21t1829r118b1908],
59	in	IN	O	in	_	0	SENT_16	[p2l151t1830r235b1907],
60	recent	JJ	O	recent	amod	61	SENT_16	[p2l269t1846r533b1908],
61	studies	NNS	O	study	prep_in	58	SENT_16	[p2l564t1829r985b1908],
62	.23	CD	NUMBER	.23	num	58	SENT_16	[p2l564t1829r985b1908],

1	Riaz	NNP	PERSON	Riaz	nsubj	2	SENT_17	[p2l148t1957r340b2039],
2	suggests	VBZ	O	suggest	_	0	SENT_17	[p2l380t1972r745b2056],
3	that	IN	O	that	complm	6	SENT_17	[p2l787t1956r958b2034],
4	our	PRP$	O	we	poss	5	SENT_17	[p2l992t1982r1137b2035],
5	results	NNS	O	result	nsubj	6	SENT_17	[p2l1173t1956r1454b2035],
6	require	VBP	O	require	ccomp	2	SENT_17	[p2l1495t1957r1800b2056],
7	correction	NN	O	correction	dobj	6	SENT_17	[p2l1838t1982r2134b2034, p2l21t2084r187b2161],
8	for	IN	O	for	_	0	SENT_17	[p2l218t2083r339b2161],
9	multiple	JJ	O	multiple	amod	12	SENT_17	[p2l367t2083r1202b2183],
10	—	NN	O	—	nn	12	SENT_17	[p2l367t2083r1202b2183],
11	hypothesis	NN	O	hypothesis	nn	12	SENT_17	[p2l367t2083r1202b2183],
12	testing	NN	O	testing	prep_for	7	SENT_17	[p2l1235t2084r1544b2183],
13	.	.	O	.	_	0	SENT_17	[p2l1235t2084r1544b2183],

1	However	RB	O	however	advmod	10	SENT_18	[p2l1580t2091r1965b2178],
2	,	,	O	,	_	0	SENT_18	[p2l1580t2091r1965b2178],
3	the	DT	O	the	det	4	SENT_18	[p2l2002t2083r2135b2161],
4	validity	NN	O	validity	nsubjpass	10	SENT_18	[p2l16t2210r335b2310],
5	of	IN	O	of	_	0	SENT_18	[p2l375t2210r475b2288],
6	our	PRP$	O	we	poss	7	SENT_18	[p2l501t2236r646b2289],
7	findings	NNS	O	finding	prep_of	4	SENT_18	[p2l688t2210r1051b2310],
8	would	MD	O	would	aux	10	SENT_18	[p2l1093t2210r1357b2289],
9	be	VB	O	be	auxpass	10	SENT_18	[p2l1401t2210r1498b2288],
10	diminished	VBN	O	diminish	_	0	SENT_18	[p2l1543t2210r2032b2288],
11	if	IN	O	if	mark	15	SENT_18	[p2l2076t2210r2153b2287],
12	gene	NN	O	gene	nn	13	SENT_18	[p2l21t2363r219b2437],
13	methylation	NN	O	methylation	nsubj	15	SENT_18	[p2l265t2337r779b2437],
14	were	VBD	O	be	cop	15	SENT_18	[p2l822t2363r1022b2416],
15	inconsistent	JJ	O	inconsistent	advcl	10	SENT_18	[p2l1068t2338r1594b2415],
16	in	IN	O	in	_	0	SENT_18	[p2l1634t2338r1717b2414],
17	different	JJ	O	different	amod	18	SENT_18	[p2l1765t2337r2140b2415],
18	tissues	NNS	O	tissue	prep_in	15	SENT_18	[p2l21t2465r309b2543],
19	in	IN	O	in	_	0	SENT_18	[p2l342t2465r425b2541],
20	their	PRP$	O	they	poss	22	SENT_18	[p2l458t2464r660b2542],
21	anatomical	JJ	O	anatomical	amod	22	SENT_18	[p2l689t2464r1169b2542],
22	context	NN	O	context	prep_in	15	SENT_18	[p2l1201t2480r1537b2542],
23	.	.	O	.	_	0	SENT_18	[p2l1201t2480r1537b2542],

1	Our	PRP$	O	we	poss	2	SENT_19	[p2l1575t2470r1741b2543],
2	findings	NNS	O	finding	nsubj	4	SENT_19	[p2l1770t2464r2133b2564],
3	were	VBD	O	be	cop	4	SENT_19	[p2l16t2617r211b2670],
4	consistent	JJ	O	consistent	_	0	SENT_19	[p2l241t2592r659b2669],
5	in	IN	O	in	_	0	SENT_19	[p2l681t2592r762b2668],
6	tumors	NNS	O	tumor	prep_in	4	SENT_19	[p2l791t2608r1087b2670],
7	and	CC	O	and	_	0	SENT_19	[p2l1116t2591r1269b2669],
8	lymph	NN	O	lymph	nn	9	SENT_19	[p2l1296t2591r1556b2691],
9	nodes	NNS	O	node	prep_in	4	SENT_19	[p2l1584t2591r1847b2669],
10	.	.	O	.	_	0	SENT_19	[p2l1584t2591r1847b2669],

1	Moreover	RB	O	moreover	advmod	9	SENT_20	[p2l1879t2598r2134b2669, p2l21t2744r221b2813],
2	,	,	O	,	_	0	SENT_20	[p2l1879t2598r2134b2669, p2l21t2744r221b2813],
3	corrections	NNS	O	correction	nsubjpass	9	SENT_20	[p2l276t2719r766b2796],
4	for	IN	O	for	_	0	SENT_20	[p2l817t2718r941b2796],
5	multiple	JJ	O	multiple	amod	6	SENT_20	[p2l987t2718r1350b2818],
6	testing	NN	O	testing	prep_for	3	SENT_20	[p2l1399t2719r1702b2818],
7	were	VBD	O	be	auxpass	9	SENT_20	[p2l1743t2744r1946b2797],
8	not	RB	O	not	neg	9	SENT_20	[p2l1995t2735r2140b2796],
9	required	VBN	O	require	_	0	SENT_20	[p2l21t2845r413b2945],
10	,	,	O	,	_	0	SENT_20	[p2l21t2845r413b2945],
11	since	IN	O	since	mark	13	SENT_20	[p2l463t2846r682b2923],
12	we	PRP	O	we	nsubj	13	SENT_20	[p2l721t2872r840b2924],
13	chose	VBD	O	choose	advcl	9	SENT_20	[p2l884t2845r1129b2923],
14	genes	NNS	O	gene	dobj	13	SENT_20	[p2l1172t2871r1417b2945],
15	on	IN	O	on	_	0	SENT_20	[p2l1463t2871r1570b2923],
16	the	DT	O	the	det	17	SENT_20	[p2l1613t2845r1747b2923],
17	basis	NN	O	basis	prep_on	13	SENT_20	[p2l1792t2845r2007b2923],
18	of	IN	O	of	_	0	SENT_20	[p2l2053t2845r2153b2923],
19	hypotheses	NNS	O	hypothesis	prep_of	17	SENT_20	[p2l21t2972r511b3072],
20	generated	VBN	O	generate	partmod	19	SENT_20	[p2l557t2972r985b3072],
21	from	IN	O	from	_	0	SENT_20	[p2l1030t2972r1243b3050],
22	earlier	JJR	O	earlier	amod	23	SENT_20	[p2l1289t2972r1568b3050],
23	studies	NNS	O	study	prep_from	20	SENT_20	[p2l1612t2972r1918b3051],
24	that	WDT	O	that	nsubj	25	SENT_20	[p2l1965t2972r2140b3050],
25	indicated	VBD	O	indicate	rcmod	23	SENT_20	[p2l20t3099r416b3177],
26	the	DT	O	the	det	27	SENT_20	[p2l449t3099r580b3177],
27	importance	NN	O	importance	dobj	25	SENT_20	[p2l612t3100r1107b3199],
28	of	IN	O	of	_	0	SENT_20	[p2l1139t3099r1239b3177],
29	methylation	NN	O	methylation	prep_of	27	SENT_20	[p2l1253t3099r1767b3199],
30	of	IN	O	of	_	0	SENT_20	[p2l1799t3099r1899b3177],
31	these	DT	O	these	det	32	SENT_20	[p2l1913t3099r2135b3177],
32	genes	NNS	O	gene	prep_of	29	SENT_20	[p2l21t3252r261b3326],
33	in	IN	O	in	_	0	SENT_20	[p2l303t3227r386b3303],
34	lung	NN	O	lung	nn	35	SENT_20	[p2l426t3226r619b3326],
35	cancer	NN	O	cancer	prep_in	25	SENT_20	[p2l657t3252r954b3304],
36	.	.	O	.	_	0	SENT_20	[p2l657t3252r954b3304],

1	We	PRP	O	we	nsubj	4	SENT_21	[p2l997t3234r1129b3304],
2	did	VBD	O	do	aux	4	SENT_21	[p2l1171t3226r1305b3304],
3	not	RB	O	not	neg	4	SENT_21	[p2l1345t3243r1487b3304],
4	embark	VB	O	embark	ccomp	25	SENT_21	[p2l1523t3226r1851b3305],
5	on	IN	O	on	_	0	SENT_21	[p2l1887t3252r1993b3304],
6	an	DT	O	a	det	7	SENT_21	[p2l2033t3252r2135b3304],
7	investigation	NN	O	investigation	prep_on	4	SENT_21	[p2l20t3354r574b3453],
8	with	IN	O	with	_	0	SENT_21	[p2l602t3353r796b3432],
9	the	DT	O	the	det	10	SENT_21	[p2l828t3353r961b3431],
10	use	NN	O	use	prep_with	4	SENT_21	[p2l993t3380r1133b3432],
11	of	IN	O	of	_	0	SENT_21	[p2l1166t3353r1265b3431],
12	a	DT	O	a	det	14	SENT_21	[p2l1278t3380r1322b3431],
13	large	JJ	O	large	amod	14	SENT_21	[p2l1352t3353r1565b3453],
14	set	NN	O	set	prep_of	10	SENT_21	[p2l1599t3370r1719b3431],
15	of	IN	O	of	_	0	SENT_21	[p2l1747t3353r1846b3431],
16	potentially	RB	O	potentially	advmod	17	SENT_21	[p2l1859t3370r2134b3453, p2l21t3480r237b3580],
17	error	NN	O	error	prep_of	14	SENT_21	[p2l267t3480r785b3558],
18	—	CD	NUMBER	—	num	20	SENT_21	[p2l267t3480r785b3558],
19	ridden	NN	O	ridden	nn	20	SENT_21	[p2l267t3480r785b3558],
20	possibilities	NNS	O	possibility	nsubj	21	SENT_21	[p2l818t3480r1333b3580],
21	(	VBP	O	(	rcmod	17	SENT_21	[p2l1374t3481r1547b3575],
22	i.e.	FW	O	i.e.	dobj	21	SENT_21	[p2l1374t3481r1547b3575],
23	,	,	O	,	_	0	SENT_21	[p2l1374t3481r1547b3575],
24	genes	NNS	O	gene	nsubj	25	SENT_21	[p2l1585t3487r1852b3580],
25	)	VBP	O	)	_	0	SENT_21	[p2l1585t3487r1852b3580],
26	based	VBN	O	base	prep	25	SENT_21	[p2l1892t3480r2135b3558],
27	primarily	RB	O	primarily	advmod	28	SENT_21	[p2l20t3607r416b3707],
28	on	IN	O	on	pcomp	26	SENT_21	[p2l448t3633r552b3685],
29	P	NN	O	p	nn	30	SENT_21	[p2l586t3614r638b3684],
30	values	NNS	O	value	pobj	28	SENT_21	[p2l667t3607r947b3686],
31	.	.	O	.	_	0	SENT_21	[p2l667t3607r947b3686],

1	However	RB	O	however	advmod	4	SENT_22	[p2l987t3615r1373b3702],
2	,	,	O	,	_	0	SENT_22	[p2l987t3615r1373b3702],
3	we	PRP	O	we	nsubj	4	SENT_22	[p2l1409t3634r1526b3686],
4	presented	VBD	O	present	_	0	SENT_22	[p2l1560t3607r1969b3707],
5	the	DT	O	the	det	7	SENT_22	[p2l2005t3607r2135b3685],
6	estimated	VBN	O	estimate	amod	7	SENT_22	[p2l21t3735r442b3813],
7	odds	NNS	O	odds	dobj	4	SENT_22	[p2l493t3735r693b3813],
8	ratios	NNS	O	ratio	npadvmod	4	SENT_22	[p2l746t3736r986b3813],
9	and	CC	O	and	_	0	SENT_22	[p2l1038t3735r1195b3813],
10	confidence	NN	O	confidence	nn	11	SENT_22	[p2l1246t3735r1716b3813],
11	intervals	NNS	O	interval	npadvmod	4	SENT_22	[p2l1766t3735r2133b3813],
12	for	IN	O	for	_	0	SENT_22	[p3l21t44r143b122],
13	all	DT	O	all	det	15	SENT_22	[p3l183t44r287b122],
14	seven	CD	NUMBER	seven	num	15	SENT_22	[p3l331t70r561b123],
15	genes	NNS	O	gene	prep_for	4	SENT_22	[p3l603t70r844b144],
16	as	IN	O	as	_	0	SENT_22	[p3l888t71r973b122],
17	the	DT	O	the	det	19	SENT_22	[p3l1018t44r1151b122],
18	main	JJ	O	main	amod	19	SENT_22	[p3l1193t45r1414b122],
19	currency	NN	O	currency	prep_as	4	SENT_22	[p3l1458t70r1829b144],
20	of	IN	O	of	_	0	SENT_22	[p3l1869t44r1968b122],
21	our	PRP$	O	we	poss	22	SENT_22	[p3l1993t70r2138b123],
22	inferences	NNS	O	inference	prep_of	19	SENT_22	[p3l20t171r484b249],
23	.	.	O	.	_	0	SENT_22	[p3l20t171r484b249],

1	In	IN	O	in	_	0	SENT_23	[p3l532t178r621b248],
2	response	NN	O	response	prep_in	14	SENT_23	[p3l665t197r1044b271],
3	to	TO	O	to	_	0	SENT_23	[p3l1089t188r1170b249],
4	Tezcan	NNP	PERSON	Tezcan	prep_to	2	SENT_23	[p3l1212t177r1536b266],
5	,	,	O	,	_	0	SENT_23	[p3l1212t177r1536b266],
6	the	DT	O	the	det	7	SENT_23	[p3l1586t171r1719b249],
7	methylation	NN	O	methylation	nsubj	14	SENT_23	[p3l1762t171r2134b271, p3l21t299r190b376],
8	of	IN	O	of	_	0	SENT_23	[p3l233t298r332b376],
9	the	DT	O	the	det	10	SENT_23	[p3l356t298r489b376],
10	genes	NNS	O	gene	prep_of	7	SENT_23	[p3l531t324r772b398],
11	we	PRP	O	we	nsubj	12	SENT_23	[p3l811t325r928b377],
12	studied	VBD	O	study	rcmod	10	SENT_23	[p3l972t298r1285b377],
13	does	VBZ	O	do	aux	14	SENT_23	[p3l1327t298r1520b376],
14	have	VB	O	have	_	0	SENT_23	[p3l1563t298r1752b377],
15	biologic	JJ	O	biologic	amod	16	SENT_23	[p3l1796t298r2136b398],
16	consequences	NNS	O	consequence	dobj	14	SENT_23	[p3l21t451r633b525],
17	,	,	O	,	_	0	SENT_23	[p3l21t451r633b525],
18	and	CC	O	and	_	0	SENT_23	[p3l694t425r852b503],
19	the	DT	O	the	det	20	SENT_23	[p3l908t425r1040b503],
20	reversal	NN	O	reversal	nsubj	24	SENT_23	[p3l1097t425r1427b504],
21	of	IN	O	of	_	0	SENT_23	[p3l1483t425r1583b503],
22	methylation	NN	O	methylation	prep_of	20	SENT_23	[p3l1621t425r2135b525],
23	may	MD	O	may	aux	24	SENT_23	[p3l21t578r199b652],
24	open	VB	O	open	conj_and	14	SENT_23	[p3l234t578r443b652],
25	new	JJ	O	new	amod	26	SENT_23	[p3l482t578r659b631],
26	possibilities	NNS	O	possibility	dobj	24	SENT_23	[p3l693t552r1209b652],
27	for	IN	O	for	_	0	SENT_23	[p3l1250t552r1373b630],
28	treatment	NN	O	treatment	prep_for	24	SENT_23	[p3l1410t569r1852b630],
29	.	.	O	.	_	0	SENT_23	[p3l1410t569r1852b630],

1	Malcolm	NNP	PERSON	Malcolm	nn	3	SENT_24	[p3l29t743r400b823],
2	V.	NNP	PERSON	V.	nn	3	SENT_24	[p3l435t750r516b823],
3	Brock	NNP	PERSON	Brock	_	0	SENT_24	[p3l559t743r819b837],
4	,	,	O	,	_	0	SENT_24	[p3l559t743r819b837],
5	M.D.	NNP	PERSON	M.D.	nn	8	SENT_24	[p3l864t750r1069b823],
6	James	NNP	PERSON	James	nn	8	SENT_24	[p3l7t874r283b970],
7	G.	NNP	PERSON	G.	nn	8	SENT_24	[p3l319t874r409b947],
8	Herman	NNP	PERSON	Herman	appos	3	SENT_24	[p3l453t874r830b961],
9	,	,	O	,	_	0	SENT_24	[p3l453t874r830b961],
10	M.D.	NNP	PERSON	M.D.	nn	13	SENT_24	[p3l874t874r1079b947],
11	Stephen	NNP	PERSON	Stephen	nn	13	SENT_24	[p3l23t992r373b1096],
12	B.	NNP	PERSON	B.	nn	13	SENT_24	[p3l418t999r490b1071],
13	Baylin	NNP	PERSON	Baylin	appos	3	SENT_24	[p3l534t992r809b1096],
14	,	,	O	,	_	0	SENT_24	[p3l534t992r809b1096],
15	M.D.	NNP	ORGANIZATION	M.D.	nn	19	SENT_24	[p3l854t999r1058b1071],
16	Johns	NNP	ORGANIZATION	Johns	nn	19	SENT_24	[p3l10t1136r205b1214],
17	Hopkins	NNP	ORGANIZATION	Hopkins	nn	19	SENT_24	[p3l237t1136r513b1215],
18	University	NNP	ORGANIZATION	University	nn	19	SENT_24	[p3l543t1141r878b1215],
19	School	NNP	ORGANIZATION	School	appos	3	SENT_24	[p3l902t1136r1124b1197],
20	of	IN	ORGANIZATION	of	_	0	SENT_24	[p3l1152t1135r1224b1197],
21	Medicine	NNP	ORGANIZATION	Medicine	nn	22	SENT_24	[p3l1242t1136r1547b1197],
22	Baltimore	NNP	ORGANIZATION	Baltimore	prep_of	19	SENT_24	[p3l26t1232r366b1303],
23	,	,	O	,	_	0	SENT_24	[p3l26t1232r366b1303],
24	MD	NNP	O	MD	nn	26	SENT_24	[p3l399t1237r514b1291],
25	21287	CD	NUMBER	21287	num	26	SENT_24	[p3l539t1236r734b1293],
26	mabrock@jhmi.edu	NN	O	mabrock@jhmi.edu	appos	3	SENT_24	[p3l24t1328r687b1407],

1	1	LS	NUMBER	1	_	0	SENT_25	[p3l22t1529r70b1580],
2	.	.	O	.	_	0	SENT_25	[p3l22t1529r70b1580],

1	Toyooka	FW	MISC	toyooka	_	0	SENT_26	[p3l146t1522r422b1597],
2	S	NN	O	s	dep	1	SENT_26	[p3l448t1526r499b1594],
3	,	,	O	,	_	0	SENT_26	[p3l448t1526r499b1594],
4	Tokumo	NNP	O	Tokumo	nn	5	SENT_26	[p3l527t1522r800b1581],
5	M	NNP	O	M	appos	2	SENT_26	[p3l825t1527r907b1594],
6	,	,	O	,	_	0	SENT_26	[p3l825t1527r907b1594],
7	Shigematsu	NNP	PERSON	Shigematsu	nn	8	SENT_26	[p3l938t1522r1319b1598],
8	H	NNP	O	H	appos	2	SENT_26	[p3l1343t1527r1417b1593],
9	,	,	O	,	_	0	SENT_26	[p3l1343t1527r1417b1593],
10	et	FW	O	et	nn	11	SENT_26	[p3l1446t1535r1506b1580],
11	al.	FW	O	al.	appos	2	SENT_26	[p3l1527t1522r1601b1581],
12	.	.	O	.	_	0	SENT_26	[p3l1527t1522r1601b1581],

1	Mutational	JJ	O	mutational	amod	4	SENT_27	[p3l1629t1522r1991b1581],
2	and	CC	O	and	_	0	SENT_27	[p3l2016t1522r2135b1581],
3	epigenetic	JJ	O	epigenetic	conj_and	1	SENT_27	[p3l21t1619r355b1694],
4	evidence	NN	O	evidence	_	0	SENT_27	[p3l390t1618r669b1677],
5	for	IN	O	for	_	0	SENT_27	[p3l703t1618r797b1677],
6	independent	JJ	O	independent	amod	7	SENT_27	[p3l828t1618r1240b1693],
7	pathways	NNS	O	pathway	prep_for	4	SENT_27	[p3l1270t1618r1574b1693],
8	for	IN	O	for	_	0	SENT_27	[p3l1609t1618r1703b1677],
9	lung	NN	O	lung	nn	10	SENT_27	[p3l1735t1618r1883b1694],
10	adenocarcinomas	NNS	O	adenocarcinoma	prep_for	7	SENT_27	[p3l1914t1618r2135b1677, p3l21t1715r398b1773],
11	arising	VBG	O	arise	partmod	4	SENT_27	[p3l430t1715r659b1790],
12	in	IN	O	in	dep	16	SENT_27	[p3l687t1715r750b1772],
13	smokers	NNS	O	smoker	pobj	12	SENT_27	[p3l782t1714r1053b1773],
14	and	CC	O	and	_	0	SENT_27	[p3l1085t1714r1205b1773],
15	never	RB	O	never	conj_and	12	SENT_27	[p3l1235t1733r1409b1773],
16	smokers	NNS	O	smoker	dobj	11	SENT_27	[p3l1440t1714r1730b1773],
17	.	.	O	.	_	0	SENT_27	[p3l1440t1714r1730b1773],

1	Cancer	NN	O	cancer	_	0	SENT_28	[p3l1765t1718r1993b1773],
2	Res	NNP	O	Res	dep	1	SENT_28	[p3l2020t1719r2134b1776],
3	2006	CD	DATE	2006	num	2	SENT_28	[p3l20t1814r537b1881],
4	;	:	O	;	_	0	SENT_28	[p3l20t1814r537b1881],
5	66:1371	CD	NUMBER	66:1371	number	6	SENT_28	[p3l20t1814r537b1881],
6	—	CD	NUMBER	—	dep	1	SENT_28	[p3l20t1814r537b1881],
7	5	CD	NUMBER	5	dep	6	SENT_28	[p3l20t1814r537b1881],
8	.	.	O	.	_	0	SENT_28	[p3l20t1814r537b1881],

1	2	LS	NUMBER	2	_	0	SENT_29	[p3l19t1913r70b1964],
2	.	.	O	.	_	0	SENT_29	[p3l19t1913r70b1964],

1	Goya	NNP	ORGANIZATION	Goya	nn	2	SENT_30	[p3l148t1910r314b1981],
2	T	NN	ORGANIZATION	t	_	0	SENT_30	[p3l339t1911r397b1977],
3	,	,	O	,	_	0	SENT_30	[p3l339t1911r397b1977],
4	Asamura	NN	PERSON	asamura	nn	5	SENT_30	[p3l427t1911r723b1965],
5	H	NN	PERSON	h	appos	2	SENT_30	[p3l750t1911r822b1977],
6	,	,	O	,	_	0	SENT_30	[p3l750t1911r822b1977],
7	Yoshimura	NN	PERSON	yoshimura	nn	8	SENT_30	[p3l852t1906r1207b1965],
8	H	NN	O	h	appos	2	SENT_30	[p3l1234t1911r1306b1977],
9	,	,	O	,	_	0	SENT_30	[p3l1234t1911r1306b1977],
10	et	FW	O	et	nn	11	SENT_30	[p3l1340t1919r1399b1964],
11	al.	FW	O	al.	appos	2	SENT_30	[p3l1423t1906r1498b1965],
12	.	.	O	.	_	0	SENT_30	[p3l1423t1906r1498b1965],

1	Prognosis	NN	O	prognosis	_	0	SENT_31	[p3l1529t1907r1854b1982],
2	of	IN	O	of	_	0	SENT_31	[p3l1885t1906r1960b1965],
3	6644	CD	DATE	6644	num	8	SENT_31	[p3l1976t1910r2136b1965],
4	resected	JJ	O	resected	amod	8	SENT_31	[p3l20t2002r289b2061],
5	non-small	JJ	O	non-small	amod	8	SENT_31	[p3l319t2002r652b2061],
6	cell	NN	O	cell	nn	8	SENT_31	[p3l682t2002r794b2060],
7	lung	NN	O	lung	nn	8	SENT_31	[p3l823t2002r970b2078],
8	cancers	NNS	O	cancer	prep_of	1	SENT_31	[p3l998t2021r1242b2060],
9	in	IN	O	in	_	0	SENT_31	[p3l1274t2003r1337b2060],
10	Japan	NNP	LOCATION	Japan	prep_in	1	SENT_31	[p3l1360t2007r1564b2077],
11	:	:	O	:	_	0	SENT_31	[p3l1360t2007r1564b2077],
12	a	DT	O	a	det	14	SENT_31	[p3l1597t2021r1630b2060],
13	Japanese	JJ	O	japanese	amod	14	SENT_31	[p3l1652t2007r1941b2077],
14	Lung	NN	O	lung	dep	1	SENT_31	[p3l1971t2007r2138b2078],
15	Cancer	NN	O	cancer	nn	17	SENT_31	[p3l20t2102r248b2157],
16	Registry	NN	O	registry	nn	17	SENT_31	[p3l270t2099r547b2174],
17	study	NN	O	study	dep	14	SENT_31	[p3l571t2098r756b2173],
18	.	.	O	.	_	0	SENT_31	[p3l571t2098r756b2173],

1	Lung	NN	O	lung	nn	2	SENT_32	[p3l786t2103r953b2174],
2	Cancer	NN	O	cancer	_	0	SENT_32	[p3l976t2102r1204b2157],
3	2005	CD	DATE	2005	dep	2	SENT_32	[p3l1227t2102r1742b2169],
4	;	:	O	;	_	0	SENT_32	[p3l1227t2102r1742b2169],
5	50:227	CD	NUMBER	50:227	number	6	SENT_32	[p3l1227t2102r1742b2169],
6	—	CD	NUMBER	—	dep	2	SENT_32	[p3l1227t2102r1742b2169],
7	34	CD	NUMBER	34	dep	6	SENT_32	[p3l1227t2102r1742b2169],
8	.	.	O	.	_	0	SENT_32	[p3l1227t2102r1742b2169],

1	3	LS	NUMBER	3	_	0	SENT_33	[p3l20t2202r70b2253],
2	.	.	O	.	_	0	SENT_33	[p3l20t2202r70b2253],

1	Pfannschmidt	NN	PERSON	pfannschmidt	nn	2	SENT_34	[p3l147t2194r613b2253],
2	J	NN	PERSON	j	nsubj	13	SENT_34	[p3l630t2199r673b2266],
3	,	,	O	,	_	0	SENT_34	[p3l630t2199r673b2266],
4	Muley	JJ	PERSON	muley	amod	5	SENT_34	[p3l704t2194r905b2269],
5	T	NN	O	t	appos	2	SENT_34	[p3l927t2199r985b2266],
6	,	,	O	,	_	0	SENT_34	[p3l927t2199r985b2266],
7	Biilzebruck	NN	O	biilzebruck	nn	8	SENT_34	[p3l1017t2194r1392b2254],
8	H	NN	O	h	appos	2	SENT_34	[p3l1418t2199r1490b2266],
9	,	,	O	,	_	0	SENT_34	[p3l1418t2199r1490b2266],
10	Hoffmann	NNP	PERSON	Hoffmann	nn	11	SENT_34	[p3l1522t2194r1868b2253],
11	H	NNP	O	H	appos	2	SENT_34	[p3l1896t2199r1969b2265],
12	,	,	O	,	_	0	SENT_34	[p3l1896t2199r1969b2265],
13	Die	VBP	O	die	_	0	SENT_34	[p3l2001t2195r2135b2253],
14	—	CD	NUMBER	—	num	18	SENT_34	[p3l2001t2195r2135b2253],
15	nemann	JJ	O	nemann	amod	18	SENT_34	[p3l20t2309r289b2348],
16	H.	NNP	O	H.	nn	18	SENT_34	[p3l323t2295r396b2349],
17	Prognostic	NNP	O	Prognostic	nn	18	SENT_34	[p3l434t2291r788b2366],
18	assessment	NN	O	assessment	dep	13	SENT_34	[p3l822t2303r1197b2348],
19	after	IN	O	after	dep	18	SENT_34	[p3l1227t2290r1382b2348],
20	surgical	JJ	O	surgical	amod	21	SENT_34	[p3l1415t2290r1676b2366],
21	resection	NN	O	resection	pobj	19	SENT_34	[p3l1711t2291r2009b2349],
22	for	IN	O	for	_	0	SENT_34	[p3l2044t2290r2138b2349],
23	non-small	JJ	O	non-small	amod	26	SENT_34	[p3l20t2386r353b2445],
24	cell	NN	O	cell	nn	26	SENT_34	[p3l383t2386r494b2444],
25	lung	NN	O	lung	nn	26	SENT_34	[p3l524t2386r672b2462],
26	cancer	NN	O	cancer	prep_for	21	SENT_34	[p3l701t2405r931b2445],
27	:	:	O	:	_	0	SENT_34	[p3l701t2405r931b2445],
28	experiences	NNS	O	experience	dep	21	SENT_34	[p3l965t2387r1346b2461],
29	in	IN	O	in	_	0	SENT_34	[p3l1378t2387r1440b2444],
30	2083	CD	DATE	2083	num	31	SENT_34	[p3l1471t2390r1625b2445],
31	patients	NNS	O	patient	prep_in	28	SENT_34	[p3l1657t2387r1937b2461],
32	.	.	O	.	_	0	SENT_34	[p3l1657t2387r1937b2461],

1	Lung	NN	O	lung	nn	2	SENT_35	[p3l1971t2391r2138b2462],
2	Cancer	NN	O	cancer	_	0	SENT_35	[p3l20t2486r248b2542],
3	2007	CD	DATE	2007	dep	2	SENT_35	[p3l271t2486r726b2552],
4	;	:	O	;	_	0	SENT_35	[p3l271t2486r726b2552],
5	55:371	CD	NUMBER	55:371	num	6	SENT_35	[p3l271t2486r726b2552],
6	—	NN	O	—	dep	2	SENT_35	[p3l271t2486r726b2552],
7	7	CD	NUMBER	7	dep	6	SENT_35	[p3l271t2486r726b2552],
8	.	.	O	.	_	0	SENT_35	[p3l271t2486r726b2552],

1	Abacavir	NNP	O	Abacavir	_	0	SENT_36	[p3l888t2627r1113b2676],
2	Hypersensitivity	NN	O	hypersensitivity	dep	1	SENT_36	[p3l1136t2628r1556b2691],

1	To	TO	O	to	_	0	SENT_37	[p3l379t2748r422b2769],
2	THE	DT	O	the	det	3	SENT_37	[p3l444t2748r507b2769],
3	EDITOR	NN	O	editor	prep_to	50	SENT_37	[p3l532t2748r663b2769],
4	:	:	O	:	_	0	SENT_37	[p3l532t2748r663b2769],
5	The	DT	O	the	det	8	SENT_37	[p3l687t2739r750b2769],
6	Prospective	JJ	O	prospective	amod	8	SENT_37	[p3l774t2739r964b2778],
7	Randomized	JJ	O	randomized	amod	8	SENT_37	[p3l988t2739r1203b2771],
8	reactions	NNS	O	reaction	dep	3	SENT_37	[p3l1242t2739r1387b2770],
9	(	CD	NUMBER	(	dep	8	SENT_37	[p3l1401t2739r1490b2774],
10	from	IN	O	from	_	0	SENT_37	[p3l1401t2739r1490b2774],
11	7.8	CD	PERCENT	7.8	number	15	SENT_37	[p3l1502t2741r1578b2770],
12	%	NN	PERCENT	%	dep	15	SENT_37	[p3l1502t2741r1578b2770],
13	to	TO	O	to	dep	15	SENT_37	[p3l1590t2746r1621b2770],
14	3.4	CD	PERCENT	3.4	number	15	SENT_37	[p3l1633t2741r1720b2774],
15	%	NN	PERCENT	%	num	16	SENT_37	[p3l1633t2741r1720b2774],
16	)	CD	NUMBER	)	prep_from	50	SENT_37	[p3l1633t2741r1720b2774],
17	among	IN	O	among	_	0	SENT_37	[p3l1733t2749r1846b2778],
18	patients	NNS	O	patient	prep_among	50	SENT_37	[p3l1856t2739r1983b2778],
19	who	WP	O	who	dobj	29	SENT_37	[p3l1993t2739r2065b2770],
20	Evaluation	NN	O	evaluation	nsubj	29	SENT_37	[p3l379t2788r554b2819],
21	of	IN	O	of	_	0	SENT_37	[p3l571t2788r610b2819],
22	DNA	NN	O	dna	nn	23	SENT_37	[p3l619t2791r700b2818],
23	Screening	NN	O	screening	prep_of	20	SENT_37	[p3l716t2788r882b2827],
24	in	IN	O	in	_	0	SENT_37	[p3l897t2788r929b2818],
25	a	DT	O	a	det	27	SENT_37	[p3l946t2798r963b2818],
26	Clinical	JJ	O	clinical	amod	27	SENT_37	[p3l979t2788r1108b2819],
27	Trial	NN	O	trial	prep_in	23	SENT_37	[p3l1123t2788r1202b2818],
28	were	VBD	O	be	cop	29	SENT_37	[p3l1240t2798r1316b2819],
29	positive	JJ	O	positive	rcmod	18	SENT_37	[p3l1329t2788r1451b2827],
30	for	IN	O	for	_	0	SENT_37	[p3l1464t2788r1510b2819],
31	the	DT	O	the	det	33	SENT_37	[p3l1522t2788r1572b2818],
32	human	JJ	O	human	amod	33	SENT_37	[p3l1585t2788r1700b2819],
33	immunodeficiency	NN	O	immunodeficiency	prep_for	29	SENT_37	[p3l1712t2788r2015b2827],
34	vi	LS	O	vi	prep	33	SENT_37	[p3l2024t2788r2065b2819, p3l381t2839r581b2872],
35	(	CD	NUMBER	(	num	36	SENT_37	[p3l2024t2788r2065b2819, p3l381t2839r581b2872],
36	PREDICT	NNP	O	PREDICT	dep	34	SENT_37	[p3l2024t2788r2065b2819, p3l381t2839r581b2872],
37	—	CD	NUMBER	—	num	36	SENT_37	[p3l2024t2788r2065b2819, p3l381t2839r581b2872],
38	1	CD	NUMBER	1	number	39	SENT_37	[p3l2024t2788r2065b2819, p3l381t2839r581b2872],
39	)	NN	O	)	amod	36	SENT_37	[p3l2024t2788r2065b2819, p3l381t2839r581b2872],
40	by	IN	O	by	_	0	SENT_37	[p3l594t2837r631b2876],
41	Mallal	NNP	PERSON	Mallal	nn	45	SENT_37	[p3l639t2837r744b2867],
42	et	FW	O	et	nn	45	SENT_37	[p3l754t2843r784b2867],
43	al.	FW	O	al.	nn	45	SENT_37	[p3l792t2837r829b2868],
44	(	FW	O	(	nn	45	SENT_37	[p3l844t2837r919b2872],
45	Feb.	NNP	DATE	Feb.	prep_by	29	SENT_37	[p3l844t2837r919b2872],
46	7	CD	DATE	7	num	47	SENT_37	[p3l932t2840r950b2867],
47	issue	NN	O	issue	nsubj	50	SENT_37	[p3l961t2837r1066b2872],
48	)	NN	O	)	amod	47	SENT_37	[p3l961t2837r1066b2872],
49	1	CD	NUMBER	1	number	48	SENT_37	[p3l961t2837r1066b2872],
50	showed	VBD	O	show	_	0	SENT_37	[p3l1077t2837r1202b2868],
51	rus	NN	O	rus	iobj	50	SENT_37	[p3l1242t2847r1294b2868],
52	(	CD	NUMBER	(	num	54	SENT_37	[p3l1311t2840r1401b2872],
53	HIV	NN	MISC	hiv	nn	54	SENT_37	[p3l1311t2840r1401b2872],
54	)	NN	O	)	dobj	50	SENT_37	[p3l1311t2840r1401b2872],
55	and	CC	O	and	_	0	SENT_37	[p3l1418t2837r1479b2868],
56	were	VBD	O	be	aux	57	SENT_37	[p3l1491t2847r1570b2868],
57	receiving	VBG	O	receive	conj_and	50	SENT_37	[p3l1584t2837r1736b2876],
58	abacavir	NN	O	abacavir	dobj	57	SENT_37	[p3l1748t2837r1894b2868],
59	.	.	O	.	_	0	SENT_37	[p3l1748t2837r1894b2868],

1	However	RB	O	however	_	0	SENT_38	[p3l1910t2840r2063b2874],
2	,	,	O	,	_	0	SENT_38	[p3l1910t2840r2063b2874],
3	that	IN	O	that	dep	1	SENT_38	[p3l380t2886r446b2916],
4	screening	VBG	O	screen	pcomp	3	SENT_38	[p3l459t2886r622b2925],
5	for	IN	O	for	_	0	SENT_38	[p3l634t2886r682b2917],
6	HLA	NN	O	hlum	prep_for	4	SENT_38	[p3l695t2886r904b2917],
7	.	.	O	.	_	0	SENT_38	[p3l695t2886r904b2917],

1	—	NN	O	—	_	0	SENT_39	[p3l695t2886r904b2917],
2	.	.	O	.	_	0	SENT_39	[p3l695t2886r904b2917],

1	B	NN	O	b	nsubj	4	SENT_40	[p3l695t2886r904b2917],
2	*	CD	NUMBER	*	num	3	SENT_40	[p3l695t2886r904b2917],
3	5701	CD	NUMBER	5701	dep	1	SENT_40	[p3l695t2886r904b2917],
4	resulted	VBD	O	result	_	0	SENT_40	[p3l918t2886r1051b2917],
5	in	IN	O	in	_	0	SENT_40	[p3l1065t2886r1098b2916],
6	a	DT	O	a	det	8	SENT_40	[p3l1112t2896r1129b2916],
7	sig	NN	O	sig	nn	8	SENT_40	[p3l1143t2886r1202b2925],
8	—	NN	O	—	prep_in	4	SENT_40	[p3l1143t2886r1202b2925],
9	because	IN	O	because	mark	26	SENT_40	[p3l1242t2886r1373b2917],
10	of	IN	O	of	_	0	SENT_40	[p3l1390t2886r1429b2917],
11	methodologic	JJ	O	methodologic	amod	12	SENT_40	[p3l1438t2886r1670b2925],
12	limitations	NNS	O	limitation	prep_of	26	SENT_40	[p3l1686t2886r1878b2923],
13	,	,	O	,	_	0	SENT_40	[p3l1686t2886r1878b2923],
14	this	DT	O	this	det	17	SENT_40	[p3l1897t2886r1960b2916],
15	study	NN	O	study	nn	17	SENT_40	[p3l1978t2886r2067b2925],
16	niﬁcant	JJ	O	niﬁcant	amod	17	SENT_40	[p3l379t2935r512b2965],
17	reduction	NN	O	reduction	nsubj	26	SENT_40	[p3l526t2935r685b2966],
18	in	IN	O	in	_	0	SENT_40	[p3l700t2935r732b2965],
19	the	DT	O	the	det	20	SENT_40	[p3l748t2935r799b2965],
20	rate	NN	O	rate	prep_in	17	SENT_40	[p3l815t2942r877b2965],
21	of	IN	O	of	_	0	SENT_40	[p3l893t2935r932b2966],
22	hypersensitivity	NN	O	hypersensitivity	prep_of	20	SENT_40	[p3l940t2935r1204b2974],
23	will	MD	O	will	aux	26	SENT_40	[p3l1240t2935r1306b2966],
24	only	RB	O	only	advmod	25	SENT_40	[p3l1320t2935r1393b2974],
25	modestly	RB	O	modestly	advmod	26	SENT_40	[p3l1406t2935r1562b2974],
26	alter	VB	O	alter	advcl	4	SENT_40	[p3l1574t2935r1651b2965],
27	clinical	JJ	O	clinical	amod	28	SENT_40	[p3l1664t2935r1789b2965],
28	practice	NN	O	practice	dobj	26	SENT_40	[p3l1803t2935r1946b2974],
29	.	.	O	.	_	0	SENT_40	[p3l1803t2935r1946b2974],

1	In	IN	O	in	_	0	SENT_41	[p3l1963t2938r1998b2965],
2	the	DT	O	the	pobj	1	SENT_41	[p3l2012t2935r2065b2965],

1	2514	CD	DATE	2514	num	4	SENT_42	[p3l92t3049r169b3072],
2	N	NN	O	n	nn	4	SENT_42	[p3l878t3059r892b3074],
3	ENGLJ	NN	O	englj	nn	4	SENT_42	[p3l906t3059r984b3081],
4	MED	NN	O	med	_	0	SENT_42	[p3l999t3059r1051b3074],
5	358	CD	NUMBER	358	num	7	SENT_42	[p3l1061t3053r1136b3081],
6	;	:	O	;	_	0	SENT_42	[p3l1061t3053r1136b3081],
7	23	CD	NUMBER	23	dep	4	SENT_42	[p3l1061t3053r1136b3081],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	9	SENT_42	[p3l1170t3059r1371b3081],
9	JUNE	NNP	DATE	JUNE	dep	4	SENT_42	[p3l1402t3059r1466b3081],
10	5	CD	DATE	5	num	9	SENT_42	[p3l1477t3059r1494b3081],
11	,	,	DATE	,	_	0	SENT_42	[p3l1477t3059r1494b3081],
12	2008	CD	DATE	2008	num	9	SENT_42	[p3l1505t3053r1568b3075],

1	The	DT	O	the	det	4	SENT_43	[p3l879t3116r930b3140],
2	New	NNP	O	New	nn	4	SENT_43	[p3l939t3117r1001b3140],
3	England	NNP	O	England	nn	4	SENT_43	[p3l1011t3116r1121b3147],
4	Journal	NNP	O	Journal	_	0	SENT_43	[p3l1130t3116r1228b3140],
5	of	IN	O	of	_	0	SENT_43	[p3l1237t3116r1266b3140],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_43	[p3l1273t3116r1398b3140],

1	CORRESPONDENCE	NN	O	correspondence	_	0	SENT_44	[p3l926t3304r1233b3323],

1	HLA	NN	O	hlum	_	0	SENT_45	[p3l11t3517r937b3618],
2	.	.	O	.	_	0	SENT_45	[p3l11t3517r937b3618],

1	—	NN	O	—	_	0	SENT_46	[p3l11t3517r937b3618],
2	.	.	O	.	_	0	SENT_46	[p3l11t3517r937b3618],

1	B	NN	O	b	_	0	SENT_47	[p3l11t3517r937b3618],
2	*	CD	NUMBER	*	number	3	SENT_47	[p3l11t3517r937b3618],
3	5701	CD	NUMBER	5701	num	1	SENT_47	[p3l11t3517r937b3618],
4	.	.	O	.	_	0	SENT_47	[p3l11t3517r937b3618],

1	—	NN	O	—	_	0	SENT_48	[p3l11t3517r937b3618],
2	.	.	O	.	_	0	SENT_48	[p3l11t3517r937b3618],

1	negative	JJ	O	negative	amod	2	SENT_49	[p3l11t3517r937b3618],
2	group	NN	O	group	nsubj	6	SENT_49	[p3l961t3543r1231b3618],
3	,	,	O	,	_	0	SENT_49	[p3l961t3543r1231b3618],
4	all	DT	O	all	det	5	SENT_49	[p3l1259t3517r1362b3596],
5	patients	NNS	O	patient	appos	2	SENT_49	[p3l1384t3518r1718b3618],
6	appeared	VBD	O	appear	_	0	SENT_49	[p3l1743t3517r2133b3618],
7	to	TO	O	to	aux	8	SENT_49	[p3l12t3662r92b3724],
8	have	VB	O	have	xcomp	6	SENT_49	[p3l124t3645r310b3724],
9	a	DT	O	a	det	13	SENT_49	[p3l341t3672r385b3724],
10	negative	JJ	O	negative	amod	13	SENT_49	[p3l414t3646r759b3746],
11	epicutaneous	JJ	O	epicutaneous	amod	13	SENT_49	[p3l791t3646r1344b3746],
12	patch	NN	O	patch	nn	13	SENT_49	[p3l1376t3645r1608b3746],
13	test	NN	O	test	dobj	8	SENT_49	[p3l1638t3662r1790b3724],
14	(	CD	NUMBER	(	npadvmod	15	SENT_49	[p3l1820t3646r2132b3736, p4l11t20r315b121],
15	immunologic	JJ	O	immunologic	amod	13	SENT_49	[p3l1820t3646r2132b3736, p4l11t20r315b121],

1	confirmation	NN	O	confirmation	_	0	SENT_50	[p4l347t20r898b99],
2	of	IN	O	of	_	0	SENT_50	[p4l932t20r1029b99],
3	a	DT	O	a	det	5	SENT_50	[p4l1042t47r1087b99],
4	hypersensitivity	NN	O	hypersensitivity	nn	5	SENT_50	[p4l1117t20r1765b121],
5	reaction	NN	O	reaction	prep_of	1	SENT_50	[p4l1793t21r2133b99],
6	to	TO	O	to	_	0	SENT_50	[p4l12t165r92b227],
7	abacavir	NN	O	abacavir	nn	8	SENT_50	[p4l122t148r517b240],
8	)	NN	O	)	prep_to	1	SENT_50	[p4l122t148r517b240],
9	.	.	O	.	_	0	SENT_50	[p4l122t148r517b240],

1	Notwithstanding	IN	O	notwithstanding	_	0	SENT_51	[p4l550t148r1282b249],
2	the	DT	O	the	det	3	SENT_51	[p4l1308t148r1439b227],
3	risks	NNS	O	risk	prep_notwithstanding	12	SENT_51	[p4l1468t148r1666b228],
4	associated	VBN	O	associate	partmod	3	SENT_51	[p4l1697t148r2133b227],
5	with	IN	O	with	_	0	SENT_51	[p4l7t276r202b356],
6	rechallenge	NN	O	rechallenge	prep_with	4	SENT_51	[p4l244t276r804b377],
7	}	CD	NUMBER	}	num	6	SENT_51	[p4l244t276r804b377],
8	the	DT	O	the	det	9	SENT_51	[p4l847t276r980b355],
9	investigators	NNS	O	investigator	nsubj	12	SENT_51	[p4l1021t277r1569b377],
10	should	MD	O	should	aux	12	SENT_51	[p4l1615t276r1902b355],
11	have	VB	O	have	aux	12	SENT_51	[p4l1943t276r2133b355],
12	taken	VBN	O	take	_	0	SENT_51	[p4l12t404r248b484],
13	this	DT	O	this	det	14	SENT_51	[p4l288t404r447b483],
14	opportunity	NN	O	opportunity	nsubj	16	SENT_51	[p4l489t405r1008b505],
15	to	TO	O	to	aux	16	SENT_51	[p4l1043t421r1124b483],
16	perform	VB	O	perform	xcomp	12	SENT_51	[p4l1163t404r1518b505],
17	a	DT	O	a	det	18	SENT_51	[p4l1556t431r1600b483],
18	rechallenge	NN	O	rechallenge	dobj	16	SENT_51	[p4l1637t404r2133b505],
19	with	IN	O	with	_	0	SENT_51	[p4l7t532r202b612],
20	abacavir	NN	O	abacavir	prep_with	16	SENT_51	[p4l238t532r595b611],
21	in	IN	O	in	_	0	SENT_51	[p4l628t533r711b610],
22	controlled	JJ	O	controlled	amod	23	SENT_51	[p4l749t532r1186b611],
23	circumstances	NNS	O	circumstance	prep_in	12	SENT_51	[p4l1224t533r1867b628],
24	,	,	O	,	_	0	SENT_51	[p4l1224t533r1867b628],
25	especially	RB	O	especially	advmod	12	SENT_51	[p4l1911t558r2132b633, p4l12t660r243b761],
26	in	IN	O	in	_	0	SENT_51	[p4l284t661r369b738],
27	patients	NNS	O	patient	prep_in	12	SENT_51	[p4l414t661r763b761],
28	in	IN	O	in	_	0	SENT_51	[p4l811t661r896b738],
29	whom	WP	O	whom	rel	35	SENT_51	[p4l938t660r1212b739],
30	the	DT	O	the	det	32	SENT_51	[p4l1259t660r1394b739],
31	hypersensitivity	NN	O	hypersensitivity	nn	32	SENT_51	[p4l1440t660r2138b761],
32	reaction	NN	O	reaction	nsubjpass	35	SENT_51	[p4l11t789r359b867],
33	could	MD	O	could	aux	35	SENT_51	[p4l399t788r633b867],
34	be	VB	O	be	auxpass	35	SENT_51	[p4l672t788r768b867],
35	explained	VBN	O	explain	rcmod	27	SENT_51	[p4l809t788r1224b889],
36	by	IN	O	by	_	0	SENT_51	[p4l1263t788r1360b889],
37	other	JJ	O	other	amod	38	SENT_51	[p4l1395t788r1623b867],
38	factors	NNS	O	factor	agent	35	SENT_51	[p4l1658t788r1974b884],
39	,	,	O	,	_	0	SENT_51	[p4l1658t788r1974b884],
40	including	VBG	O	include	_	0	SENT_51	[p4l2018t789r2132b866, p4l12t916r335b1017],
41	coadministered	JJ	O	coadministered	amod	42	SENT_51	[p4l376t916r1045b995],
42	drugs	NNS	O	drug	prep_including	12	SENT_51	[p4l1089t916r1358b1017],
43	.	.	O	.	_	0	SENT_51	[p4l1089t916r1358b1017],

1	Furthermore	RB	O	furthermore	advmod	6	SENT_52	[p4l1405t916r1977b1012],
2	,	,	O	,	_	0	SENT_52	[p4l1405t916r1977b1012],
3	no	DT	O	no	det	4	SENT_52	[p4l2027t942r2132b995],
4	information	NN	O	information	nsubjpass	6	SENT_52	[p4l11t1044r534b1123],
5	is	VBZ	O	be	auxpass	6	SENT_52	[p4l567t1045r633b1123],
6	provided	VBN	O	provide	_	0	SENT_52	[p4l667t1044r1042b1145],
7	about	IN	O	about	_	0	SENT_52	[p4l1075t1044r1319b1123],
8	the	DT	O	the	det	9	SENT_52	[p4l1348t1044r1481b1123],
9	reversibility	NN	O	reversibility	prep_about	6	SENT_52	[p4l1515t1044r2022b1145],
10	of	IN	O	of	_	0	SENT_52	[p4l2052t1044r2152b1123],
11	clinical	JJ	O	clinical	amod	13	SENT_52	[p4l12t1172r318b1251],
12	“	NN	O	“	nn	13	SENT_52	[p4l351t1172r1094b1273],
13	hypersensitivity	NN	O	hypersensitivity	prep_of	9	SENT_52	[p4l351t1172r1094b1273],
14	”	CD	NUMBER	”	num	15	SENT_52	[p4l351t1172r1094b1273],
15	symptoms	NNS	O	symptom	dep	13	SENT_52	[p4l1130t1189r1564b1273],
16	after	IN	O	after	_	0	SENT_52	[p4l1596t1172r1794b1251],
17	discontinuing	VBG	O	discontinue	prepc_after	6	SENT_52	[p4l1822t1172r2132b1251, p4l12t1301r330b1401],
18	abacavir	NN	O	abacavir	dobj	17	SENT_52	[p4l360t1300r716b1379],
19	and	CC	O	and	cc	18	SENT_52	[p4l747t1300r905b1379],
20	perhaps	RB	O	perhaps	advmod	18	SENT_52	[p4l938t1300r1278b1401],
21	other	JJ	O	other	amod	22	SENT_52	[p4l1316t1300r1543b1379],
22	drugs	NNS	O	drug	dep	18	SENT_52	[p4l1576t1300r1844b1401],
23	.	.	O	.	_	0	SENT_52	[p4l1576t1300r1844b1401],

1	These	DT	O	these	det	3	SENT_53	[p4l1881t1300r2133b1379],
2	clinical	JJ	O	clinical	amod	3	SENT_53	[p4l12t1428r325b1507],
3	decisions	NNS	O	decision	nsubj	4	SENT_53	[p4l358t1428r751b1507],
4	were	VBD	O	be	_	0	SENT_53	[p4l782t1454r983b1507],
5	not	RB	O	not	neg	4	SENT_53	[p4l1015t1445r1158b1507],
6	peer	VB	O	peer	ccomp	4	SENT_53	[p4l1183t1454r1371b1529],
7	reviewed	VBN	O	review	dep	6	SENT_53	[p4l1400t1428r1800b1507],
8	.	.	O	.	_	0	SENT_53	[p4l1400t1428r1800b1507],

1	Hence	RB	O	hence	advmod	5	SENT_54	[p4l1837t1436r2127b1524],
2	,	,	O	,	_	0	SENT_54	[p4l1837t1436r2127b1524],
3	it	PRP	O	it	nsubj	5	SENT_54	[p4l11t1557r69b1635],
4	remains	VBZ	O	remain	cop	5	SENT_54	[p4l96t1557r443b1635],
5	unclear	JJ	O	unclear	_	0	SENT_54	[p4l477t1556r798b1635],
6	whether	IN	O	whether	complm	7	SENT_54	[p4l822t1556r1177b1635],
7	rechallenge	NN	O	rechallenge	dep	5	SENT_54	[p4l1205t1556r1701b1657],
8	with	IN	O	with	_	0	SENT_54	[p4l1728t1556r1924b1635],
9	abacavir	NN	O	abacavir	prep_with	7	SENT_54	[p4l1954t1556r2132b1635, p4l12t1685r217b1763],
10	in	IN	O	in	_	0	SENT_54	[p4l247t1685r331b1762],
11	patients	NNS	O	patient	prep_in	9	SENT_54	[p4l363t1685r705b1785],
12	without	IN	O	without	dep	7	SENT_54	[p4l736t1684r1075b1763],
13	HLA	NN	O	hlum	pobj	12	SENT_54	[p4l1103t1684r1640b1763],
14	.	.	O	.	_	0	SENT_54	[p4l1103t1684r1640b1763],

1	—	NN	O	—	_	0	SENT_55	[p4l1103t1684r1640b1763],
2	.	.	O	.	_	0	SENT_55	[p4l1103t1684r1640b1763],

1	B	NN	O	b	nsubj	12	SENT_56	[p4l1103t1684r1640b1763],
2	*	CD	NUMBER	*	number	3	SENT_56	[p4l1103t1684r1640b1763],
3	5701	CD	NUMBER	5701	amod	1	SENT_56	[p4l1103t1684r1640b1763],
4	and	CC	O	and	dep	5	SENT_56	[p4l1675t1684r1832b1763],
5	with	IN	O	with	dep	3	SENT_56	[p4l1862t1684r2057b1764],
6	a	DT	O	a	det	9	SENT_56	[p4l2090t1711r2134b1763],
7	negative	JJ	O	negative	amod	9	SENT_56	[p4l11t1813r357b1913],
8	patch	NN	O	patch	nn	9	SENT_56	[p4l381t1812r613b1913],
9	test	NN	O	test	pobj	5	SENT_56	[p4l640t1829r791b1891],
10	may	MD	O	may	aux	12	SENT_56	[p4l812t1838r989b1913],
11	be	VB	O	be	cop	12	SENT_56	[p4l1011t1812r1106b1891],
12	worthwhile	JJ	O	worthwhile	_	0	SENT_56	[p4l1128t1812r1636b1891],
13	.	.	O	.	_	0	SENT_56	[p4l1128t1812r1636b1891],

1	This	DT	O	this	nsubj	4	SENT_57	[p4l1664t1812r1849b1891],
2	might	MD	O	might	aux	4	SENT_57	[p4l1877t1812r2138b1913],
3	have	VB	O	have	aux	4	SENT_57	[p4l11t1940r201b2019],
4	provided	VBN	O	provide	_	0	SENT_57	[p4l229t1940r604b2041],
5	information	NN	O	information	dobj	4	SENT_57	[p4l632t1940r1156b2019],
6	with	IN	O	with	_	0	SENT_57	[p4l1182t1940r1377b2019],
7	an	DT	O	a	det	8	SENT_57	[p4l1405t1966r1509b2019],
8	effect	NN	O	effect	prep_with	4	SENT_57	[p4l1539t1940r1781b2019],
9	on	IN	O	on	_	0	SENT_57	[p4l1806t1966r1912b2019],
10	clinical	JJ	O	clinical	amod	11	SENT_57	[p4l1942t1940r2132b2019, p4l11t2068r159b2147],
11	practice	NN	O	practice	prep_on	8	SENT_57	[p4l193t2069r554b2169],
12	.	.	O	.	_	0	SENT_57	[p4l193t2069r554b2169],

1	Linos	NNP	PERSON	Linos	nn	2	SENT_58	[p4l20t2212r245b2284],
2	Vandekerckhove	NNP	PERSON	Vandekerckhove	_	0	SENT_58	[p4l278t2205r1022b2299],
3	,	,	O	,	_	0	SENT_58	[p4l278t2205r1022b2299],
4	M.D.	NNP	O	M.D.	nn	6	SENT_58	[p4l1066t2212r1298b2299],
5	,	,	O	,	_	0	SENT_58	[p4l1066t2212r1298b2299],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_58	[p4l1343t2205r1572b2284],
7	.	.	O	.	_	0	SENT_58	[p4l1343t2205r1572b2284],

1	Stijn	NNP	PERSON	Stijn	nn	2	SENT_59	[p4l13t2337r201b2438],
2	Blot	NNP	PERSON	Blot	_	0	SENT_59	[p4l247t2332r434b2426],
3	,	,	O	,	_	0	SENT_59	[p4l247t2332r434b2426],
4	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_59	[p4l478t2332r707b2411],
5	.	.	O	.	_	0	SENT_59	[p4l478t2332r707b2411],

1	Dirk	NNP	PERSON	Dirk	nn	2	SENT_60	[p4l20t2460r194b2539],
2	Vogelaers	NNP	PERSON	Vogelaers	_	0	SENT_60	[p4l222t2460r676b2566],
3	,	,	O	,	_	0	SENT_60	[p4l222t2460r676b2566],
4	M.D.	NNP	O	M.D.	nn	6	SENT_60	[p4l721t2467r953b2554],
5	,	,	O	,	_	0	SENT_60	[p4l721t2467r953b2554],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_60	[p4l997t2460r1226b2539],
7	.	.	O	.	_	0	SENT_60	[p4l997t2460r1226b2539],

1	Ghent	NNP	ORGANIZATION	Ghent	nn	5	SENT_61	[p4l12t2602r217b2663],
2	University	NNP	ORGANIZATION	University	nn	5	SENT_61	[p4l244t2608r581b2682],
3	Hospital	NNP	ORGANIZATION	Hospital	nn	5	SENT_61	[p4l609t2602r888b2681],
4	9000	CD	ORGANIZATION	9000	num	5	SENT_61	[p4l12t2700r179b2757],
5	Ghent	NNP	ORGANIZATION	Ghent	_	0	SENT_61	[p4l203t2696r427b2767],
6	,	,	O	,	_	0	SENT_61	[p4l203t2696r427b2767],
7	Belgium	NNP	LOCATION	Belgium	nn	8	SENT_61	[p4l460t2696r728b2776],
8	stijn	NN	O	stijn	appos	5	SENT_61	[p4l12t2780r689b2860],
9	.	.	O	.	_	0	SENT_61	[p4l12t2780r689b2860],

1	b	NN	O	b	_	0	SENT_62	[p4l12t2780r689b2860],
2	|	CD	NUMBER	|	num	1	SENT_62	[p4l12t2780r689b2860],
3	ot@ugent.be	NN	O	ot@ugent.be	dep	1	SENT_62	[p4l12t2780r689b2860],
4	1	CD	NUMBER	1	num	3	SENT_62	[p4l13t2890r61b2941],
5	.	.	O	.	_	0	SENT_62	[p4l13t2890r61b2941],

1	Mallal	JJ	O	mallal	amod	2	SENT_63	[p4l137t2883r348b2941],
2	S	NN	O	s	_	0	SENT_63	[p4l378t2887r430b2954],
3	,	,	O	,	_	0	SENT_63	[p4l378t2887r430b2954],
4	Phillips	NNP	PERSON	Phillips	nn	5	SENT_63	[p4l463t2883r713b2958],
5	E	NNP	O	E	appos	2	SENT_63	[p4l743t2888r802b2954],
6	,	,	O	,	_	0	SENT_63	[p4l743t2888r802b2954],
7	Carosi	NNP	PERSON	Carosi	nn	8	SENT_63	[p4l836t2883r1046b2941],
8	G	NNP	PERSON	G	appos	2	SENT_63	[p4l1075t2887r1146b2954],
9	,	,	O	,	_	0	SENT_63	[p4l1075t2887r1146b2954],
10	et	FW	O	et	nn	11	SENT_63	[p4l1181t2895r1239b2941],
11	al.	FW	O	al.	appos	2	SENT_63	[p4l1265t2883r1340b2941],
12	.	.	O	.	_	0	SENT_63	[p4l1265t2883r1340b2941],

1	HLA	NN	O	hlum	_	0	SENT_64	[p4l1373t2883r1784b2941],
2	.	.	O	.	_	0	SENT_64	[p4l1373t2883r1784b2941],

1	—	NN	O	—	_	0	SENT_65	[p4l1373t2883r1784b2941],
2	.	.	O	.	_	0	SENT_65	[p4l1373t2883r1784b2941],

1	B	NN	O	b	_	0	SENT_66	[p4l1373t2883r1784b2941],
2	*	CD	NUMBER	*	number	3	SENT_66	[p4l1373t2883r1784b2941],
3	5701	CD	NUMBER	5701	num	4	SENT_66	[p4l1373t2883r1784b2941],
4	screening	NN	O	screening	dep	1	SENT_66	[p4l1816t2883r2136b2958],
5	for	IN	O	for	_	0	SENT_66	[p4l10t2967r104b3026],
6	hypersensitivity	NN	O	hypersensitivity	prep_for	4	SENT_66	[p4l128t2968r652b3043],
7	to	TO	O	to	_	0	SENT_66	[p4l674t2980r736b3026],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_66	[p4l763t2968r1051b3027],
9	.	.	O	.	_	0	SENT_66	[p4l763t2968r1051b3027],

1	N	NN	O	n	nn	3	SENT_67	[p4l1079t2973r1135b3027],
2	Engl	NNP	O	Engl	nn	3	SENT_67	[p4l1159t2968r1307b3043],
3	J	NNP	O	J	nsubj	4	SENT_67	[p4l1325t2973r1354b3036],
4	Med	VBD	O	med	_	0	SENT_67	[p4l1375t2968r1517b3026],
5	2008	CD	DATE	2008	dobj	4	SENT_67	[p4l1543t2972r2097b3039],
6	;	:	O	;	_	0	SENT_67	[p4l1543t2972r2097b3039],
7	358:568	CD	NUMBER	358:568	number	8	SENT_67	[p4l1543t2972r2097b3039],
8	—	CD	NUMBER	—	dep	5	SENT_67	[p4l1543t2972r2097b3039],
9	79	CD	NUMBER	79	dep	8	SENT_67	[p4l1543t2972r2097b3039],
10	.	.	O	.	_	0	SENT_67	[p4l1543t2972r2097b3039],

1	2	LS	NUMBER	2	_	0	SENT_68	[p4l9t3061r61b3112],
2	.	.	O	.	_	0	SENT_68	[p4l9t3061r61b3112],

1	Hetherington	NNP	PERSON	Hetherington	nn	2	SENT_69	[p4l138t3054r588b3129],
2	S	NNP	O	S	_	0	SENT_69	[p4l612t3058r664b3125],
3	,	,	O	,	_	0	SENT_69	[p4l612t3058r664b3125],
4	McGuirl	NNP	PERSON	McGuirl	appos	2	SENT_69	[p4l689t3054r985b3113],
5	<	JJR	O	<	amod	6	SENT_69	[p4l689t3054r985b3113],
6	S	NN	O	s	dep	4	SENT_69	[p4l1006t3058r1058b3125],
7	,	,	O	,	_	0	SENT_69	[p4l1006t3058r1058b3125],
8	Powell	NNP	PERSON	Powell	nn	9	SENT_69	[p4l1084t3054r1301b3113],
9	G	NNP	PERSON	G	appos	2	SENT_69	[p4l1323t3058r1393b3125],
10	,	,	O	,	_	0	SENT_69	[p4l1323t3058r1393b3125],
11	et	FW	O	et	nn	12	SENT_69	[p4l1421t3066r1480b3112],
12	al.	FW	O	al.	appos	2	SENT_69	[p4l1498t3054r1573b3112],
13	.	.	O	.	_	0	SENT_69	[p4l1498t3054r1573b3112],

1	Hypersensitivity	NN	O	hypersensitivity	nn	2	SENT_70	[p4l1600t3054r2138b3129],
2	reactions	NNS	O	reaction	_	0	SENT_70	[p4l10t3140r310b3198],
3	during	IN	O	during	_	0	SENT_70	[p4l342t3140r563b3215],
4	therapy	NN	O	therapy	prep_during	2	SENT_70	[p4l591t3140r838b3215],
5	with	IN	O	with	_	0	SENT_70	[p4l861t3140r1010b3199],
6	the	DT	O	the	det	11	SENT_70	[p4l1040t3140r1142b3198],
7	nucleoside	JJ	O	nucleoside	amod	11	SENT_70	[p4l1172t3140r1519b3199],
8	reverse	JJ	O	reverse	amod	11	SENT_70	[p4l1549t3159r1778b3199],
9	transcriptase	NN	O	transcriptase	nn	11	SENT_70	[p4l1809t3140r2133b3215, p4l11t3236r139b3282],
10	inhibitor	NN	O	inhibitor	nn	11	SENT_70	[p4l164t3224r459b3282],
11	abacavir	NN	O	abacavir	prep_with	2	SENT_70	[p4l482t3224r769b3283],
12	.	.	O	.	_	0	SENT_70	[p4l482t3224r769b3283],

1	Clin	NNP	O	Clin	nn	2	SENT_71	[p4l800t3224r935b3282],
2	Ther	NNP	DATE	Ther	_	0	SENT_71	[p4l959t3224r1112b3282],
3	2001	CD	DATE	2001	num	2	SENT_71	[p4l1136t3228r1687b3295],
4	;	:	O	;	_	0	SENT_71	[p4l1136t3228r1687b3295],
5	23:1603	CD	NUMBER	23:1603	number	6	SENT_71	[p4l1136t3228r1687b3295],
6	—	CD	NUMBER	—	dep	2	SENT_71	[p4l1136t3228r1687b3295],
7	14	CD	NUMBER	14	dep	6	SENT_71	[p4l1136t3228r1687b3295],
8	.	.	O	.	_	0	SENT_71	[p4l1136t3228r1687b3295],

1	TO	TO	O	to	aux	3	SENT_72	[p4l9t3496r121b3550],
2	THE	DT	O	the	det	3	SENT_72	[p4l164t3497r328b3550],
3	EDITOR	NN	O	editor	_	0	SENT_72	[p4l381t3496r717b3551],
4	:	:	O	:	_	0	SENT_72	[p4l381t3496r717b3551],
5	In	IN	O	in	_	0	SENT_72	[p4l768t3481r856b3550],
6	PREDICT	NNP	O	PREDICT	prep_in	13	SENT_72	[p4l904t3479r1398b3568],
7	—	CD	NUMBER	—	number	8	SENT_72	[p4l904t3479r1398b3568],
8	1	CD	NUMBER	1	dep	6	SENT_72	[p4l904t3479r1398b3568],
9	,	,	O	,	_	0	SENT_72	[p4l904t3479r1398b3568],
10	Mallal	NN	PERSON	mallal	nsubj	13	SENT_72	[p4l1449t3473r1724b3551],
11	and	CC	O	and	_	0	SENT_72	[p4l1772t3473r1929b3551],
12	colleagues	NNS	O	colleague	conj_and	10	SENT_72	[p4l1979t3473r2132b3551, p4l10t3601r316b3702],
13	found	VBD	O	find	dep	3	SENT_72	[p4l342t3601r586b3680],
14	that	IN	O	that	_	0	SENT_72	[p4l610t3601r776b3680],
15	prospective	JJ	O	prospective	amod	16	SENT_72	[p4l794t3602r1262b3702],
16	HLA	NN	O	hlum	prep_that	3	SENT_72	[p4l1285t3601r1803b3680],
17	.	.	O	.	_	0	SENT_72	[p4l1285t3601r1803b3680],

1	—	NN	O	—	_	0	SENT_73	[p4l1285t3601r1803b3680],
2	.	.	O	.	_	0	SENT_73	[p4l1285t3601r1803b3680],

1	B	NN	O	b	_	0	SENT_74	[p4l1285t3601r1803b3680],
2	*	CD	NUMBER	*	number	3	SENT_74	[p4l1285t3601r1803b3680],
3	5701	CD	NUMBER	5701	dep	1	SENT_74	[p4l1285t3601r1803b3680],
4	screening	NN	O	screening	dep	3	SENT_74	[p4l1829t3627r2132b3680, p5l11t21r150b121],

1	reduced	VBD	O	reduce	_	0	SENT_75	[p5l186t20r523b99],
2	the	DT	O	the	det	3	SENT_75	[p5l563t20r695b99],
3	incidence	NN	O	incidence	dobj	1	SENT_75	[p5l734t20r1140b99],
4	of	IN	O	of	_	0	SENT_75	[p5l1180t20r1280b99],
5	hypersensitivity	NN	O	hypersensitivity	nn	8	SENT_75	[p5l1301t20r1982b121],
6	re	NN	O	re	nn	8	SENT_75	[p5l2016t46r2132b99],
7	—	NN	O	—	nn	8	SENT_75	[p5l2016t46r2132b99],
8	actions	NNS	O	action	prep_of	3	SENT_75	[p5l11t149r323b227],
9	to	TO	O	to	aux	10	SENT_75	[p5l383t165r465b227],
10	abacavir	VB	O	abacavir	xcomp	1	SENT_75	[p5l524t148r889b227],
11	in	IN	O	in	_	0	SENT_75	[p5l943t149r1027b226],
12	a	DT	O	a	det	15	SENT_75	[p5l1084t175r1128b227],
13	predominantly	RB	O	predominantly	advmod	14	SENT_75	[p5l1183t148r1840b249],
14	white	JJ	O	white	amod	15	SENT_75	[p5l1889t148r2133b227],
15	population	NN	O	population	prep_in	10	SENT_75	[p5l10t276r504b377],
16	.	.	O	.	_	0	SENT_75	[p5l10t276r504b377],

1	In	IN	O	in	_	0	SENT_76	[p5l542t284r631b354],
2	our	PRP$	O	we	poss	4	SENT_76	[p5l666t302r812b355],
3	2006	CD	DATE	2006	num	4	SENT_76	[p5l843t282r1051b355],
4	study	NN	O	study	nsubj	5	SENT_76	[p5l1088t276r1318b377],
5	involving	VBG	O	involve	prepc_in	17	SENT_76	[p5l1347t276r1743b377],
6	Martinican	JJ	MISC	martinican	amod	7	SENT_76	[p5l1771t277r2132b355, p5l12t430r161b483],
7	patients	NNS	O	patient	dobj	5	SENT_76	[p5l191t405r532b505],
8	with	IN	O	with	_	0	SENT_76	[p5l562t404r757b483],
9	HIV	NN	MISC	hiv	nn	10	SENT_76	[p5l788t412r963b483],
10	infection	NN	O	infection	prep_with	5	SENT_76	[p5l990t404r1377b483],
11	or	CC	O	or	_	0	SENT_76	[p5l1409t430r1498b483],
12	AIDS	NN	MISC	aid	conj_or	10	SENT_76	[p5l1522t410r1771b500],
13	,	,	O	,	_	0	SENT_76	[p5l1522t410r1771b500],
14	most	JJS	O	most	nsubj	17	SENT_76	[p5l1808t421r2024b483],
15	of	IN	O	of	_	0	SENT_76	[p5l2051t404r2151b483],
16	whom	WP	O	whom	prep_of	14	SENT_76	[p5l7t532r278b612],
17	were	VBD	O	be	_	0	SENT_76	[p5l315t558r516b611],
18	of	IN	O	of	_	0	SENT_76	[p5l559t532r659b611],
19	sub	NN	O	sub	prep_of	17	SENT_76	[p5l684t532r1221b611],
20	.	.	O	.	_	0	SENT_76	[p5l684t532r1221b611],

1	—	NN	O	—	_	0	SENT_77	[p5l684t532r1221b611],
2	.	.	O	.	_	0	SENT_77	[p5l684t532r1221b611],

1	Saharan	JJ	MISC	saharan	amod	3	SENT_78	[p5l684t532r1221b611],
2	African	JJ	MISC	african	amod	3	SENT_78	[p5l1259t532r1583b611],
3	origin	NN	O	origin	nsubj	6	SENT_78	[p5l1626t533r1907b633],
4	,	,	O	,	_	0	SENT_78	[p5l1626t533r1907b633],
5	abacavir	NN	O	abacavir	appos	3	SENT_78	[p5l1954t532r2132b611, p5l12t661r217b739],
6	had	VBD	O	have	_	0	SENT_78	[p5l244t660r401b739],
7	to	TO	O	to	aux	9	SENT_78	[p5l431t677r513b739],
8	be	VB	O	be	auxpass	9	SENT_78	[p5l546t660r642b739],
9	discontinued	VBN	O	discontinue	xcomp	6	SENT_78	[p5l674t660r1233b739],
10	in	IN	O	in	_	0	SENT_78	[p5l1262t661r1346b738],
11	10	CD	NUMBER	10	prep_in	9	SENT_78	[p5l1379t666r1472b739],
12	of	IN	O	of	_	0	SENT_78	[p5l1504t660r1604b739],
13	414	CD	NUMBER	414	num	14	SENT_78	[p5l1615t666r1760b739],
14	patients	NNS	O	patient	prep_of	11	SENT_78	[p5l1790t661r2131b761],
15	because	IN	O	because	_	0	SENT_78	[p5l12t788r354b867],
16	of	IN	O	of	_	0	SENT_78	[p5l411t788r512b867],
17	probable	JJ	O	probable	amod	19	SENT_78	[p5l547t788r928b889],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_78	[p5l984t788r1681b889],
19	reactions	NNS	O	reaction	prep_because_of	20	SENT_78	[p5l1732t789r2131b867],
20	(	VBP	O	(	advcl	6	SENT_78	[p5l16t920r279b1010],
21	2.4	CD	PERCENT	2.4	num	22	SENT_78	[p5l16t920r279b1010],
22	%	NN	PERCENT	%	dobj	20	SENT_78	[p5l16t920r279b1010],
23	;	:	O	;	_	0	SENT_78	[p5l16t920r279b1010],
24	95	CD	PERCENT	95	number	25	SENT_78	[p5l314t920r498b994],
25	%	NN	PERCENT	%	amod	22	SENT_78	[p5l314t920r498b994],
26	confidence	NN	O	confidence	nn	27	SENT_78	[p5l529t915r1001b993],
27	interval	NN	O	interval	nsubj	20	SENT_78	[p5l1031t915r1381b1010],
28	,	,	O	,	_	0	SENT_78	[p5l1031t915r1381b1010],
29	1.2	CD	NUMBER	1.2	number	31	SENT_78	[p5l1420t921r1544b993],
30	to	TO	O	to	dep	31	SENT_78	[p5l1577t932r1658b993],
31	4.5	CD	NUMBER	4.5	appos	27	SENT_78	[p5l1689t921r1871b1006],
32	)	CD	NUMBER	)	dep	31	SENT_78	[p5l1689t921r1871b1006],
33	.	.	O	.	_	0	SENT_78	[p5l1689t921r1871b1006],

1	None	NN	O	none	nsubj	9	SENT_79	[p5l1905t922r2133b994],
2	of	IN	O	of	_	0	SENT_79	[p5l12t1043r113b1122],
3	the	DT	O	the	det	5	SENT_79	[p5l144t1043r279b1122],
4	black	JJ	O	black	amod	5	SENT_79	[p5l330t1043r564b1123],
5	patients	NNS	O	patient	prep_of	1	SENT_79	[p5l607t1044r958b1144],
6	in	IN	O	in	_	0	SENT_79	[p5l1009t1044r1093b1121],
7	this	DT	O	this	det	8	SENT_79	[p5l1143t1043r1306b1122],
8	study	NN	O	study	prep_in	5	SENT_79	[p5l1360t1043r1594b1144],
9	carried	VBD	O	carry	_	0	SENT_79	[p5l1640t1043r1948b1122],
10	the	DT	O	the	det	11	SENT_79	[p5l1998t1043r2133b1122],
11	HLA	NN	O	hlum	dobj	9	SENT_79	[p5l11t1171r538b1250],
12	.	.	O	.	_	0	SENT_79	[p5l11t1171r538b1250],

1	—	NN	O	—	_	0	SENT_80	[p5l11t1171r538b1250],
2	.	.	O	.	_	0	SENT_80	[p5l11t1171r538b1250],

1	B	NN	O	b	_	0	SENT_81	[p5l11t1171r538b1250],
2	*	CD	NUMBER	*	number	3	SENT_81	[p5l11t1171r538b1250],
3	5701	CD	NUMBER	5701	dep	1	SENT_81	[p5l11t1171r538b1250],
4	allele	NN	O	allele	dep	3	SENT_81	[p5l570t1171r811b1250],
5	.	.	O	.	_	0	SENT_81	[p5l570t1171r811b1250],

1	We	PRP	O	we	nsubj	3	SENT_82	[p5l844t1179r976b1250],
2	subsequently	RB	O	subsequently	advmod	3	SENT_82	[p5l1010t1171r1559b1272],
3	screened	VBD	O	screen	_	0	SENT_82	[p5l1588t1171r1955b1250],
4	617	CD	NUMBER	617	num	6	SENT_82	[p5l1987t1177r2132b1250],
5	consecutive	JJ	O	consecutive	amod	6	SENT_82	[p5l12t1300r520b1378],
6	patients	NNS	O	patient	dobj	3	SENT_82	[p5l571t1300r947b1400],
7	,	,	O	,	_	0	SENT_82	[p5l571t1300r947b1400],
8	seen	VBN	O	see	partmod	6	SENT_82	[p5l1006t1325r1198b1378],
9	at	IN	O	at	_	0	SENT_82	[p5l1249t1316r1329b1378],
10	our	PRP$	O	we	poss	11	SENT_82	[p5l1376t1325r1525b1378],
11	hospital	NN	O	hospital	prep_at	8	SENT_82	[p5l1573t1299r1953b1400],
12	,	,	O	,	_	0	SENT_82	[p5l1573t1299r1953b1400],
13	for	IN	O	for	_	0	SENT_82	[p5l2010t1299r2136b1378],
14	HLA	NN	O	hlum	prep_for	6	SENT_82	[p5l11t1428r548b1507],
15	.	.	O	.	_	0	SENT_82	[p5l11t1428r548b1507],

1	—	NN	O	—	_	0	SENT_83	[p5l11t1428r548b1507],
2	.	.	O	.	_	0	SENT_83	[p5l11t1428r548b1507],

1	B	NN	O	b	nn	5	SENT_84	[p5l11t1428r548b1507],
2	*	CD	NUMBER	*	num	5	SENT_84	[p5l11t1428r548b1507],
3	5701	CD	NUMBER	5701	num	5	SENT_84	[p5l11t1428r548b1507],
4	(	NNP	O	(	nn	5	SENT_84	[p5l588t1428r847b1519],
5	Table	NNP	O	Table	_	0	SENT_84	[p5l588t1428r847b1519],
6	1	CD	NUMBER	1	number	7	SENT_84	[p5l885t1434r980b1520],
7	)	CD	NUMBER	)	num	5	SENT_84	[p5l885t1434r980b1520],
8	.	.	O	.	_	0	SENT_84	[p5l885t1434r980b1520],

1	In	IN	O	in	_	0	SENT_85	[p5l1019t1436r1108b1506],
2	this	DT	O	this	det	4	SENT_85	[p5l1143t1428r1303b1507],
3	Martinican	JJ	MISC	martinican	amod	4	SENT_85	[p5l1338t1429r1821b1507],
4	cohort	NN	O	cohort	prep_in	16	SENT_85	[p5l1857t1428r2138b1507],
5	of	IN	O	of	_	0	SENT_85	[p5l12t1556r112b1635],
6	mainly	RB	O	mainly	advmod	7	SENT_85	[p5l131t1556r431b1657],
7	black	JJ	O	black	amod	9	SENT_85	[p5l465t1556r694b1636],
8	African	JJ	MISC	african	amod	9	SENT_85	[p5l724t1556r1047b1635],
9	ancestry	NN	O	ancestry	prep_of	4	SENT_85	[p5l1085t1573r1461b1657],
10	,	,	O	,	_	0	SENT_85	[p5l1085t1573r1461b1657],
11	abacavir	NN	O	abacavir	nn	12	SENT_85	[p5l1504t1556r1860b1635],
12	eXpo	NN	O	expo	nsubj	16	SENT_85	[p5l1896t1582r2132b1657],
13	—	CD	NUMBER	—	npadvmod	14	SENT_85	[p5l1896t1582r2132b1657],
14	sure	JJ	O	sure	amod	12	SENT_85	[p5l13t1710r186b1763],
15	was	VBD	O	be	cop	16	SENT_85	[p5l215t1711r375b1763],
16	frequent	JJ	O	frequent	_	0	SENT_85	[p5l411t1684r787b1785],
17	,	,	O	,	_	0	SENT_85	[p5l411t1684r787b1785],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_85	[p5l826t1684r1490b1785],
19	reactions	NNS	O	reaction	nsubj	21	SENT_85	[p5l1519t1685r1901b1763],
20	were	VBD	O	be	cop	21	SENT_85	[p5l1931t1711r2133b1763],
21	rare	JJ	O	rare	ccomp	16	SENT_85	[p5l11t1838r202b1908],
22	,	,	O	,	_	0	SENT_85	[p5l11t1838r202b1908],
23	and	CC	O	and	_	0	SENT_85	[p5l239t1812r397b1891],
24	the	DT	O	the	det	25	SENT_85	[p5l430t1812r563b1891],
25	prevalence	NN	O	prevalence	conj_and	16	SENT_85	[p5l595t1812r1048b1913],
26	of	IN	O	of	dep	25	SENT_85	[p5l1082t1812r1182b1891],
27	HLA	NN	O	hlum	pobj	26	SENT_85	[p5l1196t1812r1733b1891],
28	.	.	O	.	_	0	SENT_85	[p5l1196t1812r1733b1891],

1	—	NN	O	—	_	0	SENT_86	[p5l1196t1812r1733b1891],
2	.	.	O	.	_	0	SENT_86	[p5l1196t1812r1733b1891],

1	B	NN	O	b	nsubj	5	SENT_87	[p5l1196t1812r1733b1891],
2	*	CD	NUMBER	*	num	3	SENT_87	[p5l1196t1812r1733b1891],
3	5701	CD	NUMBER	5701	dep	1	SENT_87	[p5l1196t1812r1733b1891],
4	was	VBD	O	be	cop	5	SENT_87	[p5l1762t1839r1925b1891],
5	low	JJ	O	low	_	0	SENT_87	[p5l1958t1812r2128b1891],
6	.	.	O	.	_	0	SENT_87	[p5l1958t1812r2128b1891],

1	In	IN	O	in	_	0	SENT_88	[p5l9t1948r97b2018],
2	the	DT	O	the	det	4	SENT_88	[p5l128t1940r259b2019],
3	Caribbean	NNP	LOCATION	Caribbean	nn	4	SENT_88	[p5l291t1940r725b2019],
4	region	NN	O	region	prep_in	22	SENT_88	[p5l755t1941r1047b2041],
5	,	,	O	,	_	0	SENT_88	[p5l755t1941r1047b2041],
6	which	WDT	O	which	nsubjpass	9	SENT_88	[p5l1079t1940r1337b2019],
7	is	VBZ	O	be	auxpass	9	SENT_88	[p5l1368t1941r1432b2019],
8	significantly	RB	O	significantly	advmod	9	SENT_88	[p5l1467t1940r1997b2041],
9	affected	VBN	O	affect	dep	22	SENT_88	[p5l2023t1940r2132b2019, p5l11t2068r263b2147],
10	by	IN	O	by	_	0	SENT_88	[p5l297t2068r393b2169],
11	the	DT	O	the	det	13	SENT_88	[p5l421t2068r552b2147],
12	HIV	NN	MISC	hiv	nn	13	SENT_88	[p5l585t2076r757b2147],
13	pandemic	NN	O	pandemic	agent	9	SENT_88	[p5l785t2068r1222b2169],
14	,	,	O	,	_	0	SENT_88	[p5l785t2068r1222b2169],
15	black	JJ	O	black	amod	16	SENT_88	[p5l1262t2068r1486b2148],
16	populations	NNS	O	population	nsubj	22	SENT_88	[p5l1513t2068r2015b2169],
17	of	IN	O	of	_	0	SENT_88	[p5l2051t2068r2151b2147],
18	African	JJ	MISC	african	amod	19	SENT_88	[p5l7t2196r331b2275],
19	ancestry	NN	O	ancestry	prep_of	16	SENT_88	[p5l364t2213r728b2297],
20	do	VBP	O	do	aux	22	SENT_88	[p5l758t2196r861b2275],
21	not	RB	O	not	neg	22	SENT_88	[p5l896t2213r1039b2275],
22	appear	VB	O	appear	_	0	SENT_88	[p5l1067t2222r1359b2297],
23	to	TO	O	to	aux	24	SENT_88	[p5l1390t2213r1471b2275],
24	be	VB	O	be	xcomp	22	SENT_88	[p5l1507t2196r1604b2275],
25	at	IN	O	at	_	0	SENT_88	[p5l1637t2213r1716b2275],
26	high	JJ	O	high	amod	27	SENT_88	[p5l1745t2196r1940b2297],
27	risk	NN	O	risk	prep_at	24	SENT_88	[p5l1974t2196r2138b2276],

1	Table	NNP	O	Table	_	0	SENT_89	[p5l76t2561r265b2625],
2	1	CD	NUMBER	1	dep	1	SENT_89	[p5l292t2566r348b2625],
3	.	.	O	.	_	0	SENT_89	[p5l292t2566r348b2625],

1	HLA-B	NN	O	hla-b	_	0	SENT_90	[p5l379t2565r820b2626],
2	*	CD	NUMBER	*	number	3	SENT_90	[p5l379t2565r820b2626],
3	5701	CD	NUMBER	5701	num	4	SENT_90	[p5l379t2565r820b2626],
4	Results	NNS	O	result	dep	1	SENT_90	[p5l853t2561r1110b2626],
5	According	VBG	O	accord	rcmod	1	SENT_90	[p5l1133t2561r1496b2645],
6	to	TO	O	to	pcomp	5	SENT_90	[p5l1516t2571r1586b2626],
7	Race	NN	O	race	pobj	6	SENT_90	[p5l1614t2566r1799b2626],
8	.	.	O	.	_	0	SENT_90	[p5l1614t2566r1799b2626],

1	Patients	NNS	O	patient	_	0	SENT_91	[p5l966t2756r1251b2820],
2	Positive	JJ	O	positive	amod	1	SENT_91	[p5l1285t2756r1559b2820],
3	for	IN	O	for	_	0	SENT_91	[p5l971t2851r1072b2916],
4	HLA-B	NN	O	hla-b	prep_for	1	SENT_91	[p5l1102t2855r1542b2916],
5	*	CD	NUMBER	*	num	4	SENT_91	[p5l1102t2855r1542b2916],
6	‘	CD	NUMBER	‘	number	7	SENT_91	[p5l1102t2855r1542b2916],
7	5701	CD	NUMBER	5701	dep	1	SENT_91	[p5l1102t2855r1542b2916],
8	All	DT	O	all	det	9	SENT_91	[p5l1671t2852r1760b2915],
9	Patients	NNS	O	patient	dep	7	SENT_91	[p5l1796t2853r2081b2916],

1	Race	NN	O	race	_	0	SENT_92	[p5l82t2955r246b3013],
2	(	CD	NUMBER	(	num	3	SENT_92	[p5l1150t2955r1227b3034],
3	N	NN	O	n	dep	1	SENT_92	[p5l1150t2955r1227b3034],
4	=	JJ	O	=	quantmod	6	SENT_92	[p5l1248t2981r1292b3003],
5	7	CD	NUMBER	7	number	6	SENT_92	[p5l1309t2955r1369b3034],
6	)	CD	NUMBER	)	num	11	SENT_92	[p5l1309t2955r1369b3034],
7	(	NN	O	(	nn	11	SENT_92	[p5l1727t2955r1804b3034],
8	N	NN	O	n	nn	11	SENT_92	[p5l1727t2955r1804b3034],
9	=	JJ	O	=	amod	11	SENT_92	[p5l1825t2981r1868b3003],
10	617	CD	NUMBER	617	num	11	SENT_92	[p5l1883t2954r2029b3034],
11	)	NN	O	)	dep	3	SENT_92	[p5l1883t2954r2029b3034],

1	Black	JJ	O	black	amod	4	SENT_93	[p5l84t3103r264b3167],
2	(	JJ	O	(	amod	4	SENT_93	[p5l296t3102r562b3188],
3	African	JJ	MISC	african	amod	4	SENT_93	[p5l296t3102r562b3188],
4	origin	NN	O	origin	_	0	SENT_93	[p5l592t3109r817b3188],
5	)	NN	O	)	dep	4	SENT_93	[p5l592t3109r817b3188],
6	1	CD	NUMBER	1	num	7	SENT_93	[p5l1246t3109r1275b3167],
7	535	CD	NUMBER	535	dep	4	SENT_93	[p5l1812t3108r1930b3167],

1	White	NNP	O	White	_	0	SENT_94	[p5l76t3262r281b3327],
2	5	CD	NUMBER	5	num	3	SENT_94	[p5l1242t3269r1274b3327],
3	54	CD	NUMBER	54	dep	1	SENT_94	[p5l1854t3269r1933b3327],

1	Other	JJ	O	other	amod	2	SENT_95	[p5l79t3417r284b3481],
2	1	CD	NUMBER	1	_	0	SENT_95	[p5l1246t3423r1275b3481],
3	28	CD	NUMBER	28	dep	2	SENT_95	[p5l1853t3421r1932b3482],

1	for	IN	O	for	_	0	SENT_96	[p6l10t87r136b166],
2	hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_96	[p6l184t87r886b188],
3	reactions	NNS	O	reaction	prep_for	20	SENT_96	[p6l932t88r1360b183],
4	,	,	O	,	_	0	SENT_96	[p6l932t88r1360b183],
5	and	CC	O	and	cc	20	SENT_96	[p6l1416t87r1577b166],
6	it	PRP	O	it	nsubj	20	SENT_96	[p6l1627t88r1688b166],
7	therefore	RB	O	therefore	advmod	20	SENT_96	[p6l1734t87r2135b166],
8	seems	VBZ	O	seem	cop	20	SENT_96	[p6l12t241r271b294],
9	inappropriate	JJ	O	inappropriate	amod	20	SENT_96	[p6l320t216r905b316],
10	to	TO	O	to	aux	11	SENT_96	[p6l953t232r1034b294],
11	restrict	VB	O	restrict	xcomp	9	SENT_96	[p6l1083t216r1391b294],
12	the	DT	O	the	det	13	SENT_96	[p6l1433t215r1566b294],
13	prescription	NN	O	prescription	dobj	11	SENT_96	[p6l1612t216r2135b316],
14	of	IN	O	of	_	0	SENT_96	[p6l11t343r111b422],
15	abacavir	NN	O	abacavir	prep_of	13	SENT_96	[p6l126t343r483b422],
16	in	IN	O	in	_	0	SENT_96	[p6l513t344r597b421],
17	this	DT	O	this	det	18	SENT_96	[p6l631t343r792b422],
18	population	NN	O	population	prep_in	11	SENT_96	[p6l826t343r1299b444],
19	when	WRB	O	when	dep	18	SENT_96	[p6l1329t343r1563b423],
20	HLA	NN	O	hlum	_	0	SENT_96	[p6l1596t343r2134b422],
21	.	.	O	.	_	0	SENT_96	[p6l1596t343r2134b422],

1	—	NN	O	—	_	0	SENT_97	[p6l1596t343r2134b422],
2	.	.	O	.	_	0	SENT_97	[p6l1596t343r2134b422],

1	B	NN	O	b	nsubj	7	SENT_98	[p6l1596t343r2134b422],
2	*	CD	NUMBER	*	num	1	SENT_98	[p6l1596t343r2134b422],
3	5701	CD	NUMBER	5701	num	4	SENT_98	[p6l1596t343r2134b422],
4	genotyping	NN	O	genotyping	dep	1	SENT_98	[p6l10t472r501b572],
5	is	VBZ	O	be	cop	7	SENT_98	[p6l533t472r598b550],
6	not	RB	O	not	neg	7	SENT_98	[p6l635t488r778b550],
7	possible	JJ	O	possible	_	0	SENT_98	[p6l807t471r1180b572],
8	.	.	O	.	_	0	SENT_98	[p6l807t471r1180b572],

1	Sylvie	NNP	PERSON	Sylvie	nn	2	SENT_99	[p6l12t626r255b731],
2	Abel	NNP	PERSON	Abel	_	0	SENT_99	[p6l285t626r500b720],
3	,	,	O	,	_	0	SENT_99	[p6l285t626r500b720],
4	M.D.	NNP	PERSON	M.D.	nn	6	SENT_99	[p6l545t633r750b705],
5	Laure	NNP	PERSON	Laure	nn	6	SENT_99	[p6l19t762r253b835],
6	Paturel	NNP	PERSON	Paturel	appos	2	SENT_99	[p6l293t755r616b849],
7	,	,	O	,	_	0	SENT_99	[p6l293t755r616b849],
8	M.D.	NNP	ORGANIZATION	M.D.	nn	10	SENT_99	[p6l660t762r866b834],
9	University	NNP	ORGANIZATION	University	nn	10	SENT_99	[p6l14t903r351b977],
10	Hospital	NNP	ORGANIZATION	Hospital	appos	2	SENT_99	[p6l379t897r657b976],
11	of	IN	ORGANIZATION	of	_	0	SENT_99	[p6l686t897r758b958],
12	Fort-de-France	NNP	ORGANIZATION	Fort-de-France	prep_of	10	SENT_99	[p6l776t897r1270b958],
13	97200	CD	NUMBER	97200	num	12	SENT_99	[p6l11t1008r213b1065],
14	Fort-de-France	NNP	LOCATION	Fort-de-France	dep	2	SENT_99	[p6l241t1004r754b1076],
15	,	,	O	,	_	0	SENT_99	[p6l241t1004r754b1076],
16	France	NNP	LOCATION	France	nn	17	SENT_99	[p6l786t1010r1003b1065],
17	sylvie	NN	O	sylvie	appos	14	SENT_99	[p6l11t1089r1085b1169],
18	.	.	O	.	_	0	SENT_99	[p6l11t1089r1085b1169],

1	abe	NN	O	abe	_	0	SENT_100	[p6l11t1089r1085b1169],
2	|	SYM	O	|	dep	1	SENT_100	[p6l11t1089r1085b1169],
3	@chu	SYM	O	@chu	dep	5	SENT_100	[p6l11t1089r1085b1169],
4	-	:	O	-	_	0	SENT_100	[p6l11t1089r1085b1169],
5	fortdefrancefr	NN	O	fortdefrancefr	dep	2	SENT_100	[p6l11t1089r1085b1169],

1	André	NNP	PERSON	André	nn	2	SENT_101	[p6l8t1226r271b1306],
2	Cabié	NNP	PERSON	Cabié	nsubj	9	SENT_101	[p6l304t1226r568b1320],
3	,	,	O	,	_	0	SENT_101	[p6l304t1226r568b1320],
4	M.D.	NNP	ORGANIZATION	M.D.	nn	8	SENT_101	[p6l613t1234r820b1306],
5	Clinical	JJ	ORGANIZATION	clinical	amod	8	SENT_101	[p6l11t1369r252b1430],
6	Research	NNP	ORGANIZATION	Research	nn	8	SENT_101	[p6l285t1369r580b1430],
7	Center	NNP	ORGANIZATION	Center	nn	8	SENT_101	[p6l609t1374r830b1430],
8	ofAntil	NNP	O	ofAntil	nsubj	9	SENT_101	[p6l853t1369r1494b1449],
9	|	VBD	O	|	_	0	SENT_101	[p6l853t1369r1494b1449],
10	es	NNS	O	e	dobj	9	SENT_101	[p6l853t1369r1494b1449],
11	.	.	O	.	_	0	SENT_101	[p6l853t1369r1494b1449],

1	—	NN	O	—	_	0	SENT_102	[p6l853t1369r1494b1449],
2	.	.	O	.	_	0	SENT_102	[p6l853t1369r1494b1449],

1	Guyane	NN	O	guyane	nn	3	SENT_103	[p6l853t1369r1494b1449],
2	97200	CD	NUMBER	97200	num	3	SENT_103	[p6l11t1480r213b1537],
3	Fort-de-France	NNP	LOCATION	Fort-de-France	_	0	SENT_103	[p6l241t1476r754b1547],
4	,	,	O	,	_	0	SENT_103	[p6l241t1476r754b1547],
5	France	NNP	LOCATION	France	appos	3	SENT_103	[p6l786t1482r1003b1537],

1	THE	DT	O	the	det	3	SENT_104	[p6l8t1765r173b1819],
2	AUTHORS	NNS	O	author	nn	3	SENT_104	[p6l214t1764r623b1820],
3	REPLY	NN	O	reply	_	0	SENT_104	[p6l670t1765r937b1820],
4	:	:	O	:	_	0	SENT_104	[p6l670t1765r937b1820],
5	The	DT	O	the	det	9	SENT_104	[p6l981t1741r1143b1820],
6	PREDICT	NNP	O	PREDICT	nn	9	SENT_104	[p6l1187t1747r1658b1825],
7	—	NN	O	—	nn	9	SENT_104	[p6l1187t1747r1658b1825],
8	1	CD	NUMBER	1	num	9	SENT_104	[p6l1187t1747r1658b1825],
9	study	NN	O	study	nsubjpass	12	SENT_104	[p6l1705t1741r1935b1842],
10	was	VBD	O	be	auxpass	12	SENT_104	[p6l1971t1768r2134b1820],
11	specifically	RB	O	specifically	advmod	12	SENT_104	[p6l12t1869r500b1970],
12	designed	VBN	O	design	dep	3	SENT_104	[p6l526t1869r909b1970],
13	to	TO	O	to	aux	14	SENT_104	[p6l939t1886r1020b1948],
14	study	VB	O	study	xcomp	12	SENT_104	[p6l1053t1869r1284b1970],
15	the	DT	O	the	det	16	SENT_104	[p6l1309t1869r1442b1948],
16	effectiveness	NN	O	effectiveness	dobj	14	SENT_104	[p6l1472t1869r2021b1949],
17	of	IN	O	of	_	0	SENT_104	[p6l2053t1869r2153b1948],
18	screening	VBG	O	screen	prepc_of	16	SENT_104	[p6l12t1998r430b2098],
19	for	IN	O	for	_	0	SENT_104	[p6l476t1997r599b2076],
20	the	DT	O	the	det	21	SENT_104	[p6l647t1997r779b2076],
21	HLA	NN	O	hlum	prep_for	18	SENT_104	[p6l828t1997r1366b2076],
22	.	.	O	.	_	0	SENT_104	[p6l828t1997r1366b2076],

1	—	NN	O	—	_	0	SENT_105	[p6l828t1997r1366b2076],
2	.	.	O	.	_	0	SENT_105	[p6l828t1997r1366b2076],

1	B	NN	O	b	_	0	SENT_106	[p6l828t1997r1366b2076],
2	*	CD	NUMBER	*	number	3	SENT_106	[p6l828t1997r1366b2076],
3	5701	CD	DATE	5701	num	4	SENT_106	[p6l828t1997r1366b2076],
4	allele	NN	O	allele	dep	1	SENT_106	[p6l1415t1997r1639b2076],
5	to	TO	O	to	aux	6	SENT_106	[p6l1689t2014r1771b2076],
6	prevent	VB	O	prevent	infmod	1	SENT_106	[p6l1821t2014r2140b2098],
7	hypersensitivity	NN	O	hypersensitivity	dobj	6	SENT_106	[p6l10t2125r692b2226],
8	to	TO	O	to	_	0	SENT_106	[p6l723t2142r804b2204],
9	abacavir	NN	O	abacavir	prep_to	6	SENT_106	[p6l840t2125r1214b2204],
10	.	.	O	.	_	0	SENT_106	[p6l840t2125r1214b2204],

1	The	DT	O	the	det	4	SENT_107	[p6l1251t2125r1413b2204],
2	negative	JJ	O	negative	amod	4	SENT_107	[p6l1447t2126r1801b2226],
3	predictive	JJ	O	predictive	amod	4	SENT_107	[p6l1835t2125r2134b2226, p6l11t2254r157b2332],
4	value	NN	O	value	_	0	SENT_107	[p6l196t2253r416b2332],
5	of	IN	O	of	_	0	SENT_107	[p6l459t2253r559b2332],
6	HLA	NN	O	hlum	prep_of	4	SENT_107	[p6l582t2253r1121b2332],
7	.	.	O	.	_	0	SENT_107	[p6l582t2253r1121b2332],

1	—	NN	O	—	_	0	SENT_108	[p6l582t2253r1121b2332],
2	.	.	O	.	_	0	SENT_108	[p6l582t2253r1121b2332],

1	B	NN	O	b	nsubjpass	13	SENT_109	[p6l582t2253r1121b2332],
2	*	CD	NUMBER	*	number	3	SENT_109	[p6l582t2253r1121b2332],
3	5701	CD	NUMBER	5701	npadvmod	1	SENT_109	[p6l582t2253r1121b2332],
4	for	IN	O	for	_	0	SENT_109	[p6l1163t2253r1287b2332],
5	patch	NN	O	patch	nn	8	SENT_109	[p6l1325t2253r2135b2354],
6	—	CD	NUMBER	—	num	8	SENT_109	[p6l1325t2253r2135b2354],
7	test	NN	O	test	nn	8	SENT_109	[p6l1325t2253r2135b2354],
8	—	NN	O	—	prep_for	1	SENT_109	[p6l1325t2253r2135b2354],
9	positive	JJ	O	positive	amod	11	SENT_109	[p6l1325t2253r2135b2354],
10	abacavir	NN	O	abacavir	nn	11	SENT_109	[p6l10t2381r366b2460],
11	hypersensitivity	NN	O	hypersensitivity	dep	8	SENT_109	[p6l402t2381r1084b2482],
12	was	VBD	O	be	auxpass	13	SENT_109	[p6l1114t2408r1277b2460],
13	found	VBN	O	find	_	0	SENT_109	[p6l1318t2381r1571b2460],
14	to	TO	O	to	aux	17	SENT_109	[p6l1610t2398r1692b2460],
15	be	VB	O	be	cop	17	SENT_109	[p6l1733t2381r1829b2460],
16	100	CD	PERCENT	100	num	17	SENT_109	[p6l1871t2387r2131b2477],
17	%	NN	PERCENT	%	xcomp	13	SENT_109	[p6l1871t2387r2131b2477],
18	;	:	O	;	_	0	SENT_109	[p6l1871t2387r2131b2477],
19	We	PRP	O	we	nsubj	21	SENT_109	[p6l6t2536r124b2589],
20	therefore	RB	O	therefore	advmod	21	SENT_109	[p6l157t2509r546b2588],
21	disagree	VBP	O	disagree	parataxis	13	SENT_109	[p6l580t2509r940b2610],
22	with	IN	O	with	_	0	SENT_109	[p6l968t2509r1164b2588],
23	Vandekerckhove	NNP	O	Vandekerckhove	prep_with	21	SENT_109	[p6l1193t2509r1895b2589],
24	et	FW	O	et	nn	25	SENT_109	[p6l1928t2526r2006b2588],
25	al.	FW	O	al.	dobj	21	SENT_109	[p6l2033t2509r2130b2588],
26	that	WDT	O	that	dobj	32	SENT_109	[p6l11t2637r187b2716],
27	our	PRP$	O	we	poss	28	SENT_109	[p6l227t2663r375b2716],
28	study	NN	O	study	nsubj	32	SENT_109	[p6l419t2637r653b2738],
29	will	MD	O	will	aux	32	SENT_109	[p6l690t2637r858b2716],
30	only	RB	O	only	advmod	31	SENT_109	[p6l904t2637r1091b2738],
31	modestly	RB	O	modestly	advmod	32	SENT_109	[p6l1131t2637r1533b2738],
32	alter	VB	O	alter	rcmod	25	SENT_109	[p6l1574t2637r1772b2716],
33	clinical	JJ	O	clinical	amod	34	SENT_109	[p6l1814t2637r2136b2716],
34	practice	NN	O	practice	dobj	32	SENT_109	[p6l9t2766r353b2866],
35	.	.	O	.	_	0	SENT_109	[p6l9t2766r353b2866],

1	Randomized	NNP	O	Randomized	nsubj	11	SENT_110	[p6l391t2765r947b2861],
2	,	,	O	,	_	0	SENT_110	[p6l391t2765r947b2861],
3	placebo	NN	O	placebo	nn	4	SENT_110	[p6l984t2765r1780b2866],
4	—	NN	O	—	appos	1	SENT_110	[p6l984t2765r1780b2866],
5	controlled	VBN	O	control	partmod	4	SENT_110	[p6l984t2765r1780b2866],
6	,	,	O	,	_	0	SENT_110	[p6l984t2765r1780b2866],
7	doubleblind	JJ	O	doubleblind	amod	9	SENT_110	[p6l1820t2765r2134b2844, p6l11t2893r232b2972],
8	clinical	JJ	O	clinical	amod	9	SENT_110	[p6l272t2893r585b2972],
9	studies	NNS	O	study	nsubj	11	SENT_110	[p6l625t2893r925b2972],
10	have	VBP	O	have	aux	11	SENT_110	[p6l965t2893r1155b2972],
11	shown	VBN	O	show	_	0	SENT_110	[p6l1195t2893r1477b2972],
12	a	DT	O	a	det	17	SENT_110	[p6l1515t2920r1559b2972],
13	2	CD	NUMBER	2	number	15	SENT_110	[p6l1595t2899r1643b2970],
14	to	TO	O	to	dep	15	SENT_110	[p6l1682t2910r1764b2972],
15	7	CD	PERCENT	7	dep	16	SENT_110	[p6l1804t2898r1937b2972],
16	%	NN	PERCENT	%	dep	17	SENT_110	[p6l1804t2898r1937b2972],
17	rate	NN	O	rate	dobj	11	SENT_110	[p6l1975t2910r2135b2972],
18	of	IN	O	of	_	0	SENT_110	[p6l11t3021r111b3100],
19	hypersensitivity	NN	O	hypersensitivity	prep_of	17	SENT_110	[p6l127t3021r810b3122],
20	among	IN	O	among	_	0	SENT_110	[p6l839t3047r1139b3122],
21	patients	NNS	O	patient	prep_among	11	SENT_110	[p6l1170t3022r1512b3122],
22	who	WP	O	who	nsubj	25	SENT_110	[p6l1545t3021r1728b3100],
23	were	VBD	O	be	aux	25	SENT_110	[p6l1760t3048r1962b3100],
24	not	RB	O	not	neg	25	SENT_110	[p6l1997t3038r2140b3100],
25	receiving	VBG	O	receive	rcmod	21	SENT_110	[p6l10t3150r384b3250],
26	abacavir	NN	O	abacavir	nn	27	SENT_110	[p6l405t3149r802b3228],
27	}	NN	O	}	dobj	25	SENT_110	[p6l405t3149r802b3228],
28	Therefore	RB	O	therefore	advmod	25	SENT_110	[p6l824t3149r1246b3245],
29	,	,	O	,	_	0	SENT_110	[p6l824t3149r1246b3245],
30	the	DT	O	the	det	33	SENT_110	[p6l1277t3149r1406b3228],
31	3.4	CD	PERCENT	3.4	num	33	SENT_110	[p6l1433t3155r1635b3228],
32	%	NN	PERCENT	%	nn	33	SENT_110	[p6l1433t3155r1635b3228],
33	rate	NN	O	rate	appos	21	SENT_110	[p6l1659t3166r1813b3228],
34	among	IN	O	among	_	0	SENT_110	[p6l1838t3175r2139b3250],
35	patients	NNS	O	patient	prep_among	33	SENT_110	[p6l9t3278r351b3378],
36	with	IN	O	with	_	0	SENT_110	[p6l389t3277r585b3357],
37	a	DT	O	a	det	39	SENT_110	[p6l625t3304r670b3356],
38	clinical	JJ	O	clinical	amod	39	SENT_110	[p6l710t3277r1023b3356],
39	diagnosis	NN	O	diagnosis	prep_with	35	SENT_110	[p6l1064t3277r1476b3378],
40	of	IN	O	of	_	0	SENT_110	[p6l1520t3277r1620b3356],
41	hypersensitivity	NN	O	hypersensitivity	prep_of	39	SENT_110	[p6l1642t3277r2134b3378, p6l11t3406r227b3506],
42	but	CC	O	but	_	0	SENT_110	[p6l262t3405r402b3484],
43	a	DT	O	a	det	46	SENT_110	[p6l435t3432r479b3484],
44	negative	JJ	O	negative	amod	46	SENT_110	[p6l516t3406r870b3506],
45	patch	NN	O	patch	nn	46	SENT_110	[p6l908t3405r1144b3506],
46	test	NN	O	test	nsubjpass	48	SENT_110	[p6l1183t3422r1338b3484],
47	was	VBD	O	be	auxpass	48	SENT_110	[p6l1367t3432r1529b3484],
48	expected	VBN	O	expect	conj_but	11	SENT_110	[p6l1571t3405r1971b3506],
49	.	.	O	.	_	0	SENT_110	[p6l1571t3405r1971b3506],

1	Indeed	RB	O	indeed	advmod	14	SENT_111	[p6l2014t3413r2134b3483, p6l11t3533r233b3629],
2	,	,	O	,	_	0	SENT_111	[p6l2014t3413r2134b3483, p6l11t3533r233b3629],
3	for	IN	O	for	_	0	SENT_111	[p6l277t3533r401b3612],
4	the	DT	O	the	det	5	SENT_111	[p6l437t3533r570b3612],
5	purposes	NNS	O	purpose	prep_for	14	SENT_111	[p6l608t3559r1002b3634],
6	of	IN	O	of	_	0	SENT_111	[p6l1043t3533r1143b3612],
7	our	PRP$	O	we	poss	8	SENT_111	[p6l1165t3559r1311b3612],
8	calculation	NN	O	calculation	prep_of	5	SENT_111	[p6l1347t3533r1822b3612],
9	of	IN	O	of	_	0	SENT_111	[p6l1861t3533r1962b3612],
10	statistical	JJ	O	statistical	amod	11	SENT_111	[p6l1984t3550r2134b3612, p6l11t3661r310b3740],
11	power	NN	O	power	prep_of	8	SENT_111	[p6l353t3687r644b3762],
12	,	,	O	,	_	0	SENT_111	[p6l353t3687r644b3762],
13	we	PRP	O	we	nsubj	14	SENT_111	[p6l691t3688r810b3740],
14	anticipated	VBD	O	anticipate	_	0	SENT_111	[p6l855t3661r1342b3762],
15	a	DT	O	a	det	16	SENT_111	[p6l1387t3688r1432b3740],
16	rate	NN	O	rate	dobj	14	SENT_111	[p6l1476t3678r1639b3740],
17	of	IN	O	of	_	0	SENT_111	[p6l1685t3661r1786b3740],
18	clinical	JJ	O	clinical	amod	19	SENT_111	[p6l1814t3661r2136b3740],
19	overdiagnosis	NN	O	overdiagnosis	prep_of	16	SENT_111	[p7l11t20r616b121],
20	of	IN	O	of	_	0	SENT_111	[p7l678t20r779b99],
21	3.6	CD	PERCENT	3.6	num	22	SENT_111	[p7l819t26r1033b99],
22	%	NN	PERCENT	%	prep_of	19	SENT_111	[p7l819t26r1033b99],
23	among	IN	O	among	_	0	SENT_111	[p7l1090t46r1394b121],
24	patients	NNS	O	patient	prep_among	14	SENT_111	[p7l1448t21r1797b121],
25	in	IN	O	in	_	0	SENT_111	[p7l1857t21r1941b98],
26	the	DT	O	the	det	28	SENT_111	[p7l2000t20r2135b99],
27	screened	VBN	O	screen	amod	28	SENT_111	[p7l12t148r386b227],
28	group	NN	O	group	prep_in	24	SENT_111	[p7l425t174r700b249],
29	.	.	O	.	_	0	SENT_111	[p7l425t174r700b249],

1	In	IN	O	in	_	0	SENT_112	[p7l744t156r833b226],
2	addition	NN	O	addition	prep_in	7	SENT_112	[p7l873t148r1253b244],
3	,	,	O	,	_	0	SENT_112	[p7l873t148r1253b244],
4	nonblinded	JJ	O	nonblinded	amod	5	SENT_112	[p7l1298t148r1791b227],
5	studies	NNS	O	study	nsubj	7	SENT_112	[p7l1833t148r2133b227],
6	have	VBP	O	have	aux	7	SENT_112	[p7l10t276r200b355],
7	shown	VBN	O	show	_	0	SENT_112	[p7l234t276r516b355],
8	that	IN	O	that	complm	11	SENT_112	[p7l549t276r722b355],
9	clinical	JJ	O	clinical	amod	10	SENT_112	[p7l750t276r1064b355],
10	overdiagnosis	NN	O	overdiagnosis	nsubj	11	SENT_112	[p7l1096t276r1689b377],
11	decreases	VBZ	O	decrease	ccomp	7	SENT_112	[p7l1724t276r2133b355],
12	dramatically	RB	O	dramatically	advmod	11	SENT_112	[p7l11t404r542b505],
13	over	IN	O	over	_	0	SENT_112	[p7l573t430r749b483],
14	time	NN	O	time	prep_over	11	SENT_112	[p7l781t405r993b500],
15	,	,	O	,	_	0	SENT_112	[p7l781t405r993b500],
16	further	JJ	O	further	dobj	11	SENT_112	[p7l1033t404r1336b483],
17	providing	VBG	O	provide	partmod	16	SENT_112	[p7l1366t404r1777b505],
18	support	NN	O	support	dobj	17	SENT_112	[p7l1811t421r2140b505],
19	for	IN	O	for	_	0	SENT_112	[p7l10t532r134b611],
20	the	DT	O	the	det	22	SENT_112	[p7l169t532r302b611],
21	clinical	JJ	O	clinical	amod	22	SENT_112	[p7l341t532r655b611],
22	impact	NN	O	impact	prep_for	17	SENT_112	[p7l692t533r989b633],
23	of	IN	O	of	_	0	SENT_112	[p7l1023t532r1123b611],
24	HLA	NN	O	hlum	prep_of	22	SENT_112	[p7l1141t532r1680b611],
25	.	.	O	.	_	0	SENT_112	[p7l1141t532r1680b611],

1	—	NN	O	—	_	0	SENT_113	[p7l1141t532r1680b611],
2	.	.	O	.	_	0	SENT_113	[p7l1141t532r1680b611],

1	B	NN	O	b	nsubj	7	SENT_114	[p7l1141t532r1680b611],
2	*	CD	NUMBER	*	num	1	SENT_114	[p7l1141t532r1680b611],
3	5701	CD	NUMBER	5701	num	4	SENT_114	[p7l1141t532r1680b611],
4	screening	NN	O	screening	dep	1	SENT_114	[p7l1720t533r2139b633],
5	and	CC	O	and	cc	4	SENT_114	[p7l10t660r165b739],
6	therefore	RB	O	therefore	advmod	4	SENT_114	[p7l196t660r577b739],
7	lessening	VBG	O	lessen	partmod	22	SENT_114	[p7l607t660r1007b761],
8	the	DT	O	the	det	9	SENT_114	[p7l1034t660r1165b739],
9	need	NN	O	need	dobj	7	SENT_114	[p7l1196t660r1394b739],
10	for	IN	O	for	_	0	SENT_114	[p7l1424t660r1545b739],
11	a	DT	O	a	det	13	SENT_114	[p7l1572t687r1617b739],
12	rechallenge	NN	O	rechallenge	nn	13	SENT_114	[p7l1645t660r2135b761],
13	study	NN	O	study	prep_for	7	SENT_114	[p7l12t788r295b889],
14	.1	CD	NUMBER	.1	tmod	7	SENT_114	[p7l12t788r295b889],
15	Finally	RB	O	finally	advmod	14	SENT_114	[p7l327t788r634b889],
16	,	,	O	,	_	0	SENT_114	[p7l327t788r634b889],
17	it	PRP	O	it	nsubj	28	SENT_114	[p7l673t789r732b867],
18	would	MD	O	would	aux	22	SENT_114	[p7l756t788r1023b868],
19	not	RB	O	not	neg	22	SENT_114	[p7l1056t805r1199b867],
20	have	VB	O	have	aux	22	SENT_114	[p7l1228t788r1418b867],
21	been	VBN	O	be	cop	22	SENT_114	[p7l1453t788r1654b867],
22	safe	JJ	O	safe	_	0	SENT_114	[p7l1689t788r1880b884],
23	,	,	O	,	_	0	SENT_114	[p7l1689t788r1880b884],
24	practical	JJ	O	practical	dep	22	SENT_114	[p7l1918t814r2134b889, p7l11t916r217b1012],
25	,	,	O	,	_	0	SENT_114	[p7l1918t814r2134b889, p7l11t916r217b1012],
26	or	CC	O	or	_	0	SENT_114	[p7l255t942r343b995],
27	methodologically	RB	O	methodologically	advmod	22	SENT_114	[p7l372t916r1127b1017],
28	sound	VB	O	sound	conj_or	22	SENT_114	[p7l1156t916r1417b995],
29	to	TO	O	to	aux	30	SENT_114	[p7l1449t933r1530b995],
30	incorporate	VB	O	incorporate	xcomp	28	SENT_114	[p7l1562t917r2062b1017],
31	a	DT	O	a	det	33	SENT_114	[p7l2092t943r2137b995],
32	double	JJ	O	double	amod	33	SENT_114	[p7l11t1044r569b1140],
33	—	NN	O	—	nsubj	34	SENT_114	[p7l11t1044r569b1140],
34	blind	JJ	O	blind	xcomp	30	SENT_114	[p7l11t1044r569b1140],
35	,	,	O	,	_	0	SENT_114	[p7l11t1044r569b1140],
36	placebo	NN	O	placebo	nn	37	SENT_114	[p7l596t1044r1389b1145],
37	—	NN	O	—	conj_or	22	SENT_114	[p7l596t1044r1389b1145],
38	controlled	VBN	O	control	partmod	37	SENT_114	[p7l596t1044r1389b1145],
39	rechallenge	NN	O	rechallenge	nn	40	SENT_114	[p7l1412t1044r1897b1145],
40	component	NN	O	component	dobj	38	SENT_114	[p7l1921t1070r2134b1123, p7l9t1189r312b1273],
41	into	IN	O	into	_	0	SENT_114	[p7l342t1173r511b1251],
42	our	PRP$	O	we	poss	43	SENT_114	[p7l548t1198r694b1251],
43	study	NN	O	study	prep_into	38	SENT_114	[p7l727t1172r970b1273],
44	.	.	O	.	_	0	SENT_114	[p7l727t1172r970b1273],

1	We	PRP	O	we	nsubj	2	SENT_115	[p7l135t1308r268b1379],
2	commend	VBP	O	commend	_	0	SENT_115	[p7l301t1300r731b1379],
3	Abel	NNP	PERSON	Abel	nsubj	5	SENT_115	[p7l758t1300r953b1379],
4	et	FW	O	et	nn	5	SENT_115	[p7l985t1317r1063b1379],
5	al.	FW	O	al.	xcomp	2	SENT_115	[p7l1089t1300r1186b1379],
6	for	IN	O	for	_	0	SENT_115	[p7l1223t1300r1347b1379],
7	the	DT	O	the	det	8	SENT_115	[p7l1376t1300r1509b1379],
8	approach	NN	O	approach	prep_for	5	SENT_115	[p7l1540t1300r1936b1401],
9	that	WDT	O	that	rcmod	8	SENT_115	[p7l1968t1300r2140b1379],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_116	[p7l570t1486r648b1508],
2	MED	NNP	O	MED	_	0	SENT_116	[p7l663t1486r715b1501],
3	358	CD	NUMBER	358	num	2	SENT_116	[p7l725t1480r800b1508],
4	;	:	O	;	_	0	SENT_116	[p7l725t1480r800b1508],
5	23	CD	NUMBER	23	num	7	SENT_116	[p7l725t1480r800b1508],
6	WWW.NEJM.oRG	NN	O	www.nejm.org	nn	7	SENT_116	[p7l834t1486r1035b1508],
7	UNE5	NN	O	une5	dep	2	SENT_116	[p7l1081t1486r1158b1508],
8	,	,	O	,	_	0	SENT_116	[p7l1081t1486r1158b1508],
9	2008	CD	DATE	2008	num	10	SENT_116	[p7l1169t1480r1233b1502],
10	Z515	NN	O	z515	appos	7	SENT_116	[p7l1940t1476r2015b1499],

1	The	DT	O	the	det	5	SENT_117	[p7l702t1519r753b1543],
2	New	NNP	O	New	nn	5	SENT_117	[p7l762t1520r824b1543],
3	England	NNP	O	England	nn	5	SENT_117	[p7l833t1519r944b1550],
4	Journal	NNP	O	Journal	nn	5	SENT_117	[p7l953t1519r1050b1543],
5	o	NN	O	o	_	0	SENT_117	[p7l1060t1527r1075b1543],
6	edicine	NN	O	edicine	dep	5	SENT_117	[p7l1125t1519r1220b1543],

1	The	DT	O	the	det	4	SENT_118	[p7l672t1707r717b1728],
2	NEW	NNP	O	NEW	nn	4	SENT_118	[p7l736t1709r821b1728],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_118	[p7l840t1709r1029b1728],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_118	[p7l1048t1709r1228b1735],
5	of	IN	O	of	_	0	SENT_118	[p7l1247t1707r1276b1734],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_118	[p7l1288t1709r1487b1728],

1	they	PRP	O	they	nsubj	2	SENT_119	[p7l12t1929r195b2030],
2	took	VBD	O	take	_	0	SENT_119	[p7l233t1929r428b2009],
3	to	TO	O	to	aux	4	SENT_119	[p7l466t1946r547b2008],
4	establish	VB	O	establish	xcomp	2	SENT_119	[p7l591t1929r972b2008],
5	the	DT	O	the	det	8	SENT_119	[p7l1014t1929r1146b2008],
6	very	RB	O	very	advmod	7	SENT_119	[p7l1184t1955r1362b2030],
7	low	JJ	O	low	amod	8	SENT_119	[p7l1398t1929r1553b2008],
8	frequency	NN	O	frequency	dobj	4	SENT_119	[p7l1591t1929r2014b2030],
9	of	IN	O	of	_	0	SENT_119	[p7l2053t1929r2152b2008],
10	HLA	NN	O	hlum	prep_of	8	SENT_119	[p7l11t2057r539b2136],
11	.	.	O	.	_	0	SENT_119	[p7l11t2057r539b2136],

1	—	NN	O	—	_	0	SENT_120	[p7l11t2057r539b2136],
2	.	.	O	.	_	0	SENT_120	[p7l11t2057r539b2136],

1	B	NN	O	b	_	0	SENT_121	[p7l11t2057r539b2136],
2	*	CD	NUMBER	*	number	3	SENT_121	[p7l11t2057r539b2136],
3	5701	CD	NUMBER	5701	num	4	SENT_121	[p7l11t2057r539b2136],
4	carriage	NN	O	carriage	dep	1	SENT_121	[p7l579t2058r919b2158],
5	in	IN	O	in	_	0	SENT_121	[p7l958t2058r1040b2135],
6	a	DT	O	a	det	7	SENT_121	[p7l1078t2084r1123b2136],
7	population	NN	O	population	prep_in	4	SENT_121	[p7l1158t2057r1620b2158],
8	of	IN	O	of	_	0	SENT_121	[p7l1659t2057r1758b2136],
9	Martinican	JJ	MISC	martinican	amod	10	SENT_121	[p7l1775t2058r2133b2136, p7l12t2210r163b2262],
10	blacks	NNS	O	black	prep_of	7	SENT_121	[p7l207t2184r505b2263],
11	.	.	O	.	_	0	SENT_121	[p7l207t2184r505b2263],

1	However	RB	O	however	advmod	9	SENT_122	[p7l551t2192r953b2279],
2	,	,	O	,	_	0	SENT_122	[p7l551t2192r953b2279],
3	the	DT	O	the	det	5	SENT_122	[p7l1001t2184r1136b2262],
4	clinical	JJ	O	clinical	amod	5	SENT_122	[p7l1179t2184r1500b2262],
5	usefulness	NN	O	usefulness	nsubjpass	9	SENT_122	[p7l1542t2184r2006b2263],
6	of	IN	O	of	_	0	SENT_122	[p7l2051t2184r2152b2262],
7	screening	NN	O	screening	prep_of	5	SENT_122	[p7l13t2313r431b2413],
8	is	VBZ	O	be	auxpass	9	SENT_122	[p7l464t2313r530b2391],
9	predicated	VBN	O	predicate	_	0	SENT_122	[p7l568t2312r1019b2413],
10	on	IN	O	on	_	0	SENT_122	[p7l1057t2338r1163b2391],
11	the	DT	O	the	det	12	SENT_122	[p7l1200t2312r1332b2391],
12	reduction	NN	O	reduction	prep_on	9	SENT_122	[p7l1369t2312r1779b2391],
13	in	IN	O	in	_	0	SENT_122	[p7l1815t2313r1898b2390],
14	both	DT	O	both	prep_in	12	SENT_122	[p7l1936t2312r2134b2391],
15	immunologically	RB	O	immunologically	advmod	16	SENT_122	[p7l11t2440r767b2541],
16	confirmed	VBN	O	confirm	partmod	14	SENT_122	[p7l814t2440r1279b2519],
17	and	CC	O	and	_	0	SENT_122	[p7l1329t2440r1489b2519],
18	false	JJ	O	false	amod	21	SENT_122	[p7l1540t2440r1743b2519],
19	positive	JJ	O	positive	amod	21	SENT_122	[p7l1794t2441r2134b2541],
20	clinical	JJ	O	clinical	amod	21	SENT_122	[p7l12t2568r326b2647],
21	diagnoses	NNS	O	diagnosis	prep_on	9	SENT_122	[p7l374t2568r829b2669],
22	,	,	O	,	_	0	SENT_122	[p7l374t2568r829b2669],
23	and	CC	O	and	_	0	SENT_122	[p7l881t2568r1039b2647],
24	Abel	NNP	PERSON	Abel	nsubj	29	SENT_122	[p7l1083t2568r1278b2647],
25	et	FW	O	et	nn	26	SENT_122	[p7l1326t2585r1403b2647],
26	al.	FW	O	al.	dep	24	SENT_122	[p7l1445t2568r1542b2647],
27	do	VBP	O	do	aux	29	SENT_122	[p7l1596t2568r1699b2647],
28	not	RB	O	not	neg	29	SENT_122	[p7l1748t2585r1891b2647],
29	state	NN	O	state	conj_and	9	SENT_122	[p7l1935t2585r2133b2647],
30	whether	IN	O	whether	dep	42	SENT_122	[p7l7t2696r350b2775],
31	the	DT	O	the	det	33	SENT_122	[p7l380t2696r508b2775],
32	discontinuation	NN	O	discontinuation	nn	33	SENT_122	[p7l541t2696r1192b2775],
33	rate	NN	O	rate	nsubj	42	SENT_122	[p7l1223t2713r1377b2775],
34	of	IN	O	of	_	0	SENT_122	[p7l1410t2696r1508b2775],
35	2.4	CD	PERCENT	2.4	num	36	SENT_122	[p7l1521t2702r1726b2775],
36	%	NN	PERCENT	%	prep_of	33	SENT_122	[p7l1521t2702r1726b2775],
37	observed	VBN	O	observe	partmod	36	SENT_122	[p7l1758t2696r2134b2776],
38	in	IN	O	in	_	0	SENT_122	[p7l11t2825r95b2902],
39	the	DT	O	the	det	41	SENT_122	[p7l128t2824r260b2903],
40	prescreening	VBG	O	prescreen	amod	41	SENT_122	[p7l292t2825r853b2925],
41	phase	NN	O	phase	prep_in	37	SENT_122	[p7l881t2824r1130b2925],
42	decreased	VBD	O	decrease	dobj	29	SENT_122	[p7l1164t2824r1586b2903],
43	toward	IN	O	toward	_	0	SENT_122	[p7l1619t2824r1919b2904],
44	zero	CD	NUMBER	zero	prep_toward	42	SENT_122	[p7l1951t2850r2133b2903],
45	after	IN	O	after	mark	48	SENT_122	[p7l11t2952r210b3031],
46	screening	NN	O	screening	nsubjpass	48	SENT_122	[p7l243t2953r652b3053],
47	was	VBD	O	be	auxpass	48	SENT_122	[p7l680t2979r840b3031],
48	introduced	VBN	O	introduce	advcl	42	SENT_122	[p7l878t2952r1359b3048],
49	;	:	O	;	_	0	SENT_122	[p7l878t2952r1359b3048],
50	this	DT	O	this	det	51	SENT_122	[p7l1399t2952r1555b3031],
51	decrease	NN	O	decrease	nsubjpass	54	SENT_122	[p7l1593t2952r1952b3031],
52	has	VBZ	O	have	aux	54	SENT_122	[p7l1988t2952r2132b3031],
53	been	VBN	O	be	auxpass	54	SENT_122	[p7l12t3080r214b3159],
54	observed	VBN	O	observe	parataxis	42	SENT_122	[p7l251t3080r632b3159],
55	in	IN	O	in	_	0	SENT_122	[p7l667t3081r751b3158],
56	unblinded	JJ	O	unblinded	amod	58	SENT_122	[p7l787t3080r1226b3159],
57	screening	NN	O	screening	nn	58	SENT_122	[p7l1263t3081r1681b3181],
58	programs	NNS	O	program	prep_in	54	SENT_122	[p7l1713t3106r2132b3181],
59	reported	VBN	O	report	partmod	58	SENT_122	[p7l12t3208r379b3309],
60	on	IN	O	on	_	0	SENT_122	[p7l421t3234r527b3287],
61	elsewhere	RB	O	elsewhere	advmod	64	SENT_122	[p7l569t3208r1056b3287],
62	}	CD	NUMBER	}	pobj	61	SENT_122	[p7l569t3208r1056b3287],
63	The	DT	O	the	det	64	SENT_122	[p7l1094t3208r1255b3287],
64	approach	NN	O	approach	prep_on	59	SENT_122	[p7l1297t3208r1692b3309],
65	that	WDT	O	that	rel	69	SENT_122	[p7l1734t3208r1906b3287],
66	Abel	NNP	PERSON	Abel	nsubj	69	SENT_122	[p7l1939t3208r2134b3287],
67	and	CC	O	and	_	0	SENT_122	[p7l11t3336r167b3415],
68	colleagues	NNS	O	colleague	nsubj	69	SENT_122	[p7l203t3336r640b3437],
69	propose	VBP	O	propose	rcmod	64	SENT_122	[p7l676t3362r1015b3437],
70	may	MD	O	may	aux	72	SENT_122	[p7l1050t3362r1227b3437],
71	be	VB	O	be	cop	72	SENT_122	[p7l1258t3336r1354b3415],
72	reasonable	JJ	O	reasonable	ccomp	69	SENT_122	[p7l1389t3336r1841b3415],
73	to	TO	O	to	aux	74	SENT_122	[p7l1877t3353r1957b3415],
74	use	VB	O	use	xcomp	72	SENT_122	[p7l1993t3363r2134b3415],
75	in	IN	O	in	_	0	SENT_122	[p7l11t3465r95b3542],
76	small	JJ	O	small	prep_in	74	SENT_122	[p7l135t3464r392b3560],
77	,	,	O	,	_	0	SENT_122	[p7l135t3464r392b3560],
78	static	JJ	O	static	appos	76	SENT_122	[p7l437t3465r688b3560],
79	,	,	O	,	_	0	SENT_122	[p7l437t3465r688b3560],
80	and	CC	O	and	_	0	SENT_122	[p7l731t3464r888b3543],
81	select	JJ	O	select	amod	82	SENT_122	[p7l929t3464r1169b3543],
82	populations	NNS	O	population	dep	86	SENT_122	[p7l1201t3464r1714b3565],
83	in	IN	O	in	_	0	SENT_122	[p7l1754t3465r1837b3542],
84	which	WDT	O	which	prep_in	82	SENT_122	[p7l1872t3464r2134b3543],
85	the	DT	O	the	det	86	SENT_122	[p7l12t3592r147b3671],
86	epidemiology	NN	O	epidemiology	conj_and	42	SENT_122	[p7l200t3592r796b3693],
87	of	IN	O	of	_	0	SENT_122	[p7l844t3592r945b3671],
88	HLA	NN	O	hlum	prep_of	86	SENT_122	[p7l978t3592r1525b3671],
89	.	.	O	.	_	0	SENT_122	[p7l978t3592r1525b3671],

1	—	NN	O	—	_	0	SENT_123	[p7l978t3592r1525b3671],
2	.	.	O	.	_	0	SENT_123	[p7l978t3592r1525b3671],

1	B	NN	O	b	nsubjpass	7	SENT_124	[p7l978t3592r1525b3671],
2	*	CD	NUMBER	*	num	1	SENT_124	[p7l978t3592r1525b3671],
3	5701	CD	NUMBER	5701	num	4	SENT_124	[p7l978t3592r1525b3671],
4	carriage	NN	O	carriage	dep	1	SENT_124	[p7l1578t3593r1934b3693],
5	has	VBZ	O	have	aux	7	SENT_124	[p7l1986t3592r2132b3671],
6	been	VBN	O	be	auxpass	7	SENT_124	[p8l12t20r207b99],
7	deﬁned	VBN	O	deﬁned	_	0	SENT_124	[p8l248t20r561b99],
8	and	CC	O	and	_	0	SENT_124	[p8l600t20r753b99],
9	access	NN	O	access	nsubj	14	SENT_124	[p8l792t47r1047b99],
10	to	TO	O	to	_	0	SENT_124	[p8l1089t37r1168b99],
11	screening	NN	O	screening	prep_to	9	SENT_124	[p8l1210t21r1612b121],
12	may	MD	O	may	aux	14	SENT_124	[p8l1647t46r1822b121],
13	be	VB	O	be	cop	14	SENT_124	[p8l1858t20r1952b99],
14	unavailable	JJ	O	unavailable	conj_and	7	SENT_124	[p8l1991t46r2133b99, p8l11t148r407b244],
15	;	:	O	;	_	0	SENT_124	[p8l1991t46r2133b99, p8l11t148r407b244],
16	however	RB	O	however	advmod	19	SENT_124	[p8l444t148r819b244],
17	,	,	O	,	_	0	SENT_124	[p8l444t148r819b244],
18	we	PRP	O	we	nsubj	19	SENT_124	[p8l853t175r971b228],
19	caution	VBP	O	caution	parataxis	7	SENT_124	[p8l1005t149r1322b227],
20	against	IN	O	against	_	0	SENT_124	[p8l1354t149r1670b249],
21	the	DT	O	the	det	22	SENT_124	[p8l1698t148r1831b227],
22	generalization	NN	O	generalization	prep_against	19	SENT_124	[p8l1864t174r2133b249, p8l11t276r372b355],
23	of	IN	O	of	_	0	SENT_124	[p8l403t276r501b355],
24	this	DT	O	this	det	25	SENT_124	[p8l513t276r666b355],
25	approach	NN	O	approach	prep_of	22	SENT_124	[p8l698t276r1078b377],
26	to	TO	O	to	_	0	SENT_124	[p8l1108t293r1188b355],
27	other	JJ	O	other	amod	29	SENT_124	[p8l1220t276r1440b355],
28	nonwhite	JJ	O	nonwhite	amod	29	SENT_124	[p8l1467t276r1854b355],
29	populations	NNS	O	population	prep_to	19	SENT_124	[p8l1884t302r2133b377, p8l11t404r308b483],
30	with	IN	O	with	_	0	SENT_124	[p8l357t404r556b483],
31	a	DT	O	a	det	33	SENT_124	[p8l607t431r651b483],
32	low	JJ	O	low	amod	33	SENT_124	[p8l700t404r858b483],
33	prevalence	NN	O	prevalence	prep_with	29	SENT_124	[p8l905t404r1369b505],
34	of	IN	O	of	_	0	SENT_124	[p8l1422t404r1523b483],
35	HLA	NN	O	hlum	prep_of	33	SENT_124	[p8l1555t404r2129b483],
36	.	.	O	.	_	0	SENT_124	[p8l1555t404r2129b483],

1	—	NN	O	—	_	0	SENT_125	[p8l1555t404r2129b483],
2	.	.	O	.	_	0	SENT_125	[p8l1555t404r2129b483],

1	B	NN	O	b	_	0	SENT_126	[p8l1555t404r2129b483],
2	*	CD	NUMBER	*	number	3	SENT_126	[p8l1555t404r2129b483],
3	5701	CD	NUMBER	5701	num	1	SENT_126	[p8l1555t404r2129b483],
4	.	.	O	.	_	0	SENT_126	[p8l1555t404r2129b483],

1	Given	VBN	O	give	_	0	SENT_127	[p8l12t533r256b611],
2	that	IN	O	that	_	0	SENT_127	[p8l294t532r467b611],
3	HLA	NN	O	hlum	prep_that	1	SENT_127	[p8l500t532r1037b611],
4	.	.	O	.	_	0	SENT_127	[p8l500t532r1037b611],

1	—	NN	O	—	_	0	SENT_128	[p8l500t532r1037b611],
2	.	.	O	.	_	0	SENT_128	[p8l500t532r1037b611],

1	B	NN	O	b	nsubjpass	6	SENT_129	[p8l500t532r1037b611],
2	*	CD	NUMBER	*	num	3	SENT_129	[p8l500t532r1037b611],
3	5701	CD	NUMBER	5701	dep	1	SENT_129	[p8l500t532r1037b611],
4	has	VBZ	O	have	aux	6	SENT_129	[p8l1076t532r1220b611],
5	been	VBN	O	be	auxpass	6	SENT_129	[p8l1261t532r1462b611],
6	shown	VBN	O	show	_	0	SENT_129	[p8l1502t532r1784b611],
7	to	TO	O	to	aux	8	SENT_129	[p8l1823t549r1904b611],
8	have	VB	O	have	xcomp	6	SENT_129	[p8l1944t532r2134b611],

1	100	CD	PERCENT	100	number	2	SENT_130	[p8l15t665r251b739],
2	%	NN	PERCENT	%	amod	3	SENT_130	[p8l15t665r251b739],
3	sensitivity	NN	O	sensitivity	_	0	SENT_130	[p8l288t661r722b761],
4	for	IN	O	for	mark	6	SENT_130	[p8l754t660r877b739],
5	immunologically	RB	O	immunologically	advmod	6	SENT_130	[p8l910t660r1648b761],
6	confirmed	VBN	O	confirm	dep	3	SENT_130	[p8l1680t660r2134b739],
7	hypersensitivity	NN	O	hypersensitivity	nsubj	20	SENT_130	[p8l12t788r709b889],
8	to	TO	O	to	_	0	SENT_130	[p8l757t805r839b867],
9	abacavir	NN	O	abacavir	prep_to	7	SENT_130	[p8l892t788r1256b867],
10	in	IN	O	in	_	0	SENT_130	[p8l1303t789r1388b866],
11	both	CC	O	both	preconj	12	SENT_130	[p8l1440t788r1641b867],
12	black	JJ	O	black	amod	15	SENT_130	[p8l1694t788r1927b868],
13	and	CC	O	and	_	0	SENT_130	[p8l1974t788r2134b867],
14	white	JJ	O	white	conj_and	12	SENT_130	[p8l7t916r253b995],
15	patients	NNS	O	patient	prep_in	9	SENT_130	[p8l306t917r660b1017],
16	in	IN	O	in	_	0	SENT_130	[p8l715t917r801b994],
17	the	DT	O	the	det	19	SENT_130	[p8l856t916r991b995],
18	United	NNP	LOCATION	United	nn	19	SENT_130	[p8l1046t916r1342b995],
19	States	NNPS	LOCATION	States	prep_in	15	SENT_130	[p8l1399t922r1725b1012],
20	}	FW	O	}	xcomp	6	SENT_130	[p8l1399t922r1725b1012],
21	selective	JJ	O	selective	amod	22	SENT_130	[p8l1781t916r2150b995],
22	screening	NN	O	screening	dep	20	SENT_130	[p8l13t1045r443b1145],
23	on	IN	O	on	_	0	SENT_130	[p8l484t1070r592b1123],
24	the	DT	O	the	det	25	SENT_130	[p8l635t1044r771b1123],
25	basis	NN	O	basis	prep_on	6	SENT_130	[p8l815t1044r1033b1123],
26	of	IN	O	of	_	0	SENT_130	[p8l1079t1044r1181b1123],
27	the	DT	O	the	det	29	SENT_130	[p8l1205t1044r1341b1123],
28	perceived	VBN	O	perceive	amod	29	SENT_130	[p8l1383t1044r1798b1145],
29	race	NN	O	race	prep_of	25	SENT_130	[p8l1841t1070r2018b1123],
30	or	CC	O	or	_	0	SENT_130	[p8l2063t1070r2153b1123],
31	ethnic	JJ	O	ethnic	amod	32	SENT_130	[p8l12t1172r278b1251],
32	background	NN	O	background	conj_or	3	SENT_130	[p8l312t1172r821b1273],
33	of	IN	O	of	_	0	SENT_130	[p8l855t1172r955b1251],
34	the	DT	O	the	det	35	SENT_130	[p8l971t1172r1102b1251],
35	patient	NN	O	patient	nsubj	37	SENT_130	[p8l1135t1173r1433b1273],
36	is	VBZ	O	be	cop	37	SENT_130	[p8l1461t1173r1527b1251],
37	unlikely	JJ	O	unlikely	prepc_of	3	SENT_130	[p8l1563t1172r1906b1273],
38	to	TO	O	to	aux	40	SENT_130	[p8l1936t1189r2017b1251],
39	be	VB	O	be	cop	40	SENT_130	[p8l2053t1172r2150b1251],
40	practical	JJ	O	practical	xcomp	37	SENT_130	[p8l11t1300r399b1401],
41	,	,	O	,	_	0	SENT_130	[p8l11t1300r399b1401],
42	ethical	JJ	O	ethical	conj_or	40	SENT_130	[p8l436t1300r743b1396],
43	,	,	O	,	_	0	SENT_130	[p8l436t1300r743b1396],
44	or	CC	O	or	_	0	SENT_130	[p8l779t1326r868b1379],
45	safe	JJ	O	safe	conj_or	40	SENT_130	[p8l896t1300r1062b1379],
46	in	IN	O	in	_	0	SENT_130	[p8l1092t1301r1175b1378],
47	most	JJS	O	most	amod	48	SENT_130	[p8l1205t1317r1420b1379],
48	settings	NNS	O	setting	prep_in	45	SENT_130	[p8l1447t1301r1780b1401],
49	because	IN	O	because	_	0	SENT_130	[p8l1814t1300r2150b1379],
50	of	IN	O	of	_	0	SENT_130	[p8l12t1428r114b1507],
51	increasing	VBG	O	increase	amod	52	SENT_130	[p8l133t1429r587b1529],
52	rates	NNS	O	rate	prep_because_of	40	SENT_130	[p8l623t1445r826b1507],
53	of	IN	O	of	_	0	SENT_130	[p8l869t1428r969b1507],
54	racial	JJ	O	racial	amod	57	SENT_130	[p8l991t1428r1227b1507],
55	or	CC	O	or	_	0	SENT_130	[p8l1266t1454r1356b1507],
56	ethnic	JJ	O	ethnic	amod	57	SENT_130	[p8l1393t1428r1663b1507],
57	admixture	NN	O	admixture	prep_of	52	SENT_130	[p8l1702t1428r2150b1507],
58	and	CC	O	and	_	0	SENT_130	[p8l11t1556r170b1635],
59	global	JJ	O	global	amod	60	SENT_130	[p8l209t1556r478b1657],
60	migration	NN	O	migration	conj_and	57	SENT_130	[p8l517t1557r950b1657],
61	and	CC	O	and	_	0	SENT_130	[p8l988t1556r1147b1635],
62	because	IN	O	because	_	0	SENT_130	[p8l1187t1556r1526b1635],
63	of	IN	O	of	prepc_because_of	88	SENT_130	[p8l1567t1556r1667b1635],
64	the	DT	O	the	det	65	SENT_130	[p8l1689t1556r1822b1635],
65	unreliability	NN	O	unreliability	pobj	88	SENT_130	[p8l1862t1556r2149b1635, p8l11t1684r284b1785],
66	of	IN	O	of	_	0	SENT_130	[p8l316t1684r417b1763],
67	the	DT	O	the	det	68	SENT_130	[p8l434t1684r568b1763],
68	assignment	NN	O	assignment	prep_of	65	SENT_130	[p8l603t1685r1108b1785],
69	of	IN	O	of	_	0	SENT_130	[p8l1139t1684r1239b1763],
70	race	NN	O	race	dep	84	SENT_130	[p8l1256t1710r1430b1763],
71	or	CC	O	or	_	0	SENT_130	[p8l1467t1710r1556b1763],
72	ethnic	JJ	O	ethnic	amod	73	SENT_130	[p8l1590t1684r1861b1763],
73	group	NN	O	group	dep	84	SENT_130	[p8l1895t1710r2149b1785],
74	by	IN	O	by	_	0	SENT_130	[p8l12t1812r110b1913],
75	the	DT	O	the	det	76	SENT_130	[p8l146t1812r280b1891],
76	patient	NN	O	patient	prep_by	73	SENT_130	[p8l319t1813r623b1913],
77	or	CC	O	or	_	0	SENT_130	[p8l658t1838r748b1891],
78	his	PRP$	O	he	amod	82	SENT_130	[p8l784t1812r910b1891],
79	or	CC	O	or	_	0	SENT_130	[p8l953t1838r1043b1891],
80	her	PRP$	O	she	conj_or	78	SENT_130	[p8l1079t1812r1219b1891],
81	clinician	NN	O	clinician	nn	82	SENT_130	[p8l1256t1812r1693b1891],
82	.3	NN	NUMBER	.3	prep_by	73	SENT_130	[p8l1256t1812r1693b1891],
83	Elizabeth	NNP	PERSON	Elizabeth	nn	84	SENT_130	[p8l20t1949r412b2029],
84	Phillips	NNP	PERSON	Phillips	prep_of	68	SENT_130	[p8l457t1949r796b2054],
85	,	,	O	,	_	0	SENT_130	[p8l457t1949r796b2054],
86	M.D.	NNP	O	M.D.	nn	88	SENT_130	[p8l840t1957r1048b2029],
87	David	NNP	PERSON	David	nn	88	SENT_130	[p8l20t2078r262b2159],
88	Nolan	NNP	PERSON	Nolan	conj_and	37	SENT_130	[p8l307t2078r591b2173],
89	,	,	O	,	_	0	SENT_130	[p8l307t2078r591b2173],
90	M.B.	NNP	LOCATION	M.B.	appos	88	SENT_130	[p8l636t2086r857b2173],
91	,	,	O	,	_	0	SENT_130	[p8l636t2086r857b2173],
92	B.S.	NNP	PERSON	B.S.	nn	94	SENT_130	[p8l902t2084r1060b2159],
93	Simon	NNP	PERSON	Simon	nn	94	SENT_130	[p8l14t2213r293b2288],
94	Mallal	NNP	PERSON	Mallal	appos	88	SENT_130	[p8l338t2207r622b2302],
95	,	,	O	,	_	0	SENT_130	[p8l338t2207r622b2302],
96	M.B.	NNP	LOCATION	M.B.	appos	88	SENT_130	[p8l667t2215r887b2302],
97	,	,	O	,	_	0	SENT_130	[p8l667t2215r887b2302],
98	B.S.	NNP	O	B.S.	appos	88	SENT_130	[p8l932t2213r1090b2288],

1	Murdoch	NNP	PERSON	Murdoch	nn	3	SENT_131	[p8l17t2351r318b2412],
2	University	NNP	PERSON	University	nn	3	SENT_131	[p8l350t2356r688b2430],
3	Murdoch	NNP	PERSON	Murdoch	nsubj	9	SENT_131	[p8l17t2435r339b2506],
4	,	,	O	,	_	0	SENT_131	[p8l17t2435r339b2506],
5	WA	NNP	LOCATION	WA	appos	3	SENT_131	[p8l364t2439r481b2496],
6	6150	CD	NUMBER	6150	num	5	SENT_131	[p8l505t2439r679b2506],
7	,	,	O	,	_	0	SENT_131	[p8l505t2439r679b2506],
8	Australia	NNP	LOCATION	Australia	appos	5	SENT_131	[p8l705t2435r1005b2496],
9	s.	VBD	O	s.	_	0	SENT_131	[p8l13t2522r918b2595],
10	ma	FW	O	ma	nn	11	SENT_131	[p8l13t2522r918b2595],
11	|	FW	O	|	dobj	9	SENT_131	[p8l13t2522r918b2595],
12	la	FW	O	la	prep	11	SENT_131	[p8l13t2522r918b2595],
13	|	FW	O	|	nn	14	SENT_131	[p8l13t2522r918b2595],
14	@murdoch.edu	FW	O	@murdoch.edu	pobj	12	SENT_131	[p8l13t2522r918b2595],
15	.	.	O	.	_	0	SENT_131	[p8l13t2522r918b2595],

1	au	IN	O	au	_	0	SENT_132	[p8l13t2522r918b2595],

1	1	LS	NUMBER	1	_	0	SENT_133	[p8l13t2694r62b2746],
2	.	.	O	.	_	0	SENT_133	[p8l13t2694r62b2746],

1	Phillips	NNP	PERSON	Phillips	nn	3	SENT_134	[p8l140t2686r391b2762],
2	E	NNP	O	E	nn	3	SENT_134	[p8l424t2691r505b2759],
3	]	NNP	O	]	_	0	SENT_134	[p8l424t2691r505b2759],
4	,	,	O	,	_	0	SENT_134	[p8l424t2691r505b2759],
5	Mallal	NNP	O	Mallal	nn	6	SENT_134	[p8l539t2686r751b2745],
6	SA	NNP	O	SA	appos	3	SENT_134	[p8l784t2690r887b2746],
7	.	.	O	.	_	0	SENT_134	[p8l784t2690r887b2746],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_135	[p8l922t2686r1532b2763],
2	and	CC	O	and	_	0	SENT_135	[p8l1564t2686r1685b2746],
3	the	DT	O	the	det	4	SENT_135	[p8l1718t2686r1820b2745],
4	potential	NN	O	potential	conj_and	1	SENT_135	[p8l1851t2686r2152b2762],
5	for	IN	O	for	_	0	SENT_135	[p8l11t2782r106b2841],
6	the	DT	O	the	det	7	SENT_135	[p8l129t2782r231b2841],
7	individualization	NN	O	individualization	prep_for	4	SENT_135	[p8l256t2782r826b2842],
8	of	IN	O	of	_	0	SENT_135	[p8l851t2782r927b2841],
9	antiretroviral	JJ	O	antiretroviral	amod	10	SENT_135	[p8l939t2782r1382b2842],
10	therapy	NN	O	therapy	prep_of	7	SENT_135	[p8l1408t2782r1667b2857],
11	.	.	O	.	_	0	SENT_135	[p8l1408t2782r1667b2857],

1	Curr	NNP	O	Curr	nn	4	SENT_136	[p8l1697t2786r1848b2842],
2	Opin	NNP	O	Opin	nn	4	SENT_136	[p8l1871t2783r2034b2857],
3	Infect	NNP	O	Infect	nn	4	SENT_136	[p8l2058t2787r2150b2840, p8l11t2878r133b2937],
4	Dis	NNP	O	Dis	_	0	SENT_136	[p8l155t2879r261b2936],
5	2008	CD	DATE	2008	num	4	SENT_136	[p8l289t2882r768b2949],
6	;	:	O	;	_	0	SENT_136	[p8l289t2882r768b2949],
7	21:16	CD	TIME	21:16	number	8	SENT_136	[p8l289t2882r768b2949],
8	—	CD	NUMBER	—	dep	4	SENT_136	[p8l289t2882r768b2949],
9	24	CD	NUMBER	24	dep	8	SENT_136	[p8l289t2882r768b2949],
10	.	.	O	.	_	0	SENT_136	[p8l289t2882r768b2949],

1	2	LS	NUMBER	2	_	0	SENT_137	[p8l10t2983r62b3035],
2	.	.	O	.	_	0	SENT_137	[p8l10t2983r62b3035],

1	Saag	NNP	PERSON	Saag	nn	2	SENT_138	[p8l143t2979r296b3052],
2	M	NNP	O	M	_	0	SENT_138	[p8l320t2980r403b3047],
3	,	,	O	,	_	0	SENT_138	[p8l320t2980r403b3047],
4	Balu	NNP	PERSON	Balu	nn	5	SENT_138	[p8l434t2975r581b3035],
5	R	NNP	O	R	appos	2	SENT_138	[p8l608t2980r674b3048],
6	,	,	O	,	_	0	SENT_138	[p8l608t2980r674b3048],
7	Phillips	NNP	PERSON	Phillips	nn	8	SENT_138	[p8l706t2975r957b3051],
8	E	NNP	O	E	appos	2	SENT_138	[p8l986t2980r1046b3047],
9	,	,	O	,	_	0	SENT_138	[p8l986t2980r1046b3047],
10	et	FW	O	et	nn	11	SENT_138	[p8l1079t2988r1138b3034],
11	al.	FW	O	al.	appos	2	SENT_138	[p8l1162t2975r1238b3035],
12	.	.	O	.	_	0	SENT_138	[p8l1162t2975r1238b3035],

1	High	JJ	O	high	amod	2	SENT_139	[p8l1270t2975r1435b3052],
2	sensitivity	NN	O	sensitivity	nsubj	14	SENT_139	[p8l1465t2976r1801b3051],
3	of	IN	O	of	_	0	SENT_139	[p8l1827t2975r1903b3035],
4	human	JJ	O	human	amod	5	SENT_139	[p8l1917t2975r2151b3035],
5	leukocyte	NN	O	leukocyte	prep_of	2	SENT_139	[p8l10t3072r326b3148],
6	antigen-B	JJ	O	antigen-b	amod	5	SENT_139	[p8l350t3072r866b3149],
7	*	CD	NUMBER	*	number	8	SENT_139	[p8l350t3072r866b3149],
8	5701	CD	NUMBER	5701	dep	6	SENT_139	[p8l350t3072r866b3149],
9	as	IN	O	as	_	0	SENT_139	[p8l890t3092r956b3131],
10	a	DT	O	a	det	11	SENT_139	[p8l982t3092r1015b3131],
11	marker	NN	O	marker	prep_as	5	SENT_139	[p8l1039t3072r1278b3132],
12	for	IN	O	for	prep	11	SENT_139	[p8l1300t3072r1395b3132],
13	immunologically	RB	O	immunologically	pcomp	12	SENT_139	[p8l1417t3072r1987b3149],
14	confirmed	VBN	O	confirm	_	0	SENT_139	[p8l2009t3091r2150b3132, p8l11t3168r238b3227],
15	abacavir	NN	O	abacavir	nn	16	SENT_139	[p8l279t3168r554b3228],
16	hypersensitivity	NN	O	hypersensitivity	dobj	14	SENT_139	[p8l594t3168r1121b3243],
17	in	IN	O	in	_	0	SENT_139	[p8l1159t3169r1223b3226],
18	white	JJ	O	white	amod	21	SENT_139	[p8l1261t3168r1445b3228],
19	and	CC	O	and	_	0	SENT_139	[p8l1486t3168r1607b3227],
20	black	JJ	O	black	conj_and	18	SENT_139	[p8l1650t3168r1826b3228],
21	patients	NNS	O	patient	prep_in	16	SENT_139	[p8l1863t3169r2147b3243],
22	.	.	O	.	_	0	SENT_139	[p8l1863t3169r2147b3243],

1	Clin	NNP	O	Clin	nn	3	SENT_140	[p8l11t3264r148b3323],
2	Infect	NNP	O	Infect	nn	3	SENT_140	[p8l172t3264r369b3323],
3	Dis	NNP	O	Dis	_	0	SENT_140	[p8l390t3265r496b3322],
4	2008	CD	DATE	2008	num	3	SENT_140	[p8l524t3268r1050b3335],
5	;	:	O	;	_	0	SENT_140	[p8l524t3268r1050b3335],
6	46:1111	CD	NUMBER	46:1111	number	7	SENT_140	[p8l524t3268r1050b3335],
7	—	CD	NUMBER	—	dep	3	SENT_140	[p8l524t3268r1050b3335],
8	8	CD	NUMBER	8	dep	7	SENT_140	[p8l524t3268r1050b3335],
9	.	.	O	.	_	0	SENT_140	[p8l524t3268r1050b3335],

1	3	LS	NUMBER	3	_	0	SENT_141	[p8l11t3368r62b3421],
2	.	.	O	.	_	0	SENT_141	[p8l11t3368r62b3421],

1	Phillips	NNP	PERSON	Phillips	nn	2	SENT_142	[p8l140t3361r391b3437],
2	E	NNP	O	E	_	0	SENT_142	[p8l420t3366r501b3430],
3	]	NN	O	]	dep	2	SENT_142	[p8l420t3366r501b3430],
4	.	.	O	.	_	0	SENT_142	[p8l420t3366r501b3430],

1	Genetic	JJ	O	genetic	amod	2	SENT_143	[p8l533t3362r787b3421],
2	screening	NN	O	screening	_	0	SENT_143	[p8l815t3362r1139b3438],
3	to	TO	O	to	aux	4	SENT_143	[p8l1164t3374r1227b3421],
4	prevent	VB	O	prevent	infmod	2	SENT_143	[p8l1255t3374r1502b3437],
5	abacavir	NN	O	abacavir	nn	7	SENT_143	[p8l1525t3361r1801b3421],
6	hypersensitivity	NN	O	hypersensitivity	nn	7	SENT_143	[p8l1826t3361r2150b3437, p8l12t3458r233b3533],
7	reaction	NN	O	reaction	dobj	4	SENT_143	[p8l256t3458r545b3517],
8	:	:	O	:	_	0	SENT_143	[p8l256t3458r545b3517],
9	are	VBP	O	be	cop	10	SENT_143	[p8l573t3477r673b3516],
10	we	PRP	O	we	dep	2	SENT_143	[p8l696t3477r786b3518],
11	there	RB	O	there	advmod	12	SENT_143	[p8l813t3457r980b3516],
12	yet	RB	O	yet	advmod	10	SENT_143	[p8l1003t3456r1126b3533],
13	?	.	O	?	_	0	SENT_143	[p8l1003t3456r1126b3533],

1	Clin	NNP	O	Clin	nn	3	SENT_144	[p8l1152t3457r1289b3517],
2	Infect	NNP	O	Infect	nn	3	SENT_144	[p8l1314t3457r1511b3516],
3	Dis	NNP	O	Dis	_	0	SENT_144	[p8l1532t3458r1638b3516],
4	2006	CD	DATE	2006	num	3	SENT_144	[p8l1666t3461r2145b3529],
5	;	:	O	;	_	0	SENT_144	[p8l1666t3461r2145b3529],
6	43:103	CD	NUMBER	43:103	number	7	SENT_144	[p8l1666t3461r2145b3529],
7	-5	CD	NUMBER	-5	dep	3	SENT_144	[p8l1666t3461r2145b3529],
8	.	.	O	.	_	0	SENT_144	[p8l1666t3461r2145b3529],

1	Bare-Metal	JJ	O	bare-metal	_	0	SENT_145	[p8l445t3608r727b3657],
2	versus	CC	O	versus	prep	1	SENT_145	[p8l749t3624r918b3657],
3	Drug-Eluting	JJ	O	drug-eluting	amod	5	SENT_145	[p8l943t3608r1274b3672],
4	Coronary	JJ	O	coronary	amod	5	SENT_145	[p8l1293t3612r1532b3672],
5	Stents	NNS	O	stent	dep	2	SENT_145	[p8l1551t3612r1715b3657],

1	TO	TO	O	to	aux	3	SENT_146	[p9l7t93r120b149],
2	THE	DT	O	the	det	3	SENT_146	[p9l154t94r319b148],
3	EDITOR	NN	O	editor	_	0	SENT_146	[p9l361t93r700b149],
4	:	:	O	:	_	0	SENT_146	[p9l361t93r700b149],
5	Marroquin	NNP	PERSON	Marroquin	dep	3	SENT_146	[p9l737t71r1208b171],
6	et	FW	O	et	nn	7	SENT_146	[p9l1246t87r1324b149],
7	al.	FW	O	al.	dep	5	SENT_146	[p9l1355t70r1453b149],
8	(	FW	O	(	dep	9	SENT_146	[p9l1500t77r1692b162],
9	Jan.	NNP	DATE	Jan.	rcmod	7	SENT_146	[p9l1500t77r1692b162],
10	24	CD	DATE	24	num	9	SENT_146	[p9l1734t76r1833b149],
11	issue	NN	O	issue	nn	12	SENT_146	[p9l1869t71r2148b162],
12	)	NN	O	)	dep	7	SENT_146	[p9l1869t71r2148b162],
13	1	CD	NUMBER	1	num	14	SENT_146	[p9l1869t71r2148b162],
14	attempt	NN	O	attempt	dep	12	SENT_146	[p9l8t215r346b299],
15	to	TO	O	to	aux	16	SENT_146	[p9l372t215r454b277],
16	address	VB	O	address	xcomp	3	SENT_146	[p9l485t198r812b277],
17	the	DT	O	the	det	18	SENT_146	[p9l845t198r978b277],
18	lack	NN	O	lack	dobj	16	SENT_146	[p9l1008t198r1186b277],
19	of	IN	O	of	_	0	SENT_146	[p9l1212t198r1312b277],
20	evidence	NN	O	evidence	prep_of	18	SENT_146	[p9l1325t198r1693b277],
21	regarding	VBG	O	regard	partmod	20	SENT_146	[p9l1724t198r2151b299],
22	off	RP	O	off	prt	21	SENT_146	[p9l10t326r360b405],
23	—	CD	NUMBER	—	num	25	SENT_146	[p9l10t326r360b405],
24	label	NN	O	label	nn	25	SENT_146	[p9l10t326r360b405],
25	use	NN	O	use	dobj	21	SENT_146	[p9l386t353r526b405],
26	of	IN	O	of	_	0	SENT_146	[p9l553t326r653b405],
27	drug	NN	O	drug	nn	30	SENT_146	[p9l662t326r1197b427],
28	—	NN	O	—	nn	30	SENT_146	[p9l662t326r1197b427],
29	eluting	VBG	O	elute	amod	30	SENT_146	[p9l662t326r1197b427],
30	stents	NNS	O	stent	prep_of	25	SENT_146	[p9l1222t343r1490b405],
31	.	.	O	.	_	0	SENT_146	[p9l1222t343r1490b405],

1	However	RB	O	however	advmod	24	SENT_147	[p9l1522t334r1912b422],
2	,	,	O	,	_	0	SENT_147	[p9l1522t334r1912b422],
3	their	PRP$	O	they	poss	4	SENT_147	[p9l1945t326r2150b405],
4	use	NN	O	use	nsubj	24	SENT_147	[p9l9t481r150b533],
5	of	IN	O	of	_	0	SENT_147	[p9l202t454r302b533],
6	a	DT	O	a	det	9	SENT_147	[p9l334t481r379b533],
7	historical	JJ	O	historical	amod	9	SENT_147	[p9l427t454r838b533],
8	comparison	NN	O	comparison	nn	9	SENT_147	[p9l888t455r1402b555],
9	group	NN	O	group	prep_of	4	SENT_147	[p9l1451t480r1706b555],
10	that	WDT	O	that	nsubj	11	SENT_147	[p9l1758t454r1932b533],
11	predated	VBD	O	predate	rcmod	9	SENT_147	[p9l1975t480r2147b555, p9l10t582r246b661],
12	the	DT	O	the	det	13	SENT_147	[p9l276t582r410b661],
13	group	NN	O	group	dobj	11	SENT_147	[p9l440t608r694b683],
14	With	IN	O	with	_	0	SENT_147	[p9l720t582r917b662],
15	drug	NN	O	drug	nn	16	SENT_147	[p9l948t582r1494b683],
16	—	NN	O	—	prep_with	11	SENT_147	[p9l948t582r1494b683],
17	eluting	VBG	O	elute	xcomp	11	SENT_147	[p9l948t582r1494b683],
18	stents	NNS	O	stent	dobj	17	SENT_147	[p9l1522t599r1773b661],
19	by	IN	O	by	_	0	SENT_147	[p9l1806t582r1904b683],
20	up	RB	DURATION	up	quantmod	22	SENT_147	[p9l1928t608r2032b683],
21	to	TO	DURATION	to	dep	22	SENT_147	[p9l2064t599r2147b661],
22	9	CD	DURATION	9	num	23	SENT_147	[p9l9t716r57b789],
23	years	NNS	NUMBER	year	prep_by	17	SENT_147	[p9l95t736r316b811],
24	raises	VBZ	O	raise	_	0	SENT_147	[p9l360t711r606b789],
25	major	JJ	O	major	amod	26	SENT_147	[p9l650t711r903b811],
26	concerns	NNS	O	concern	dobj	24	SENT_147	[p9l942t736r1352b789],
27	.	.	O	.	_	0	SENT_147	[p9l942t736r1352b789],

1	First	RB	ORDINAL	first	advmod	12	SENT_148	[p9l1398t711r1616b806],
2	,	,	O	,	_	0	SENT_148	[p9l1398t711r1616b806],
3	the	DT	O	the	det	5	SENT_148	[p9l1664t710r1797b789],
4	control	NN	O	control	nn	5	SENT_148	[p9l1840t710r2148b789],
5	group	NN	O	group	nsubj	12	SENT_148	[p9l9t864r263b939],
6	that	WDT	O	that	nsubj	7	SENT_148	[p9l294t838r467b917],
7	received	VBD	O	receive	rcmod	5	SENT_148	[p9l490t838r839b917],
8	bare	JJ	O	bare	amod	11	SENT_148	[p9l868t838r1335b917],
9	—	NN	O	—	nn	11	SENT_148	[p9l868t838r1335b917],
10	metal	NN	O	metal	nn	11	SENT_148	[p9l868t838r1335b917],
11	stents	NNS	O	stent	dobj	7	SENT_148	[p9l1365t855r1615b917],
12	included	VBD	O	include	_	0	SENT_148	[p9l1645t838r2015b917],
13	all	DT	O	all	det	14	SENT_148	[p9l2042t838r2148b917],
14	patients	NNS	O	patient	dobj	12	SENT_148	[p9l8t967r352b1067],
15	who	WP	O	who	nsubj	16	SENT_148	[p9l391t966r575b1045],
16	received	VBD	O	receive	rcmod	14	SENT_148	[p9l618t966r966b1045],
17	a	DT	O	a	det	18	SENT_148	[p9l1006t993r1051b1045],
18	stent	NN	O	stent	dobj	16	SENT_148	[p9l1093t983r1303b1045],
19	between	IN	O	between	_	0	SENT_148	[p9l1340t966r1701b1045],
20	1997	CD	DATE	1997	prep_between	18	SENT_148	[p9l1745t972r1947b1045],
21	and	CC	DATE	and	_	0	SENT_148	[p9l1989t966r2148b1045],
22	2002	CD	DATE	2002	prep_between	18	SENT_148	[p9l9t1101r240b1175],
23	.	.	O	.	_	0	SENT_148	[p9l9t1101r240b1175],

1	Patients	NNS	O	patient	nsubjpass	13	SENT_149	[p9l287t1096r630b1175],
2	treated	VBN	O	treat	partmod	1	SENT_149	[p9l676t1095r977b1175],
3	with	IN	O	with	_	0	SENT_149	[p9l1015t1095r1212b1176],
4	bare	JJ	O	bare	amod	7	SENT_149	[p9l1256t1095r1724b1175],
5	—	NN	O	—	nn	7	SENT_149	[p9l1256t1095r1724b1175],
6	metal	NN	O	metal	nn	7	SENT_149	[p9l1256t1095r1724b1175],
7	stents	NNS	O	stent	prep_with	2	SENT_149	[p9l1768t1112r2018b1175],
8	in	IN	O	in	_	0	SENT_149	[p9l2063t1096r2148b1173],
9	2004	CD	DATE	2004	prep_in	7	SENT_149	[p9l9t1230r220b1303],
10	and	CC	DATE	and	_	0	SENT_149	[p9l259t1224r418b1303],
11	2006	CD	DATE	2006	prep_in	7	SENT_149	[p9l458t1230r668b1303],
12	were	VBD	O	be	auxpass	13	SENT_149	[p9l704t1250r907b1303],
13	considered	VBN	O	consider	_	0	SENT_149	[p9l948t1224r1415b1303],
14	to	TO	O	to	aux	17	SENT_149	[p9l1455t1241r1537b1303],
15	be	VB	O	be	auxpass	17	SENT_149	[p9l1579t1224r1676b1303],
16	highly	RB	O	highly	advmod	17	SENT_149	[p9l1716t1224r1991b1325],
17	selected	VBN	O	select	xcomp	13	SENT_149	[p9l2028t1251r2147b1303, p9l8t1352r262b1431],
18	and	CC	O	and	_	0	SENT_149	[p9l307t1352r466b1431],
19	were	VBD	O	be	auxpass	20	SENT_149	[p9l507t1379r710b1432],
20	excluded	VBN	O	exclude	conj_and	13	SENT_149	[p9l757t1352r1133b1431],
21	from	IN	O	from	_	0	SENT_149	[p9l1178t1352r1390b1431],
22	the	DT	O	the	det	23	SENT_149	[p9l1436t1352r1570b1431],
23	study	NN	O	study	prep_from	20	SENT_149	[p9l1617t1352r1862b1453],
24	.	.	O	.	_	0	SENT_149	[p9l1617t1352r1862b1453],

1	However	RB	O	however	advmod	29	SENT_150	[p9l1913t1360r2147b1432, p9l10t1506r197b1576],
2	,	,	O	,	_	0	SENT_150	[p9l1913t1360r2147b1432, p9l10t1506r197b1576],
3	the	DT	O	the	det	4	SENT_150	[p9l230t1480r362b1559],
4	group	NN	O	group	nsubj	29	SENT_150	[p9l389t1506r639b1581],
5	with	IN	O	with	_	0	SENT_150	[p9l663t1480r857b1559],
6	drug	NN	O	drug	nn	7	SENT_150	[p9l885t1480r1420b1581],
7	—	NN	O	—	prep_with	4	SENT_150	[p9l885t1480r1420b1581],
8	eluting	VBG	O	elute	partmod	7	SENT_150	[p9l885t1480r1420b1581],
9	stents	NNS	O	stent	dobj	8	SENT_150	[p9l1446t1497r1691b1559],
10	that	WDT	O	that	nsubj	11	SENT_150	[p9l1721t1480r1892b1559],
11	made	VBD	O	make	rcmod	9	SENT_150	[p9l1914t1480r2147b1559],
12	up	RP	O	up	prt	11	SENT_150	[p9l9t1634r114b1709],
13	the	DT	O	the	det	16	SENT_150	[p9l148t1608r282b1687],
14	remaining	VBG	O	remain	amod	16	SENT_150	[p9l315t1609r770b1709],
15	78	CD	NUMBER	78	number	16	SENT_150	[p9l801t1613r986b1687],
16	°	CD	NUMBER	°	dobj	11	SENT_150	[p9l801t1613r986b1687],
17	/	:	O	/	punct	18	SENT_150	[p9l801t1613r986b1687],
18	o	NN	O	o	dep	16	SENT_150	[p9l801t1613r986b1687],
19	of	IN	O	of	_	0	SENT_150	[p9l1019t1608r1120b1687],
20	patients	NNS	O	patient	prep_of	18	SENT_150	[p9l1131t1609r1476b1709],
21	who	WP	O	who	nsubj	22	SENT_150	[p9l1506t1608r1690b1687],
22	received	VBD	O	receive	rcmod	16	SENT_150	[p9l1724t1608r2073b1687],
23	a	DT	O	a	det	24	SENT_150	[p9l2104t1635r2149b1687],
24	stent	NN	O	stent	dobj	22	SENT_150	[p9l11t1753r222b1815],
25	during	IN	O	during	_	0	SENT_150	[p9l249t1736r540b1837],
26	the	DT	O	the	det	28	SENT_150	[p9l570t1736r703b1815],
27	same	JJ	O	same	amod	28	SENT_150	[p9l737t1762r959b1815],
28	period	NN	O	period	prep_during	22	SENT_150	[p9l989t1736r1269b1837],
29	was	VBD	O	be	_	0	SENT_150	[p9l1296t1763r1459b1816],
30	also	RB	O	also	advmod	29	SENT_150	[p9l1493t1736r1689b1832],
31	,	,	O	,	_	0	SENT_150	[p9l1493t1736r1689b1832],
32	therefore	RB	O	therefore	advmod	29	SENT_150	[p9l1727t1736r2142b1832],
33	,	,	O	,	_	0	SENT_150	[p9l1727t1736r2142b1832],
34	a	DT	O	a	det	36	SENT_150	[p9l8t1891r54b1943],
35	selected	VBN	O	select	amod	36	SENT_150	[p9l88t1864r431b1943],
36	group	NN	O	group	dep	29	SENT_150	[p9l465t1890r742b1965],
37	.	.	O	.	_	0	SENT_150	[p9l465t1890r742b1965],

1	Inevitably	RB	O	inevitably	advmod	5	SENT_151	[p9l780t1864r1220b1965],
2	,	,	O	,	_	0	SENT_151	[p9l780t1864r1220b1965],
3	this	DT	O	this	det	4	SENT_151	[p9l1261t1864r1421b1943],
4	selection	NN	O	selection	nsubj	5	SENT_151	[p9l1460t1864r1842b1943],
5	resulted	VBD	O	result	_	0	SENT_151	[p9l1876t1864r2147b1943, p9l10t1992r106b2071],
6	in	IN	O	in	_	0	SENT_151	[p9l137t1993r220b2070],
7	bias	NN	O	bias	prep_in	5	SENT_151	[p9l253t1992r444b2088],
8	,	,	O	,	_	0	SENT_151	[p9l253t1992r444b2088],
9	as	IN	O	as	mark	10	SENT_151	[p9l480t2019r565b2071],
10	illustrated	VBN	O	illustrate	advcl	5	SENT_151	[p9l599t1992r1030b2071],
11	by	IN	O	by	_	0	SENT_151	[p9l1063t1992r1159b2093],
12	the	DT	O	the	det	15	SENT_151	[p9l1187t1992r1319b2071],
13	markedly	RB	O	markedly	advmod	14	SENT_151	[p9l1351t1992r1751b2093],
14	different	JJ	O	different	amod	15	SENT_151	[p9l1780t1992r2153b2071],
15	percentages	NNS	O	percentage	prep_by	10	SENT_151	[p9l8t2137r513b2221],
16	of	IN	O	of	_	0	SENT_151	[p9l546t2120r645b2199],
17	patients	NNS	O	patient	prep_of	15	SENT_151	[p9l655t2121r992b2221],
18	with	IN	O	with	_	0	SENT_151	[p9l1020t2120r1213b2199],
19	important	JJ	O	important	amod	20	SENT_151	[p9l1243t2121r1679b2221],
20	confounders	NNS	O	confounder	prep_with	17	SENT_151	[p9l1704t2120r2147b2199, p9l10t2274r157b2327],
21	.	.	O	.	_	0	SENT_151	[p9l1704t2120r2147b2199, p9l10t2274r157b2327],

1	Second	RB	ORDINAL	second	advmod	7	SENT_152	[p9l199t2248r528b2344],
2	,	,	O	,	_	0	SENT_152	[p9l199t2248r528b2344],
3	randomized	VBN	O	randomize	csubj	7	SENT_152	[p9l568t2248r1093b2327],
4	trials	NNS	O	trial	dobj	3	SENT_152	[p9l1127t2248r1348b2327],
5	have	VBP	O	have	aux	7	SENT_152	[p9l1385t2248r1576b2327],
6	largely	RB	O	largely	advmod	7	SENT_152	[p9l1608t2248r1902b2349],
7	compared	VBN	O	compare	_	0	SENT_152	[p9l1932t2274r2147b2327, p9l8t2376r253b2477],
8	drug	NN	O	drug	nn	9	SENT_152	[p9l297t2376r844b2477],
9	—	NN	O	—	dobj	7	SENT_152	[p9l297t2376r844b2477],
10	eluting	VBG	O	elute	xcomp	7	SENT_152	[p9l297t2376r844b2477],
11	stents	NNS	O	stent	nsubj	15	SENT_152	[p9l886t2393r1136b2455],
12	with	IN	O	with	_	0	SENT_152	[p9l1178t2376r1375b2455],
13	their	PRP$	O	they	poss	14	SENT_152	[p9l1418t2376r1624b2455],
14	thicl	NN	O	thicl	prep_with	11	SENT_152	[p9l1665t2376r2142b2472],
15	<	JJR	O	<	xcomp	10	SENT_152	[p9l1665t2376r2142b2472],
16	.	.	O	.	_	0	SENT_152	[p9l1665t2376r2142b2472],

1	—	NN	O	—	_	0	SENT_153	[p9l1665t2376r2142b2472],
2	.	.	O	.	_	0	SENT_153	[p9l1665t2376r2142b2472],

1	strut	NN	O	strut	nsubj	13	SENT_154	[p9l1665t2376r2142b2472],
2	,	,	O	,	_	0	SENT_154	[p9l1665t2376r2142b2472],
3	stainless	JJ	O	stainless	amod	8	SENT_154	[p9l11t2504r621b2583],
4	—	NN	O	—	nn	8	SENT_154	[p9l11t2504r621b2583],
5	steel	NN	O	steel	nn	8	SENT_154	[p9l11t2504r621b2583],
6	bare	JJ	O	bare	amod	8	SENT_154	[p9l663t2504r1380b2583],
7	—	NN	O	—	nn	8	SENT_154	[p9l663t2504r1380b2583],
8	metal	NN	O	metal	appos	1	SENT_154	[p9l663t2504r1380b2583],
9	—	CD	NUMBER	—	num	11	SENT_154	[p9l663t2504r1380b2583],
10	stent	NN	O	stent	nn	11	SENT_154	[p9l663t2504r1380b2583],
11	platforms	NNS	O	platform	dep	8	SENT_154	[p9l1416t2504r1864b2605],
12	,	,	O	,	_	0	SENT_154	[p9l1416t2504r1864b2605],
13	limiting	VBG	O	limit	_	0	SENT_154	[p9l1911t2504r2147b2583, p9l8t2633r145b2733],
14	generalizability	NN	O	generalizability	dobj	13	SENT_154	[p9l170t2632r827b2733],
15	.	.	O	.	_	0	SENT_154	[p9l170t2632r827b2733],

1	The	DT	O	the	det	2	SENT_155	[p9l858t2632r1016b2711],
2	development	NN	O	development	nsubj	16	SENT_155	[p9l1046t2632r1577b2733],
3	of	IN	O	of	_	0	SENT_155	[p9l1602t2632r1700b2711],
4	thin	JJ	O	thin	amod	14	SENT_155	[p9l1710t2632r2142b2728],
5	—	NN	O	—	nn	14	SENT_155	[p9l1710t2632r2142b2728],
6	strut	NN	O	strut	nn	14	SENT_155	[p9l1710t2632r2142b2728],
7	,	,	O	,	_	0	SENT_155	[p9l1710t2632r2142b2728],
8	cobalt	NN	O	cobalt	dep	14	SENT_155	[p9l10t2761r787b2840],
9	—	NN	O	—	nn	14	SENT_155	[p9l10t2761r787b2840],
10	chromium	NN	O	chromium	nn	14	SENT_155	[p9l10t2761r787b2840],
11	bare	JJ	O	bare	amod	14	SENT_155	[p9l826t2761r1293b2840],
12	—	NN	O	—	nn	14	SENT_155	[p9l826t2761r1293b2840],
13	metal	NN	O	metal	nn	14	SENT_155	[p9l826t2761r1293b2840],
14	stents	NNS	O	stent	prep_of	2	SENT_155	[p9l1333t2778r1583b2840],
15	has	VBZ	O	have	aux	16	SENT_155	[p9l1623t2761r1768b2840],
16	reduced	VBN	O	reduce	ccomp	38	SENT_155	[p9l1809t2761r2148b2840],
17	the	DT	O	the	det	18	SENT_155	[p9l10t2889r144b2968],
18	rate	NN	O	rate	dobj	16	SENT_155	[p9l177t2906r339b2968],
19	of	IN	O	of	_	0	SENT_155	[p9l373t2889r474b2969],
20	restenosis	NN	O	restenosis	nn	21	SENT_155	[p9l489t2890r987b2969],
21	.2	NN	NUMBER	.2	prep_of	18	SENT_155	[p9l489t2890r987b2969],
22	Thus	RB	O	thus	advmod	16	SENT_155	[p9l1018t2889r1255b2984],
23	,	,	O	,	_	0	SENT_155	[p9l1018t2889r1255b2984],
24	the	DT	O	the	det	25	SENT_155	[p9l1295t2889r1429b2968],
25	use	NN	O	use	nsubj	38	SENT_155	[p9l1463t2916r1605b2969],
26	of	IN	O	of	_	0	SENT_155	[p9l1639t2889r1740b2969],
27	a	DT	O	a	det	30	SENT_155	[p9l1754t2916r1799b2968],
28	historical	JJ	O	historical	amod	30	SENT_155	[p9l1831t2889r2147b2969, p9l21t3029r142b3108],
29	control	NN	O	control	nn	30	SENT_155	[p9l172t3029r479b3108],
30	group	NN	O	group	prep_of	25	SENT_155	[p9l507t3055r761b3130],
31	in	IN	O	in	_	0	SENT_155	[p9l792t3030r875b3107],
32	the	DT	O	the	det	33	SENT_155	[p9l905t3029r1038b3108],
33	study	NN	O	study	prep_in	30	SENT_155	[p9l1070t3029r1300b3130],
34	by	IN	O	by	_	0	SENT_155	[p9l1326t3029r1424b3130],
35	Marroquin	NNP	PERSON	Marroquin	prep_by	33	SENT_155	[p9l1446t3030r1916b3130],
36	et	FW	O	et	nn	37	SENT_155	[p9l1946t3046r2024b3108],
37	al.	FW	O	al.	dep	35	SENT_155	[p9l2048t3029r2145b3108],
38	makes	VBZ	O	make	_	0	SENT_155	[p9l20t3168r296b3248],
39	the	DT	O	the	det	40	SENT_155	[p9l333t3168r467b3247],
40	results	NNS	O	result	nsubj	44	SENT_155	[p9l502t3168r786b3247],
41	equally	RB	O	equally	advmod	42	SENT_155	[p9l824t3168r1134b3269],
42	difficult	JJ	O	difficult	dep	44	SENT_155	[p9l1165t3168r1521b3247],
43	to	TO	O	to	aux	44	SENT_155	[p9l1552t3185r1634b3247],
44	extrapolate	VB	O	extrapolate	xcomp	38	SENT_155	[p9l1670t3168r2150b3269],
45	to	TO	O	to	_	0	SENT_155	[p9l20t3323r102b3385],
46	contemporary	JJ	O	contemporary	amod	48	SENT_155	[p9l139t3323r747b3407],
47	clinical	JJ	O	clinical	amod	48	SENT_155	[p9l778t3306r1093b3385],
48	practice	NN	O	practice	prep_to	44	SENT_155	[p9l1126t3307r1489b3407],
49	.	.	O	.	_	0	SENT_155	[p9l1126t3307r1489b3407],

1	David	NNP	PERSON	David	nn	2	SENT_156	[p9l28t3455r269b3536],
2	Austin	NNP	PERSON	Austin	_	0	SENT_156	[p9l304t3460r612b3550],
3	,	,	O	,	_	0	SENT_156	[p9l304t3460r612b3550],
4	M.R.C.P.	NNP	O	M.R.C.P.	appos	2	SENT_156	[p9l656t3461r1029b3536],

1	Jill	NNP	PERSON	Jill	nn	3	SENT_157	[p9l7t3618r119b3722],
2	P.	NNP	PERSON	P.	nn	3	SENT_157	[p9l164t3626r232b3699],
3	Pe	NNP	PERSON	Pe	nsubj	4	SENT_157	[p9l276t3618r445b3713],
4	|	VBD	O	|	_	0	SENT_157	[p9l276t3618r445b3713],
5	|	CD	NUMBER	|	dobj	4	SENT_157	[p9l276t3618r445b3713],
6	,	,	O	,	_	0	SENT_157	[p9l276t3618r445b3713],
7	M.D.	NNP	O	M.D.	appos	5	SENT_157	[p9l490t3626r697b3699],

1	University	NNP	O	University	nn	5	SENT_158	[p10l24t32r362b107],
2	ofG	NNP	O	ofG	nn	5	SENT_158	[p10l384t26r759b108],
3	|	NN	O	|	nn	5	SENT_158	[p10l384t26r759b108],
4	asgow	NN	O	asgow	nn	5	SENT_158	[p10l384t26r759b108],
5	Glasgow	NNP	LOCATION	Glasgow	_	0	SENT_158	[p10l20t124r309b204],
6	G12	NN	O	g12	nn	7	SENT_158	[p10l332t128r462b184],
7	8RZ	NN	O	8rz	dep	5	SENT_158	[p10l488t128r640b195],
8	,	,	O	,	_	0	SENT_158	[p10l488t128r640b195],
9	United	NNP	LOCATION	United	nn	10	SENT_158	[p10l671t124r890b185],
10	Kingdom	NNP	LOCATION	Kingdom	appos	7	SENT_158	[p10l924t124r1221b204],

1	Keith	NNP	PERSON	Keith	nn	3	SENT_159	[p10l28t261r238b341],
2	G.	NNP	PERSON	G.	nn	3	SENT_159	[p10l277t266r368b341],
3	Oldroyd	NNP	PERSON	Oldroyd	_	0	SENT_159	[p10l406t261r782b366],
4	,	,	O	,	_	0	SENT_159	[p10l406t261r782b366],
5	M.D.	NNP	O	M.D.	nn	10	SENT_159	[p10l826t268r1033b340],
6	Western	NNP	O	Western	nn	10	SENT_159	[p10l17t410r294b465],
7	Infirmary	NNP	O	Infirmary	nn	10	SENT_159	[p10l328t404r637b484],
8	Glasgow	NNP	LOCATION	Glasgow	nn	10	SENT_159	[p10l20t500r309b580],
9	G11	NN	O	g11	nn	10	SENT_159	[p10l332t505r457b561],
10	6NT	NN	O	6nt	appos	3	SENT_159	[p10l486t505r640b571],
11	,	,	O	,	_	0	SENT_159	[p10l486t505r640b571],
12	United	NNP	LOCATION	United	nn	14	SENT_159	[p10l671t500r891b562],
13	Kingdom	NNP	LOCATION	Kingdom	nn	14	SENT_159	[p10l924t500r1221b580],
14	keith	NN	O	keith	appos	10	SENT_159	[p10l23t596r1424b676],
15	.	.	O	.	_	0	SENT_159	[p10l23t596r1424b676],

1	o	NN	O	o	nn	4	SENT_160	[p10l23t596r1424b676],
2	|	CD	NUMBER	|	num	4	SENT_160	[p10l23t596r1424b676],
3	droyd@northg	NN	O	droyd@northg	nn	4	SENT_160	[p10l23t596r1424b676],
4	|	NN	O	|	_	0	SENT_160	[p10l23t596r1424b676],
5	asgow	NN	O	asgow	dep	4	SENT_160	[p10l23t596r1424b676],
6	.	.	O	.	_	0	SENT_160	[p10l23t596r1424b676],

1	scot	NN	O	scot	_	0	SENT_161	[p10l23t596r1424b676],
2	.	.	O	.	_	0	SENT_161	[p10l23t596r1424b676],

1	nhs	NNS	O	nh	_	0	SENT_162	[p10l23t596r1424b676],
2	.	.	O	.	_	0	SENT_162	[p10l23t596r1424b676],

1	uk	NN	O	uk	_	0	SENT_163	[p10l23t596r1424b676],

1	Drs.	NNP	O	Drs.	nn	2	SENT_164	[p10l104t705r238b759],
2	Austin	NNP	PERSON	Austin	nsubj	5	SENT_164	[p10l270t701r489b760],
3	and	CC	O	and	_	0	SENT_164	[p10l520t701r640b759],
4	Pell	NNP	ORGANIZATION	Pell	conj_and	2	SENT_164	[p10l670t700r791b759],
5	report	NN	O	report	_	0	SENT_164	[p10l821t713r1027b776],
6	receiving	VBG	O	receive	xcomp	5	SENT_164	[p10l1054t701r1356b776],
7	research	NN	O	research	nn	8	SENT_164	[p10l1384t701r1663b759],
8	funding	NN	O	funding	dobj	6	SENT_164	[p10l1694t700r1961b776],
9	from	IN	O	from	_	0	SENT_164	[p10l1990t700r2151b759],
10	Boston	NNP	ORGANIZATION	Boston	nn	11	SENT_164	[p10l18t801r249b855],
11	Scientific	NNP	ORGANIZATION	Scientific	prep_from	8	SENT_164	[p10l292t796r620b868],
12	;	:	O	;	_	0	SENT_164	[p10l292t796r620b868],
13	and	CC	O	and	_	0	SENT_164	[p10l665t797r785b855],
14	Dr.	NNP	O	Dr.	nn	20	SENT_164	[p10l825t801r923b855],
15	Oldroyd	NNP	PERSON	Oldroyd	nn	20	SENT_164	[p10l969t796r1251b872],
16	,	,	O	,	_	0	SENT_164	[p10l969t796r1251b872],
17	speaking	VBG	O	speak	amod	15	SENT_164	[p10l1298t796r1599b872],
18	and	CC	O	and	_	0	SENT_164	[p10l1637t797r1758b855],
19	consulting	VBG	O	consult	nn	20	SENT_164	[p10l1800t797r2153b872],
20	fees	NNS	O	fee	conj_and	8	SENT_164	[p10l19t893r146b953],
21	from	IN	O	from	_	0	SENT_164	[p10l183t893r344b953],
22	Boston	NNP	ORGANIZATION	Boston	nn	23	SENT_164	[p10l380t898r611b953],
23	Scientific	NNP	ORGANIZATION	Scientific	prep_from	20	SENT_164	[p10l649t893r976b966],
24	,	,	O	,	_	0	SENT_164	[p10l649t893r976b966],
25	Medtronic	NNP	ORGANIZATION	Medtronic	prep_from	20	SENT_164	[p10l1015t893r1375b966],
26	,	,	O	,	_	0	SENT_164	[p10l1015t893r1375b966],
27	and	CC	O	and	_	0	SENT_164	[p10l1415t894r1536b953],
28	Cordis	NNP	ORGANIZATION	Cordis	prep_from	20	SENT_164	[p10l1573t894r1806b953],
29	.	.	O	.	_	0	SENT_164	[p10l1573t894r1806b953],

1	No	DT	O	no	det	4	SENT_165	[p10l1846t899r1941b953],
2	other	JJ	O	other	amod	4	SENT_165	[p10l1978t894r2153b953],
3	potential	JJ	O	potential	amod	4	SENT_165	[p10l18t989r311b1065],
4	conﬂict	NN	O	conﬂict	nsubjpass	12	SENT_165	[p10l335t989r588b1048],
5	of	IN	O	of	_	0	SENT_165	[p10l609t989r684b1048],
6	interest	NN	O	interest	prep_of	4	SENT_165	[p10l693t990r940b1048],
7	relevant	JJ	O	relevant	amod	6	SENT_165	[p10l959t990r1217b1049],
8	to	TO	O	to	_	0	SENT_165	[p10l1237t1002r1299b1048],
9	this	DT	O	this	det	10	SENT_165	[p10l1324t990r1444b1048],
10	letter	NN	O	letter	prep_to	7	SENT_165	[p10l1469t990r1639b1048],
11	was	VBD	O	be	auxpass	12	SENT_165	[p10l1657t1009r1779b1049],
12	reported	VBN	O	report	_	0	SENT_165	[p10l1804t989r2100b1065],
13	.	.	O	.	_	0	SENT_165	[p10l1804t989r2100b1065],

1	1	LS	NUMBER	1	_	0	SENT_166	[p10l21t1100r70b1151],
2	.	.	O	.	_	0	SENT_166	[p10l21t1100r70b1151],

1	Marroquin	NNP	O	Marroquin	nn	2	SENT_167	[p10l146t1093r506b1168],
2	OC	NNP	O	OC	_	0	SENT_167	[p10l533t1097r654b1164],
3	,	,	O	,	_	0	SENT_167	[p10l533t1097r654b1164],
4	Selzer	NNP	PERSON	Selzer	nn	5	SENT_167	[p10l687t1093r885b1151],
5	F	NN	O	f	appos	2	SENT_167	[p10l908t1098r961b1164],
6	,	,	O	,	_	0	SENT_167	[p10l908t1098r961b1164],
7	Mulukutla	NNP	O	Mulukutla	nn	8	SENT_167	[p10l990t1092r1336b1152],
8	SR	NN	O	sr	appos	2	SENT_167	[p10l1364t1097r1466b1164],
9	,	,	O	,	_	0	SENT_167	[p10l1364t1097r1466b1164],
10	et	FW	O	et	nn	11	SENT_167	[p10l1498t1105r1558b1151],
11	al.	FW	O	al.	appos	2	SENT_167	[p10l1580t1093r1656b1151],
12	.	.	O	.	_	0	SENT_167	[p10l1580t1093r1656b1151],

1	A	DT	O	a	det	2	SENT_168	[p10l1684t1098r1734b1150],
2	comparison	NN	O	comparison	_	0	SENT_168	[p10l1759t1093r2151b1168],
3	of	IN	O	of	_	0	SENT_168	[p10l20t1188r96b1247],
4	bare	JJ	O	bare	amod	6	SENT_168	[p10l114t1189r471b1247],
5	—	NN	O	—	nn	6	SENT_168	[p10l114t1189r471b1247],
6	metal	NN	O	metal	prep_of	2	SENT_168	[p10l114t1189r471b1247],
7	and	CC	O	and	_	0	SENT_168	[p10l502t1188r623b1247],
8	drug-eluting	JJ	O	drug-eluting	amod	9	SENT_168	[p10l655t1188r1073b1264],
9	stents	NNS	O	stent	prep_of	2	SENT_168	[p10l1103t1201r1295b1247],
10	for	IN	O	for	_	0	SENT_168	[p10l1328t1188r1423b1247],
11	off	RB	O	off	quantmod	12	SENT_168	[p10l1452t1188r1728b1247],
12	—	CD	NUMBER	—	num	14	SENT_168	[p10l1452t1188r1728b1247],
13	label	NN	O	label	nn	14	SENT_168	[p10l1452t1188r1728b1247],
14	indications	NNS	O	indication	prep_for	2	SENT_168	[p10l1758t1188r2147b1247],
15	.	.	O	.	_	0	SENT_168	[p10l1758t1188r2147b1247],

1	N	NN	O	n	nn	2	SENT_169	[p10l17t1290r74b1343],
2	EnglJ	NN	O	englj	nsubj	3	SENT_169	[p10l98t1285r293b1360],
3	Med	VBD	O	med	_	0	SENT_169	[p10l315t1285r458b1343],
4	2008	CD	DATE	2008	dobj	3	SENT_169	[p10l484t1289r1041b1356],
5	;	:	O	;	_	0	SENT_169	[p10l484t1289r1041b1356],
6	358:342	CD	NUMBER	358:342	number	7	SENT_169	[p10l484t1289r1041b1356],
7	—	CD	NUMBER	—	dep	4	SENT_169	[p10l484t1289r1041b1356],
8	52	CD	NUMBER	52	dep	7	SENT_169	[p10l484t1289r1041b1356],
9	.	.	O	.	_	0	SENT_169	[p10l484t1289r1041b1356],

1	2	LS	NUMBER	2	_	0	SENT_170	[p10l18t1388r70b1439],
2	.	.	O	.	_	0	SENT_170	[p10l18t1388r70b1439],

1	Tung	NNP	PERSON	Tung	nn	2	SENT_171	[p10l146t1385r316b1456],
2	R	NNP	PERSON	R	_	0	SENT_171	[p10l339t1385r405b1452],
3	,	,	O	,	_	0	SENT_171	[p10l339t1385r405b1452],
4	Kaul	NNP	PERSON	Kaul	nn	5	SENT_171	[p10l434t1381r586b1441],
5	S	NNP	O	S	appos	2	SENT_171	[p10l613t1385r665b1452],
6	,	,	O	,	_	0	SENT_171	[p10l613t1385r665b1452],
7	Diamond	NNP	ORGANIZATION	Diamond	nn	8	SENT_171	[p10l694t1381r1002b1439],
8	GA	NNP	ORGANIZATION	GA	appos	2	SENT_171	[p10l1028t1385r1149b1452],
9	,	,	O	,	_	0	SENT_171	[p10l1028t1385r1149b1452],
10	Shah	NNP	PERSON	Shah	nn	11	SENT_171	[p10l1181t1380r1341b1439],
11	PK	NNP	O	PK	appos	2	SENT_171	[p10l1367t1385r1473b1441],
12	.	.	O	.	_	0	SENT_171	[p10l1367t1385r1473b1441],

1	Drug-eluting	JJ	O	drug-eluting	amod	2	SENT_172	[p10l1502t1381r1933b1456],
2	stents	NNS	O	stent	_	0	SENT_172	[p10l1958t1393r2149b1439],
3	for	IN	O	for	_	0	SENT_172	[p10l19t1476r114b1535],
4	the	DT	O	the	det	5	SENT_172	[p10l137t1477r238b1535],
5	management	NN	O	management	prep_for	2	SENT_172	[p10l263t1489r698b1552],
6	of	IN	O	of	_	0	SENT_172	[p10l719t1476r796b1535],
7	restenosis	NN	O	restenosis	prep_of	5	SENT_172	[p10l806t1477r1156b1535],
8	:	:	O	:	_	0	SENT_172	[p10l806t1477r1156b1535],
9	a	DT	O	a	det	11	SENT_172	[p10l1183t1496r1217b1535],
10	critical	JJ	O	critical	amod	11	SENT_172	[p10l1241t1476r1470b1535],
11	appraisal	NN	O	appraisal	dep	2	SENT_172	[p10l1494t1477r1797b1552],
12	of	IN	O	of	_	0	SENT_172	[p10l1822t1476r1898b1535],
13	the	DT	O	the	det	14	SENT_172	[p10l1909t1477r2011b1535],
14	evidence	NN	O	evidence	prep_of	11	SENT_172	[p10l2037t1477r2150b1536, p10l20t1573r225b1633],
15	.	.	O	.	_	0	SENT_172	[p10l2037t1477r2150b1536, p10l20t1573r225b1633],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_173	[p10l253t1579r392b1632],
2	Intern	NNP	O	Intern	nn	3	SENT_173	[p10l418t1579r621b1633],
3	Med	NNP	O	Med	_	0	SENT_173	[p10l645t1574r787b1633],
4	2006	CD	DATE	2006	num	3	SENT_173	[p10l813t1578r1336b1646],
5	;	:	O	;	_	0	SENT_173	[p10l813t1578r1336b1646],
6	144:913	CD	NUMBER	144:913	number	7	SENT_173	[p10l813t1578r1336b1646],
7	—	CD	NUMBER	—	dep	3	SENT_173	[p10l813t1578r1336b1646],
8	9	CD	NUMBER	9	dep	7	SENT_173	[p10l813t1578r1336b1646],
9	.	.	O	.	_	0	SENT_173	[p10l813t1578r1336b1646],

1	To	TO	O	to	dep	18	SENT_174	[p10l18t1858r130b1914],
2	THE	DT	O	the	det	3	SENT_174	[p10l160t1859r325b1913],
3	EDITOR	NN	O	editor	pobj	1	SENT_174	[p10l363t1858r701b1914],
4	:	:	O	:	_	0	SENT_174	[p10l363t1858r701b1914],
5	Despite	IN	O	despite	_	0	SENT_174	[p10l736t1836r1058b1936],
6	the	DT	O	the	det	8	SENT_174	[p10l1091t1835r1225b1914],
7	careful	JJ	O	careful	amod	8	SENT_174	[p10l1258t1835r1558b1914],
8	nature	NN	O	nature	prep_despite	18	SENT_174	[p10l1591t1852r1868b1914],
9	of	IN	O	of	_	0	SENT_174	[p10l1902t1835r2003b1914],
10	the	DT	O	the	det	11	SENT_174	[p10l2017t1835r2151b1914],
11	article	NN	O	article	prep_of	8	SENT_174	[p10l19t1963r287b2042],
12	by	IN	O	by	_	0	SENT_174	[p10l332t1963r429b2064],
13	Marroquin	NNP	PERSON	Marroquin	prep_by	11	SENT_174	[p10l464t1964r934b2064],
14	and	CC	O	and	_	0	SENT_174	[p10l976t1963r1134b2042],
15	colleagues	NNS	O	colleague	conj_and	13	SENT_174	[p10l1178t1963r1652b2064],
16	,	,	O	,	_	0	SENT_174	[p10l1178t1963r1652b2064],
17	we	PRP	O	we	nsubj	18	SENT_174	[p10l1696t1990r1814b2043],
18	believe	VBP	O	believe	_	0	SENT_174	[p10l1858t1963r2150b2043],
19	there	EX	O	there	expl	20	SENT_174	[p10l20t2091r234b2170],
20	are	VBP	O	be	ccomp	18	SENT_174	[p10l263t2117r390b2170],
21	some	DT	O	some	det	22	SENT_174	[p10l421t2117r643b2170],
22	drawbacks	NNS	O	drawback	nsubj	20	SENT_174	[p10l673t2091r1145b2171],
23	.	.	O	.	_	0	SENT_174	[p10l673t2091r1145b2171],

1	First	RB	ORDINAL	first	advmod	5	SENT_175	[p10l1179t2092r1390b2187],
2	,	,	O	,	_	0	SENT_175	[p10l1179t2092r1390b2187],
3	the	DT	O	the	det	4	SENT_175	[p10l1426t2091r1557b2170],
4	patients	NNS	O	patient	nsubj	5	SENT_175	[p10l1585t2092r1920b2192],
5	were	VBD	O	be	_	0	SENT_175	[p10l1947t2117r2150b2170],

1	2516	CD	DATE	2516	num	4	SENT_176	[p10l149t2267r226b2291],
2	N	NN	O	n	nn	4	SENT_176	[p10l935t2278r948b2293],
3	ENGLJ	NN	O	englj	nn	4	SENT_176	[p10l963t2278r1041b2300],
4	MED35	NN	O	med35	_	0	SENT_176	[p10l1056t2278r1142b2300],
5	;	:	O	;	_	0	SENT_176	[p10l1160t2278r1180b2298],
6	2	CD	NUMBER	2	num	7	SENT_176	[p10l1160t2278r1180b2298],
7	www	NN	O	www	dep	4	SENT_176	[p10l1226t2278r1428b2300],
8	.	.	O	.	_	0	SENT_176	[p10l1226t2278r1428b2300],

1	NEJM	NNP	ORGANIZATION	NEJM	nn	4	SENT_177	[p10l1226t2278r1428b2300],
2	,	,	O	,	_	0	SENT_177	[p10l1226t2278r1428b2300],
3	oRG	NNP	O	oRG	appos	4	SENT_177	[p10l1226t2278r1428b2300],
4	JUNE5	NNP	O	JUNE5	_	0	SENT_177	[p10l1459t2278r1551b2300],
5	,	,	O	,	_	0	SENT_177	[p10l1459t2278r1551b2300],
6	2008	CD	DATE	2008	appos	4	SENT_177	[p10l1562t2272r1625b2294],

1	The	DT	O	the	det	4	SENT_178	[p10l936t2311r987b2335],
2	New	NNP	O	New	nn	4	SENT_178	[p10l996t2312r1058b2335],
3	Englan	NNP	O	Englan	nn	4	SENT_178	[p10l1067t2311r1161b2342],
4	ournal	NN	O	ournal	_	0	SENT_178	[p10l1200t2311r1284b2335],
5	of	IN	O	of	_	0	SENT_178	[p10l1294t2311r1323b2335],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_178	[p10l1330t2311r1455b2335],

